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Abstract
Serine and cysteine proteases are potently inhibited by peptide aldehydes. 
Compared to the plethora of methods available for the solution synthesis of peptide 
aldehydes, there are relatively few methods for the solid phase synthesis of peptide 
aldehydes. The development of novel linkers 234/296 for the solid phase synthesis 
of peptide aldehydes is reported (Scheme 1). When X = NH, 234 the aldehyde 171 
can be cleaved with mild acid in >97% enantiomeric excess. When X = O, 296 base 
hydrolysis results in aldehyde 173 cleavage with complete epimerisation of the cc- 
stereocentre of the aldehyde. The use of Mucor javanicus lipase and Penicillin 
acylase generates the aldehyde 171 in 18 and 31% yield respectively, with complete 
retention of chiral integrity (>99%). The utility of the linkers 234/296 was 
demonstrated by the solid phase synthesis of a tetrapeptide aldehyde.
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The following symbols have been used as abbreviations for general types of 
solid supports.
O c unspecified resin
polystyrene 1% crosslinked with DVB
macroporous polystyrene
Tentagel
Polymer lab PEGA^oo resin
Controlled pore glass
Some of the resins which have been used in the experimental section of this 
thesis are illustrated below;
Amino-methyl polystyrene: The polystyrene resin was based on copoly(styrene-l% 
divinylbenzene).
Amino-Tentagel: The Novasyn® TentaGel resin was based on a composite of low- 
cross linked polystyrene and polyethylene glycol which had been terminally 
functionalized with amino groups.
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Enzymatic methods have many advantages over classical chemical techniques 
because enzyme catalysed transformations proceed under very mild conditions (pH5- 
8, 25-37 °C) and with striking chemo-, regio-, and stereoselectivity. Hydrolytic 
enzymes catalyse the cleavage of C-O, C-N and C-C bonds and some other bonds 
including phosphoric anhydride bonds. 1 Hydrolytic enzymes are the most useful 
enzymes for synthesis because of their versatility and ease of use.
1. 1. 1 Role and action of Penicillin acylase
Penicillin acylase (EC 3.5.1.11) from Escherichia coli (ATCC 9637) is a serine 
type enzyme, which catalyses the hydrolysis of penicillin G to 6-aminopenicillanic 




Scheme 2: Reagents and conditions: i. Penicillin G acylase.
Penicillin acylase is a heterodimeric protein consisting of a small a subunit 
and a large p subunit. The catalytic nucleophile, a serine, is found at the TV-terminus, 
which is characteristic of the family of JV-terminal-nucleophilic hydrolases. The
f\
catalytic domain is constructed exclusively from the p chain and is situated at the 
base of a large cavity whose walls are mostly formed by the p chain. This cavity 
contains a hydrophobic pocket which is lined with a number of aromatic residues and 
hydrophobic side chains. This renders the enzyme highly specific for the 
phenylacetyl group of penicillin G. Figure 1 shows the structure of penicillin acylase 
with penicillin G in the active site.
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Figure 1: Structure of Penicillin acylase with penicillin G in the active site. 3
The mechanism of hydrolysis is based on a 'catalytic triad' composed of 
aspartate, histidine and serine (Scheme 3). Initially, a covalent O-acyl intermediate 
is formed, which is de-acetylated with water in the second step.
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O
Scheme 3: Mechanism of penicillin acylase catalysed formation ofO-acyl intermediate.
Penicillin acylase has been successfully employed in organic synthesis for the 
cleavage of N- or (9-phenylacetyl protecting group from amino acids, peptides, 
amines, alcohols and sugars.4'5 In general, the enzyme accepts substrates with stereo- 
structures related to L-amino acids 1 (Figure 2).
A = CONH2 , CO2 R, CH2CO2H, (CH2)nCO2H (n = 0-2) 
B = alkyl groups
Figure 2: Preferred stereoisomer for penicillin acylase hydrolysis.
1.1.2 Role and action of Upases and hemiaminalases
Lipases and esterases are serine hydrolases that catalyse the hydrolysis and 
synthesis of water insoluble long chain triglycerides and small partially water soluble 
esters, respectively. The active site of lipases is characterised by a triad made up of
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serine, histidine and aspartate/glutamate6 and is similar to that found in serine 
proteases (Scheme 3). Unlike esterases, lipases display little activity in aqueous 
solutions with soluble substrates. A sharp increase in activity is observed when the 
substrate concentration is increased beyond its critical micellular concentration 







Figure 3: Interfacial activation of lipases.
In addition, most lipases possess a helical oligopeptide unit that shields the 
active site, termed a 'lid'. This 'lid' 8 , upon contact with a hydrophobic interface, 
moves away to expose the active site providing access for the substrate. It should be 
noted however, that not all lipases contain a 'lid' or show interfacial activation.6
1.1.3 The use of//pases/esferases in organic synthesis
Lipases and esterases are the most commonly used enzymes in synthetic 
organic chemistry, catalyzing the chemo-, regio- and/or stereoselective hydrolysis of 
carboxylic acid esters or the reverse reaction in organic solvents6'9' 10 (Scheme 4).
RC0 2 H + R'OH J-'pase * RC02 R' + H 20 
Scheme 4: Reversible lipase/esterase catalysed reactions.
Lipases and esterases have been widely applied to the preparation of 
enantiopure compounds from racemic mixtures, prochiral or /w&so-compounds, or
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diastereomeric mixtures.6 In kinetic resolutions, theoretical yields are limited to 50% 
because the enzyme only hydrolyses one enantiomer of the racemic starting material. 
This limits the applicability of enzymes to organic synthesis; however, the advent of 
dynamic kinetic resolution has overcome this problem. Dynamic kinetic resolution 







OH  O R3 OH
1
in situ racemization 
Scheme 5: Dynamic kinetic resolution. 1
In addition, lipases/esterases have been utilized for the mild, selective removal
of protecting groups from amines 11 and alcohols etc. 12 These are described in several
4 *5 n reviews. ' '
1.2 Biocatalysis in polymer-supported synthesis/hydrolysis
In classical organic synthesis, enzymes have been used for many years for a 
wide variety of chemical transformations, yet their application to solid phase 
synthesis has been limited. 14 In order for a reaction to occur in polymer matrices, 
swelling and diffusion of solvents and reagents into the polymer matrix needs to 
prevail, before a reaction can take place. It is now accepted that polymer supports 
should be treated as solvents in which the reactions are performed15, rather than as 
inert solid supports. Therefore, the choice of polymer support is crucial to the 
success of enzyme hydrolysis on solid support. Enzyme hydrolysis is usually 
performed in aqueous media, which considerably limits the suitability of the 
available solid supports. The types of resin suitable for enzymatic transformations 
fall into three broad categories:
  Swelling resins that allow penetration by the enzyme.
  Non-swelling resins where reaction occurs at a functionalized surface.
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• Soluble resins where the enzymatic transformation occurs in solution and 
the resin is precipitated at the end of the reaction.
Enzyme catalysis on solid supported substrates is attracting interest for various 
applications: e.g. chemo-enzymatic synthesis on solid supports, 16' 17 'on-bead' 
screening for enzyme substrates or inhibitors, 18 enzyme cleavable protecting groups 
in solid phase chemistry4 and enzyme cleavable linkers for release of polymer bound 
substrates. 19 Several reviews have been published that deal with polymer supported 
enzyme transformations; although, these focus on enzyme cleavable linkers in 
polymer supported synthesis. 14' 19 '20 The purpose of the following review is to 
provide a more complete picture of the literature, covering general polymer- 
supported enzymatic transformations.
1.2.1 Chemo-enzymatic synthesis on solid supports
1.2.1.1 Swelling resins
The first application of beaded polyethylene glycol polyacrylamide copolymer 
(PEGAigoo) as a solid support for the chemo-enzymatic synthesis of glycopeptides
1 7 _ _
was reported by Meldal et. al (Scheme 6). The glycopeptide, was anchored to 
PEGAi9oo via an acid labile linker 1. Treatment of 1, with bovine P-(1,4)- 
galactosyltransferase (50 kDa) and UDP-Gal for 48 hours, afforded glycopeptide 2 in 
95% yield, after acid cleavage. It was discovered that pre-incubation of 1 with 
enzyme and buffer for 3 days at 4 °C before addition of UDP-Gal gave >90% 
conversion in 6 hours. Therefore, it was proposed that the extended reaction time 
(48 h) was probably needed for the polyethylene glycol (PEG)-polymer to refold 
around the protein, allowing it to move around inside the gel-like resin and access all 
the reaction sites.
Similar synthesis experiments carried out using a more highly crosslinked 
PEGAi900/300 resin resulted in only 50% conversion of 1 after 72 hours. This
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Scheme 6: Reagents and conditions: i. bovine p-(l,4)glycosyltransferase, UDP-Gal, buffer pH 7.4, 
23 °C, 48 h, 95%; ii. 95% TFA/H2O, 23 °C, 2 h.
In 1998, Blixt and Norberg21 utilized a sepharose 6B matrix for the enzymatic 
synthesis of a sialyl Lewis X tetrasaccharide 5 (Scheme 7). Sepharose 6B is an 
agarose based gel matrix which swells in aqueous media and is permeable to large 
biomolecules. One drawback is that sepharose 6B is unstable in organic solvents, 
and thus, it is unsuitable for chemical synthesis. Enzymatic glycosylation of 4 with 
galactosyl-, sialyl- and fucosyltransferase afforded sepharose bound tetrasaccharide
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5, after cleavage from Sepharose with dithiothreitol (DTT) (in 57% overall yield). 
Linkers of various lengths, n, were tested to optimize the galactosylation with 
galactosyltransferase. A clear correlation between linker length, n, and yield was 








H H OH OH
Scheme 7: Reagents and conditions: i. cacodylate, MnCk, TritonX, pH 7.5, 0-1,4- 
galactosyltransferase, alkaline phosphatase, a-lactalalbumin, UDP-Gal, 37 °C, 5 d, when n = 3, 98%; 
ii. buffer pH 7.45, oc-2,3-sialyltransferase, CMP-Neu5Ac, alkaline phosphatase, 5 d, when n = 3, 75%; 




Nishimura and Yamada introduced the use of ceramide glycanase for the 
synthesis of ganglioside GM3, 9 (Scheme 8). Radical polymerization of 6, generated 
the water-soluble polyacrylamide bound glycopolymer 7. Ganglioside 9, was 
synthesized by sialylation of 7 with sialyltransferase, followed by transglycosylation 






Scheme 8: Reagents and conditions: i. acrylamide, TEMED, ammonium peroxodisulfate, DMSO- 
H2O, 50 °C, 48 h; ii. CMP-NeuAc, sialyltransferase, BSA, MnCl2, CIAP, sodium cacodylate buffer 




Halcomb et. al. have utilized glycosyltransferases for the solid phase synthesis 
of a tetrasaccharide, 12 (Scheme 9). A disaccharide primer was attached to 
controlled pore glass via an ester spacer group to give 10. Enzymatic glycosylation 
was carried out with UDP-Gal and p-l,4-galactosyltransferase to afford trisaccharide 
11, which was sialylated using a-sialyltransferase. Subsequent cleavage with
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hydrazine hydrate gave tetrasaccharide 12 in >98% yield. No details were given 






Scheme 9: Reagents and conditions: i. p-(l,4)-galactosyltransferase, UDP-Gal, DTT, HEPES buffer 
pH 7.2, MnCl2, 48 h; ii. a-sialyltransferase, CMP-NeuAc, DTT, Triton-X, alkaline phosphatase, BSA, 
buffer pH 7.5, 48 h; iii. hydrazine monohydrate, r.t., 24 h.
1.2.2 'On bead' screening for enzyme substrates or inhibitors
Resins suitable for solid-phase enzymatic synthesis are often also useful for the 
solid-phase screening of enzyme substrates/inhibitors.
1.2.2.1 Swelling resins
The limited accessibility of enzymes to the interior of polymer beads was 
exploited in the generation and screening of encoded combinatorial peptide libraries. 
Barany et. at. 24 used the different physical characteristics of the 'surface' and 
'interior' of TentaGel resin to selectively cleave short TV-protected peptide substrates 
with chymotrypsin (22 kDa), from the surface area only, ('shaving') (Scheme 10). 
The interior sites were left uncleaved to give 14. Chymotrypsin shaving saturated at 
2-2.5% of the total sites, whereas elastase or pepsin access 10-15% of the sites. It
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was also found that increased exposure to the enzyme did not increase the amount 
shaved. Fmoc-chemistry was utilized to attach the first residue 15. Subsequent 
elaboration of the interior sites using orthogonal Boc chemistry generated the code 
structure. Repetition of this process furnished a surface peptide, which was encoded 
internally 16. Biological screening was carried out with different receptors (anti-p- 
endorphin antibody (170 kDa), streptavidin (60 kDa) and thrombin (35 kDa)) to 
reveal the active species on the surface areas, and sequencing of the beads thus 
identified gave the corresponding interior coding structures. These coding structures 
were used to deduce the binding structures of the surface active species. This 
screening method led to the discovery of a new thrombin ligand Arg-Gly-Arg-Pro-o- 








2. Coupling of Boc-CFmoc—S—P 1






Scheme 10: 'Shaving' experiments on TentaGelresin.




Bradley et. at. 25 performed experiments to compare resin and solution screening 
methodologies in combinatorial chemistry. This was achieved by the preparation of 
three identical polyarnine peptide libraries; one in solution and the other two were 
resin-based (PEGA 17 and TentaGel 18) (Figure 4). All three libraries were assayed 
for inhibition of the enzyme, trypanothione reductase (55 kDa). In the case of the 
TentaGel-based library 18, no reduction in activity of the enzyme was observed. 
However, screening of PEGA resin library 17 was successful and inhibitors of 
trypanothione reductase were identified. Most importantly, there was good 






17: P = PEGA 
18: P = TentaGel
Figure 4: Polyamine libraries on PEGA 17 and TentaGel 18 resins.
In 1994, Meldal et. at. 26 described a solid phase assay for the complete subsite 
mapping of the active site of endoproteases. Kieselguhr-supported 
polydimethylacrylamide and PEGA resins were used as solid supports for the 
synthesis of a library of protease substrates. 0-aminobenzamide (Abz) and 3- 
nitrotyrosine (Y(NO2) were used as donor-acceptor pairs for the visualisation of 
internally quenched substrates by fluorescence resonance energy transfer (FRET) 
analysis. The Abz group can be observed visually in the absence of 3-nitrotyrosine, 
whereas peptides containing both donor and acceptor are quenched and appear dark 
under a fluorescence microscope. Peptide synthesis was performed and the 
permeability of the resin was studied using subtilisin Carlsberg (27 kDa) on the 
model substrate, [Y(NO2)FQPLDEK(Abz)] bound to PEGA resin 19 (Figure 5). It 
was found that upon addition of the enzyme to the beads containing the model 
substrate 19, a clear blue ring formed rapidly at the periphery of substrate-containing 
beads, 20. Within 1 hour, the beads were completely illuminated and peptide
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Introduction
sequencing showed the substrate to be 80% cleaved, 21. After 24 hours, the cleavage 
was quantitative, 22 indicating the complete permeability of the PEGA resin. The 
PEGA resin contained a high content of polyethylene glycol, however the molecular 
weight of the resin was not specified.
Similar results were obtained with the kieselguhr-supported model substrate.26 
This assay allowed for determination of the substrate preferences for subtilisin 
Carlsberg and the result was compared with data from kinetic studies in solution. 
Although there were discrepancies between the assay on solid phase and in solution, 
which may be due to the differences in the micro-environment and dynamic 
properties of the substrates; the ranking of substrates in solution and solid phase was 
identical. Therefore, the influence of the solid support on the substrate preference of 
the enzyme was small enough to allow for the design of substrates using this assay.
19 20 21 22 
[Y(NO2)FQPLDEK(Abz)J
Figure 5: Visualisation of PEGA resin under a fluorescence microscope after treatment with 
subtilisin Carlsberg; i. addition of subtilisin Carlsberg; ii. 2 h later (80% cleaved); iii. 24 h later 
(quantitative cleavage).
T7
Meares et. al. have also successfully employed the internally quenched 
fluorescence donor/acceptor pairs (Abz/Y(NO2) for the FRET-based visualisation of 
substrates for endoproteases, cathepsin B and D (52 and 56 kDa), bound to PEGAgoo 
resin.
O2
Balasubramanian et. al. have developed a combinatorial screening method for 
identifying substrates for protein tyrosine phosphatases (PTP) (35 kDa) (Scheme 11). 
Phosphotyrosyl peptides were synthesised on amino-functionalised resin using Fmoc 
chemistry. Near quantitative dephosphorylation of the resin bound peptide 23 was 
achieved on Kieselguhr and PEGA resin with leukocyte antigen receptor (LAR) PTP, 
compared to less than 2% with TentaGel resin. Gel filtration studies showed that the 
size exclusion limit of TentaGel was below 14 kDa. The screening strategy is
13
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illustrated in Scheme 11. A phosphopeptide library is synthesized in which the 
phosphotyrosyl (pY) position was doped with glycine to form the encoding strand. 
Dephosphorylation was carried out by incubation with LAR FTP to afford tyrosine 
peptides 24. Subsequent treatment with a-chymotrypsin, selectively cleaved the 
dephosphorylated peptides. Coupling of a chromogenic probe, such as 
carboxyfluorescein to 25 allowed for isolation of the active substrate 26 which was 








chromogenic probe H9 N
Remove Fmoc, isolate 'hits' and decode
Scheme 11: Reagents and conditions: i. leukocyte antigen receptor (LAR) phosphatase, HEPES (pH 
7.4), NaCl, DTT; ii. Chymotrypsin, Tris-HCl pH 8.0, NaCl; iii. Carboxyfluorescein, 
pyBOP/HOBt/DIPEA.
Burger and Bartlett29 have synthesized an analogue of trypsin inhibitor 
A90720A, 28 by trypsin mediated macrocyclisation on PEGA resin 27 (Scheme 12). 
Analysis of the product mixture revealed a 1:1 mixture of cyclised product 28 to 
hydrolysis product 29. Only a small amount of precursor 30 was obtained, indicating 
that most of the material on 27 was accessible to the enzyme. When similar 
enzymatic cyclisations were attempted with TentaGel resin, no products from 


























Scheme 12: Reagents and conditions: i. trypsin, 30:30:40 DMF/ethanol/pH 6.5 Tris buffer; ii. 
Photolysis.
Fluorescence resonance energy transfer (FRET) analysis has also been 
employed in the screening of peptide libraries for the identification of substrates for 
proteolytic enzymes, E. coli Leader peptidase (37 kDa) and Napsin A (38 kDa)30 
(Scheme 13). Lucifer yellow was used as the fluorescent donor and Dabsyl, as 
fluorescent quenching acceptor. The peptide library was synthesized on PEGAi 9oo 
resin. When the beads 31 are incubated with a protease, the enzyme cleaves its 
preferred substrate sequence and liberates the quencher 32 from those peptides into 
solution. The beads carrying a cleaved substrate 33 become fluorescent and can be 
detected under a fluorescent microscope among the quenched and therefore dark 
beads. The fluorescent beads 33 are collected and sequenced by Edman degradation.
15
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Dabsyl I x^ PEGA1900 




P1 quenched by FRET
Dabsyl f" PEGA1900 
KT-SX 1 X2X3A + x4 -E-Lucifer yellow
32 P1 r 33
Fluorescent bead
Scheme 13: Reagents and conditions: i. E. coli leader peptidase, Tris-HCl buffer pH 7.4, MgCl2, 
Triton X-100, glycerol. Black arrow indicates site of cleavage. X represents all possible 
combinations of the 19 natural amino acids. Abbreviations for the amino acid residues are as 
follows: K = Lys, T = Thr, A = Ala, S = Ser, E = Glu, G = Gly, P = Pro.
Meldal et. al. 31 have described the synthesis of high molecular weight PEGAeooo 
resins and their use as solid supports for identification of substrates for matrix 
metalloproteinase (MMP-9, 67/83 kDa). PEGAeooo bound peptide libraries (general 
formula; XXY(NO2)XXXXXXK(Abz)PPPM-PEGA60oo, where X represents 20 
amino acids except cysteine) were synthesized with o-aminobenzamide (Abz) and 3- 
nitrotryrosine as the fluorescent donor-acceptor pair for visualization by fluorescence 
microscopy. Treatment of the resin bound peptide libraries with MMP-9 at 37 °C for 
40 h resulted in fluorescent beads which could be separated from the non-fluorescent 
beads and subsequent peptide sequencing carried out to determine the preferred 
substrate sequences for MMP-9.
Buchardt et. al. 32 have screened a solid phase library of 165,000 phosphinic 
peptide inhibitors for activity against MMP-12. The library was assembled on 
PEGAi9oo resin as a one-bead-two compound library 34 and every bead contained a 
common quenched fluorogenic substrate and a different inhibitor (Figure 6). When 
MMP-12 (22 kDa) enters one of these beads, competition occurs between the 
substrate and inhibitor: the stronger the inhibitor present on a specific bead, the less
16
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substrate is cleaved. A bead containing a poor inhibitor would allow the enzyme to 
cleave the quenched fluorogenic substrate and the bead would light up when viewed 
under a fluorescence microscope. Therefore, the darkest beads were selected and 
irradiated with a Hg lamp, which released the inhibitor from the photolabile linker. 















Figure 6: Structure of the one-bead-two compounds solid phase library 34 for the screening of 
phosphinic peptide inhibitors of MMP-12. X represents arbitrary a-amino acids.
Meldal et. a/. 33 '34 have also used one-bead-two compound fluorescent inhibitor 
assays, for the successful identification of inhibitors of cysteine proteases from 
Leishmania mexicana CPB2.8ACTE and cruzipain (57kDa). In the first paper,33 the 
inhibitor assay was bound to PEGA^oo resin and in the second paper,34 PEGAipoo 
resin was used as the solid support. It was found that cruzipain could not penetrate 
into the interior of the PEGAigoo beads to enable complete cleavage of the substrate 
from solid support.
In 1998, Leon et. al. 35 studied the compatibility of TentaGel, ArgoGel and 
PEG A, in the screening of papain (23 kDa) activity towards peptide substrates. 
ArgoGel displays similar characteristics to TentaGel but swells more extensively 
than TentaGel in aqueous environments, owing to a higher polyethylene glycol 
(PEG) content. It was therefore expected that ArgoGel might offer greater 
accessibility to biomolecules. The three sets of beads, 35-37 were treated with 
papain in pH 6.6 buffer for 1 hour, and examined by fluorescence microscopy. In the
17
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case of PEGA bound peptide 35, significant reduction in the fluorescence of the 
beads was observed (Figure 7). Peptide sequencing confirmed near quantitative 
cleavage of 35. This indicated that the interior of the PEGA beads was freely 
accessible to biomolecules such as papain. This is in agreement with the results 
obtained by Meldal et. al. 11 '26 In contrast, TentaGel and ArgoGel substrates, 36 and 
37, only afforded low levels of hydrolysis even after prolonged treatment with 
papain. Additionally, the subsite specificities of papain and chymotrypsin (22 kDa) 
was determined using PEGA-bound peptide libraries. Unfortunately, no details were 
given on the molecular weight of PEGA and therefore, the length of PEG chain 





35; P = PEGA 
36; P = TentaGel 
37; P = ArgoGel 
NMe2
Figure 7: Resin bound peptide substrates 35-37 labeled with dansyl fluorophore, showing the 
expected site of cleavage by papain.
St Hilaire et. al. 36 have also used PEGA resin for the mapping of substrate 
specificities of papain, a cysteine protease. PEGA^oo resin was chosen due to its 
large pore size and proven success with biocatalysts. 31 Internally quenched 
fluorescent peptide libraries were synthesized with the general structure 38 shown in 
Figure 8. The libraries were incubated with papain for 2.5 h at 25 °C, and the beads 
were examined under a UV light to identify fluorescent beads. Subsequent 
sequencing of the fluorescent beads, by Edman degradation, afforded the peptide 
sequence. The best substrate was Y(NO2)PMPPLCTSMK(Abz), which afforded 









Abz base labile linker
H2N-Y(NO2)— X8X7XXXXXX1 -K-HMP,
38
Figure 8: General peptide library construct. XrX7 are arbitrary amino acids, X8 is Pro
In 2002, Meldal et. at. 31 introduced a new polymer, EXPOsooo, for synthesis and 
enzymatic assays. The resin is a co-polymer of bis-functionalised PEGsooo and a 
highly functionalized hydrophobic silyl crosslinker. Low swelling was achieved in 
all solvents until cleavage of the silyl based crosslinker on 39, expands the resin to 
render it accessible to enzymes (Scheme 14). Treatment of 40 with subtilisin 
Carlsberg (27 kDa), followed by photolysis afforded a mixture of uncleaved peptide, 
41 and hydrolysed peptide, 42. Unfortunately, no enzymatic cleavage yields were 
given.




H2N-Val-Ala-Leu-Pro-Asn-Phe-Ac + H2N-Val-Ala-Leu-Pro-Asn-H 
41 42
1 = photolabile linker 
Scheme 14: Reagents and conditions: i. TBAF/AcOH, THF; ii. subtilisin Carlsberg, 30 min; iii. hv.
1.2.2.2 Non-swelling resins
Arrays of up to 1000 peptide nucleic acid (PNA) oligomers were generated on







Figure 9: Trypsin labile linker 43 for the synthesis ofpeptide nucleic acid (PNA) oligomer synthesis.
In the first step, the amino functionalized membrane was coupled with peptide 
spacer glutamic acid-(y-te7t-butylester)-(s-aminohexanoic acid)-(s-aminohexanoic 
acid) using Fmoc chemistry. Subsequent to coupling of the trypsin labile Glu-Lys 
handle, the membrane was mounted in an ASP 222 automated SPOT robot39 and a 
grid of the desired format was spotted at each position. Further chain elongation was 
performed with Fmoc-protected PNA monomers to synthesize the desired PNA 
oligomers 43. Finally, they were cleaved with bovine trypsin at the Glu-Lys handle 
and analysed by mass spectrometry.
1.2.3 Enzyme cleavable protecting groups in solid phase chemistry
1.2.3.1 Non -Swelling resins
In 1997, Waldmann and Reidel40 reported the deprotection of phenylacetyl 
moieties from oligonucleotides immobilized on controlled pore glass beads using 
penicillin G acylase (Scheme 15). Pentanucleotide 44, immobilized on controlled 
pore glass beads, was treated with the enzyme to give the deprotected 
pentanucleotide 46. Subsequent treatment with ammonia released the 
pentanucleotide, which was analysed by digestion with phosphodiesterase and 
HPLC. Only deoxyguanidine (dG) and thymidine (T) 47 were found (i.e. no
20
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phenylacetyl-protected nucleosides could be detected by HPLC), indicating that 












Scheme 15: Reagents and conditions: i. concentrated ammonia, 45 min, r.t.; ii. Penicillin G acylase 
pH 7, r.t., 2 h; iii. Phosphodiesterase from Crotalus duriscus, alkaline phosphatase from E. coli, TRIS 
buffer, MgCl2, 37 °C, 12 h.
1.2.4 Enzyme cleavable linkers for release of polymer-bound substrates
1.2.4.1 Non-swelling resins
An example of an enzyme cleavable linker was reported by Wong et. al. 41 in 
1994. They employed an oc-chymotrypsin sensitive, phenylalanine ester linker for 
the preparation of a glycopeptide 52 using p-(l,4)-glycosyltransferase (50 kDa) and 
oc-(2,3)-sialyltransferase which was released from solid support using a- 
chymotrypsin (22 kDa) (Scheme 16). Styrene- and sugar-based polymers were 
unsuitable, as they tend to swell which led to low coupling yields. Aminopropyl 
silica was chosen as the solid support, since it was compatible with aqueous and 
organic solvents and possessed a large surface area due to the non-swelling open
21
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pore structure. In addition, amino propyl silica has a reasonable density of functional 






Scheme 16: Reagents and conditions: i. 25% TFA/CH2C12 ; ii. 0-(7V-?Boc-phenylalanyl)glycolic acid, 
BOP/HOBt, DIPEA; iii. 25% TFA/CH2C12 ; iv. Boc-Gly-OH, BOP/HOBt, DIPEA; v. TFA/CH2C12 ; 
vi. Boc-Asn(GlyNAcp)-OH, BOP, DIPEA; vii. galactosyltransferase, UDP-Gal, HEPES pH 7.0, 
MnCl2, 55%; viii.sialyltransferase, CMP-NeuAc, HEPES pH 7.0, MnCl2, 65%; ix. a-chymotrypsin, 
H2O pH 7.0; x. ultrafiltration; xi. fucosyltransferase, GDP-Fuc, HEPES pH 7.0.
The linker 49, was constructed on a hexaglycine spacer 48 which was attached 
to the silica support to give a markedly reduced substitution of 0.2 mmol g" 1 (c.f. -1.5 
mmol g" 1 ). The phenylalanine ester was coupled using the BOP/HOBt coupling 
procedure to give 49. Subsequent, formation of the glycopeptide was achieved by
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Introduction
galactosyl transfer catalysed by galactosyltransferase in 55% yield, followed by 
sialylation to give the glycopeptide, 51 in good yield (65%). The desired product 52 
was released from the solid support in high yield (95%) after fucosylation with 
fucosyltransferase.
Schmitz and Reetz42 ultilised kieselguhr/polydimethylacrylamide resins for the 
synthesis of oligonucleotides on the solid phase using T4 RNA ligase. This rigid 
support consists of cross linked polydimethylacrylamide gel polymerized within the 
pores of macroporous kieselguhr (SiOz) particles. The pores are freely permeated by 
large molecules and are suitable for enzymatic synthesis. RNase A selectively 
cleaved the last bound nucleotide at the ribose sugar 53 leaving a 3 ',5'- 






Scheme 17: Reagents and conditions: i. RNase A
1.2.4.2 Soluble polymers
Waldmann et. at. have published two papers reporting the synthesis of a safety 
catch linker, 55 that can be cleaved by penicillin G acylase43 '44 (Scheme 18). 
Cleavage with penicillin G acylase gives the benzylamine intermediate, 56 which 
spontaneously cyclises to release the target molecule. Various solid supports 
(TentaGel, CPG (pore size 50 nm), PEGAi 50o and POE6ooo), pH values, temperatures 
and co-solvents were investigated with a view to optimizing the enzyme cleavage 
yields. Although the solution phase analogue of 55, was hydrolysed in excellent 
yield (90%); only low cleavage yields were obtained on TentaGel, PEGA and CPG 
resins (1,13 and 10% respectively). It was thought that penicillin acylase (80 kDa)
"7R
was too large to penetrate efficiently into the interior of the TentaGel beads. The 
incorporation of longer spacers for CPG and PEGA resins were suggested, to 
improve enzyme cleavage. The use of soluble polyethyleneglycol (POE6ooo), 
dramatically increased the cleavage yields of 57, to 59%. POE6ooo is soluble in many
23
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organic solvents but can be precipitated in diethylether, filtered and washed to allow 
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Scheme 18: Reagents and conditions: i. Penicillin G acylase suspension (pH 7.0), 10% methanol, 20
The application of the POEeooo linker was tested for a variety of 
transformations, including Pd(0) catalysed reactions. For example, Heck, Suzuki and 
Sonogashira reactions were carried out on polymer bound aryl iodide 59 to give 
cinnamic acid ester 63, biphenyl 64 and alkyne 65 respectively (Scheme 19). 
Subsequent penicillin acylase hydrolysis was carried out to afford the respective 
products 66-68 in high yields and purity (>95%). Mitsunobu- and Diels-Alder 
















Scheme 19: Reagents and conditions: i. [Pd(OAc)2], Bu4NBr, PPh3, DMF/Et3N/H2O 9:1:1, 50 °C, 24 
h, 91%; ii. [Pd(PPh3)4], K3PO4, DMF, 80 °C, 20 h, 93%; iii. [Pd(PPh3)2Cl2], Cul, dioxane/Et3N 2:1, 20 
°C, 24 h, 97%; iv. Penicillin G acylase, pH 7.0, 10% methanol, 37 °C.
Yamada et. al. have published two papers45 '46 describing the enzymatic 
synthesis of oligosaccharide derivatives, 73, which were cleaved from solid support 
with a-chymotrypsin (Scheme 20). Trisaccharide 72, was generated on a water- 
soluble solid support, by enzymatic transformation with galactosyl- and sialyl- 



















Scheme 20: Reagents and conditions: i. Z-Phe-NH-(CH2)6-OH, CSA, (CHC12)2 , 70 °C; ii. H2, Pd/C, 
MeOH, 50 °C; iii. CH2=CHCONH(CH2)5COOH, EtOH-benzene; iv. NaOMe (cat.), MeOH/THF; v. 
CH2=CHCONH2, TMEDA, APS, DMSO-H2O, 50 °C; vi. Galactosyltransferase; vii. Sialyl 
transferase; viii. a-chymotrypsin, Tris-HCl buffer, pH 7.8, 48 °C.
1.2.4.3 Swelling Resins
In 1999, Meldal et. al. 47 developed a novel poly(ethylene)glycol (PEG) based 
resin (SPOCC), for the enzymatic cleavage of a resin-bound decapeptide using a 
27 kDa protease, subtilisin BNP'(Scheme 21). Edman degradation and HPLC of the 
residual fragment 76, confirmed quantitative enzyme cleavage of 74 within 30 
minutes. In contrast, the reaction of 74, bearing a substrate for matrix 
metalloprotease MMP-9, a much larger protease of 72 kDa, was not cleaved by the 
enzyme. It was proposed that the enzymatic reaction was impeded by the resin
26
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excluding the larger protease, indicating the importance of the permeability of the 





H-AY(N02 )GPLGLY + H-ARKGG-Q-
75 Abz SPOCC 1500
76 
fluorescent
Scheme 21: Reagents and conditions: i. subtilisin BNP', phosphate buffer pH 7, 3 h.
SPOCC resin 80 is a polar support which is based on cross-linked 
poly(ethylene)glycol (PEG) terminally substituted with oxetane by cationic ring 
opening polymerization (Scheme 22). The polymer 80 was prepared using boron 
trifluoride diethyl etherate as initiator either via bulk polymerization in solution or 










R = Ac or H
80
Scheme 22: Reagents and conditions: i. potassium hexamethyldisilazane, toluene/DMF (1:1), 15 
rnin, r.t.; ii. (3-methyloxetan-3-yl)methyl 4-toluene sulfonate, 12 h, 75 °C; iii. boron trifluoride diethyl 
etherate.
The first esterase that was discovered to cleave linker groups on solid support 
was a phosphodiesterase. Elmore et. al. 4S reported the synthesis of a linker 
containing a phosphodiester moiety on a hydrophilic polyacrylamide resin (Pepsyn K 
resin) (Scheme 23). The utility of this linker 81 was demonstated by the generation 
of a collagenase substrate as the /7-hydroxymethylbenzyl ester, 82 in good yield 
(83%), which was released from the solid support using calf spleen 









Scheme 23: Reagents and conditions: i. calf spleen phosphodiesterase, pH 5.7, 7 d, 83%.
Waldmann et. al. 49 have described the use of the 4-acyloxy-3- 
carboxybenzyloxy moiety as an esterase/lipase-labile linker for the synthesis of 
amines, alcohols and carboxylic acids (Scheme 24). Cleavage of the acyl group of 
83 by lipase or esterase generates a phenolate 84 which fragments to give quinine 
methide 86 and the desired target compound 85. TentaGel resin, a polystyrene resin 
with grafted polyethylene glycol units, was chosen as the solid support due to its 
compatibility with aqueous media.
o











Scheme 24: Mechanism of lipase catalysed cleavage of amines, alcohols and carboxylic acids from 
83.
The best enzyme cleavage yields were obtained using recombinant lipase 
RB001-05. For example, leucine tert-buiy\ ester was cleaved in 73% yield, at pH 5.8 
and 40 °C. Other examples include, carboxylic acids (i.e. tetrahydro-p-carbolines, 
70-80%) and alcohols (68%). It was claimed that the substrate specificity of the 
enzyme guaranteed that only the intended ester was cleaved.
In 1996, Flitsch et. al. 50 reported the first synthesis of a penicillin G acylase 
cleavable linker 87 (Scheme 25). This linker was suitable for the immobilization of
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alcohols and amines on solid support. Cleavage of the phenylacetamide moiety with 
penicillin G acylase affords the hemiaminal 88, which spontaneously fragments in 
aqueous media to release the desired product 89. The maximum enzyme cleavage 
yield obtained was 50% using TentaGel resin and RX = SEt. Alternatively, the 
linker 87 could also be cleaved using mild acid hydrolysis.
O O
NH,
Scheme 25: Reagents and conditions: i. Penicillin amidase, phosphate buffer pH 7.5, 16 h, r.t.
Concern over the permeability of resins to bio-molecules has led to various 
studies being carried out. Bradley et. al. 14 have carried out a systematic study into 
the permeability of enzymes to various solid supports [TentaGel resin, PEGAi 90o, 
CPG (pore size, 100 nm)]. Enzymes with a wide range of molecular weights (e.g.
30
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MMP-12 (22 kDa), thermolysin (35 kDa), MMP-13 (42.5 kDa), clostridium 
collagenase (68 kDa), and NEP (90 kDa)) were incubated with the support bound 4- 
cyanobenzamide-Gly-Pro-Leu-Gly-Leu-Phe-Ala-Arg-OH. Confocal Raman 
microscopy was employed to monitor the absence/presence of the cyano stretching 
frequency. It was discovered that none of the enzymes could enter the TentaGel, 
PEGAigoo was permeable to enzymes up to 35 kDa, while CPG was successful with 
enzymes up to 90 kDa. No mention was made of the substrate specificities of these 
proteases as presumably this would affect the amount of peptide cleaved by each 
enzyme.
1.2.5 Summary of biocatalysis in polymer supported synthesis/hydrolysis.
From the discrepancies in the literature reviewed above, it is obvious that the 
validity of solid phase mediated enzymatic transformations is still the subject of 
much debate (Appendix A). For example, it is generally agreed that only the surface 
sites of TentaGel are accessible to enzymes,24'29'35 '43 '44 however two studies 
contradict this.49'50 ArgoGel is also unsuitable for enzymatic transformations even 
with an enzyme of low molecular weight (23 kDa).35 ArgoGel is very similar to 
TentaGel resin but possesses better swelling in aqueous media. However, it is 
thought that only surface sites are accessible to the enzyme.
The most commonly used solid support for enzymatic transformations is PEGA 
resin, 17 '25"29 '33 '35 '36 '43 '44 which is available in a variety of molecular weights. Graph 1 
shows the relationship between percentage enzymatic conversion and the molecular 
weight of the enzyme for a variety of PEGA resins with different PEG lengths. It 
should be noted that where enzymatic conversion yields were not quoted, these 
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Graph 1 : Correlation between percentage enzymatic conversion and molecular weight of enzyme.
In the case of PEGAi 90o resin for enzymatic hydrolysis (light blue cross), it can 
be seen that the resin is compatible with enzymes up to 35 kDa14'34 . For synthesis on 
PEGAi9oo resin (yellow triangle), it seems that the resin is accessible to enzymes 
with a molecular weight of up to 50 kDa17 (galactosyltransferase). This suggests 
that synthesis is favoured over hydrolysis, using solid support bound substrates. 
Recent reports by Flitsch et. a/. 51 '52 have shown that synthesis is favoured when 
reagents are bound to the solid support. This occurs because the synthesis/hydolysis 







Scheme 26: Reversible synthesis/hydrolysis on solid support.
There are several explanations for the shift in equilibrium. Firstly, the presence 
of large excesses of starting materials shifts the equilibrium to synthesis according to 
Le Chatelier's principle. Secondly, PEGAi 90o resin is relatively hydrophobic
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compared to the bulk aqueous media, thus hydrophobic starting materials are 
attracted into the PEGAi 90o matrix, which in turn favours synthesis. Lastly, the shift 
in equilibrium was explained by suppression of ionisation of the resin bound amine 
due to electrostatic repulsion between the amines which are held in close proximity 
to each other by the polymer matrix. In contrast, solution phase molecules can ionise 
independently of each other.
For hydrolysis on PEGA^oo resin31 '36 (pink squares), it seems that there is a 
clear correlation between percentage conversion and molecular weight of the 
enzyme; as expected, percentage conversion is decreased with increasing molecular 
weight. It should also be noted that, increased crosslinking of the PEGA resin 
(purple star and yellow triangle) (i.e. PEGAigoo and PEGAi900/300) decreased the 
percentage enzymatic hydrolysis, 17 presumably caused by restricted accessibility of 
the enzyme to the resin due to smaller pore sizes. Finally, it can be seen that no 
correlation between PEGA size and percentage conversion exists, however, 
PEGAi9oo resin has produced the best enzymatic conversion yields.
Several resins have been specifically developed for use in enzymatic 
transformations on solid support, e.g. EXPOsooo37 and SPOCC,47 both of which are 
based on co-polymers of polyethylene glycol (PEG). However, only small enzymes 
were successful (27 kDa) and in the case of SPOCC resin, no cleavage was observed 
for an enzyme with a molecular weight of 72 kDa.
The use of macroporous resins for enzymatic transformations is limited but 
interest is slowly increasing in the use of these solvent independent 
resins. 14'23 '26 '28 '40 '42 "44 In the case of Keiselguhr/polydimethylacrylamide resin, 
hydrolysis/synthesis has only been reported using fairly small enzymes (22-44 
kDa).26'28 '42 Enzymatic hydrolysis on controlled pore glass (CPG) has been carried 
out with varying success (10% hydrolysis), however this was probably due to the 
small pore size used (50 nm).43 '44 A report by Bradley et. at. 14 supports this, with 
claims that enzymes up to 90 kDa are accessible to CPG with a pore size of 100 nm. 
Therefore, the pore size of CPG (100 nm) seems crucial for the accessibility of
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enzymes. Other reports on the use of CPG23 '40 have not stated the pore size of the 
resin used. Aminopropyl silica has been used for enzymatic transformations using 
glycosyltransferases/ chymotrypsin (50 kDa/22 kDa) in moderate to good yields (55- 
65%).41 However, no further studies have employed aminopropyl silica for 
enzymatic transformations.
Soluble polymers, such as polyacrylamide and polyethylene glycol have had 
limited but successful use in enzymatic transformations.43 "46 These polymers are 
soluble in aqueous media and selected organic solvents but can be precipitated in 
diethylether, filtered and washed so as to facilitate purification of products from the 
reaction mixture. So far, soluble polymers have not been widely used for organic 





Serine and cysteine proteases are potently inhibited by peptide aldehydes53 . 
Inhibition arises from the formation of a hemiacetal or hemithioacetal tetrahedral 
adduct within the active site of the protease which mimics the proposed structure of 
the transition state (Scheme 3). Many serine and cysteine proteases have been 
implicated in a number of disease states; thus, their inhibition has been widely 
exploited medicinally.
1.3.1 Methods for the preparation of C-terminal peptide aldehydes from solid 
support
Various methods for the solution synthesis of peptide aldehydes have been 
described54"57 ; however, relatively few methods have been developed for the solid 
phase synthesis of peptide aldehydes. The following criteria are necessary for a good 
peptide aldehyde linker:
  Must be cost effective.
  Must be easy to construct.
  Must be chemically stable under solid phase peptide synthesis conditions.
  Must give crude products with high purity, stereochemical integrity and 
high yield.
  Must be time economical.
Most of the methods available for the solid phase synthesis of peptide 
aldehydes are based on analogous solution phase methodologies. Aldehydes can be 
'masked' or protected in a variety of ways; for example, as an alcohol, ester, amide, 
imine or ethylene, which may be converted to the aldehyde by oxidation or 
reduction, or they can be protected as O, O-acetals,58'59 0,7V-acetals,60 O,S-acetals, 
SS-acetals,61 £?,£?-acetals62 or as a thiazole.63
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An early report by Webb et. al. M in 1992, described the use of a semicarbazone 
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R = CH3 , CH2Ph or CH(CH3)2 
n = 2-3
= amino acidMBHA resin
Scheme 27: Reagents and conditions: i. Boc-amino aldehyde, NaOAc, ethanol, reflux; ii. MBHA 
resin, BOP; iii. peptide elongation; iv. dilute aqueous acid, formaldehyde.
The appropriate Boc-protected amino aldehyde was protected as its 
semicarbazone 93 by treatment with 92. 93 was coupled to acid labile 4- 
methylbenzhydrylamine (MBHA) resin using benzotriazol-1- 
yloxytrisdimethylamino-phosphonium hexafluorophosphate (BOP) reagent to give 
94. After peptide synthesis, 95 was treated with aqueous acid/formaldehyde to 
generate the peptide aldehyde 96 from the support. Several examples of peptide 
aldehydes were prepared using this procedure; however no reference to the optical 
purity of the resulting peptide aldehydes was made.
In a later publication, Patterson and Ramage65 investigated linker 97 based on a 
dibenzosuberyl system for the synthesis of peptide semicarbazones 100 which can be 







Scheme 28: Reagents and conditions: i. Fmoc-phenylalanine, DIPEA, 90%, 5 h; ii. TFA/H2O (9:1), 
1.5 h; iii. pyruvic acid.
This methodology was effective in generating peptide semicarbazones 100 and 
aldehydes 101 with no epimerisation at the C-terminal chiral centre. Despite this, the 
method has not been widely applied.
A more useful method for the solid phase synthesis of peptide aldehydes was 
inspired by the use of Weinreb amides for the solution phase synthesis of amino 
aldehydes66 . Martinez et. at. 67 '6* have prepared one such linker 102 and synthesized 
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Scheme 29: Reagents and conditions: i. Boc synthesis, BOP/DIPEA, Boc-AA-OH; ii. Boc 
deprotection; iii. acetylation; iv. LiAlH4, THF, 0 °C.
The tripeptide aldehyde 104 was removed from the solid support by reduction 
with lithium aluminium hydride. The crude peptide aldehyde 104 was studied by 
reverse-phase HPLC and ! H NMR. Examination of the ! H NMR spectrum revealed 
the presence of a single aldehyde proton signal, indicating the absence of 
epimerisation. Purification of the peptide aldehyde 104 was carried out by flash
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chromatography on silica gel (0.1% pyridine as eluent) or by reverse phase HPLC. 
Both purification methods resulted in a loss of optical purity as confirmed by 
appearance of two peaks in the aldehyde proton region of the ! H NMR spectra.
At around the same time, Armstrong and Dinh69 were also developing a 
Weinreb type linker for the synthesis of simple aldehydes and ketones 109 (Scheme 
30).
O : O 00
Pr. v ^OH ——————^ PrT ^^ NHOMe PtT ^ N ^^ ^OMe
105 106 OMe
107
iv O O O
—————^ Ph^-AN-^^N^ ——-———- Ph^^^H(R)
OMe H 109 
108
Scheme 30: Reagents and conditions: i. pivaloyl chloride, NEt3, THF, 0 °C, 2.5 h; ii. MeONH3Cl, 
NEt3, 0 °C-r.t, 1 d; iii. cat. fBuOK, methylacrylate, PhMe, 70 °C, 8 h (83%); iv. LiOH, THF, r.t., 1 h 
(95%); v. Polymer-NH2, DCC, HOBt, DMF, r.t., 1 d, (>95%); vi. LiAlH4, THF, 5 °C, 15 h or RMgX, 
THF, 15 h, r.t.-60 °C.
Tong and Hong70 have employed a Weinreb amide linker 110 for the synthesis 
of tetrapeptide aspartyl aldehydes 112 (Scheme 31). Reverse phase HPLC analysis 
of the crude peptide aldehyde 112 revealed some impurities; however, no further 
purification was carried out. No reference was made to the optical purity of the 
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Scheme 31: Reagents and conditions: i. 20% piperidine/DMF; ii. Fmoc-Asp(O?Bu)-OH, HATU, 
DIPEA; iii. Fmoc synthesis, PyBOP, HOBt, DIPEA; iv. acetylation; v. TFA, scavenger mixture; vi. 
LiAlH4, THF, -20 °C.
In 2000, O'Donnell et. al. 71 reported the solid phase synthesis of unnatural 
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R1 = 4-MeC6H 4CH2 or Et 
R2 = Boc, Cbz or 2-naphthoyl
Scheme 32: Reagents and conditions: i. benzophenone imine, 1-methyl-2-pyrrolidinone, 24 h, r.t; ii. 
1,4-methyl benzyl bromide or ethyl iodide, methyl-2-pyrrolidrnone, dichloromethane, BTPP, 24 h; iii. 
1 M HC1, THF, 4 h; iv. amine protection; v. R3MgX or DIBALH, THF, 2 h then 1M HC1:THF (1:1), 
15 min.
The synthesis of compound 118 was achieved by the addition of an unnatural 
side chain to a benzophenone imine-activated Weinreb resin bound glycine 114 to 
generate 115. Subsequent hydrolysis of the alkylated imine 115, followed by 
protection of the resulting amine 116 and cleavage with either DIBAL-H or 
Grignard reagent resulted in aldehyde or ketone 118 respectively (55-87% yield). 
The degree of epimerisation at the oc-stereocentre was dependent on the conditions 
used for alkylation of 114 (i.e. choice of base and alkyl halide). It is now possible to 
obtain Weinreb amide linker from various commercial sources,72 which is a 
testament to the success of this method.
The use of ozonolysis to generate peptide aldehydes from solid support was
T\first exploited by Martinez et. al. (Scheme 33). The protected a,p-unsaturated y- 
amino acid 120 was prepared using a Wittig reaction between carboethoxymethylene 
triphenylphosphorane and protected amino aldehyde 119. A model tripeptide 
aldehyde Boc-Phe-Val-Ala-H was prepared in high purity with no detectable trace of 












Scheme 33: Reagents and conditions: i. carboethoxymethylene triphenylphosphorane, toluene, 80 °C, 
1 h; ii. NaOH, EtOH, 5 h; iii. MBHA resin, BOP; iv. peptide elongation using BOP reagent; v. O3 , 
DCM, -80 °C, 20 min then thiourea, methanol, 10 min.
This method of generating aldehydes is limited to sequences which are stable to 
ozonolysis. Nevertheless, Hall and Sutherland74 have demonstrated the utility of 
ethylenic linkers by preparing 27 tripeptide aldehydes 128 (Scheme 34). The peptide 
aldehydes 128 were obtained as single diastereomers with purity >90% (by LCMS). 
The limitations of this method were illustrated when methionine was incorporated 
into the tripeptide. Two products were observed after ozonolysis; the corresponding 
sulfoxide and sulfone in a 1:1 ratio. This indicated that the side chain sulphide was 
oxidised by the ozone.

















127 - 128 
Scheme 34: Reagents and conditions: i. NaHMDS, THF, r.t., 15 min; ii. Boc-amino aldehyde, THF, 
r.t., 20 h; iii. 25% TFA/DCM, r.t., 20 min; iv. Fmoc-AA-OH, PyBOP, DIPEA, DMF, r.t., 2 h; v. 20% 
piperidine, DMF, r.t., 15 min; vi. Cbz-amino acid, PyBOP, DIPEA, DMF, r.t., 2 h; vii. O3 , DCM, -78 
°C, 5 min; viii. Me2 S, DCM, 3 h.
Barany et. at. 75 '76 have reported the synthesis of peptide aldehydes 133 from 
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Scheme 35: Reagents and conditions: i. NaBH3CN, DMF/HOAc, 25 °C, 1-12 h; ii. chain elongation; 
iii. TFA/H2O(19:1).
Alaninal acetal 129 was coupled to polystyrene based resin 130 by reductive 
amination to afford 131. Peptide elongation was carried out by acylation of the 
secondary BAL-linked amine 131 using either Fmoc-amino acid as preformed 
symmetrical anhydrides or the Fmoc-amino acid activated in situ by 
HATU/diisopropylethylamine. Further chain elongation followed standard Fmoc 
procedures. Treatment of 132 with tnfluoroacetic acid resulted in concomitant acetal 
deprotection and peptide aldehyde, 133 liberation from the solid support. The 
cleaved peptide aldehyde 133 was found to be a diastereomeric mixture. It was 
unclear at which stage in the process the racemization occurred.
In 2000, Tarn et. al. 71 described the synthesis of peptide aldehydes through a 
cyclic acetal resin 135 (Scheme 36). Fmoc-3-amino-l,2-propanediol was coupled to 
benzaldehyde- polystyrene 134 in the presence of catalytic /?-toluenesulfonic acid. 
After peptide elongation using standard Fmoc chemistry, peptide acetal 137 was 
released by acid hydrolysis and periodate oxidation generated the peptide aldehyde 
138 in quantitative yield. This method offers the possibility of recycling the 













Scheme 36: Reagents and conditions: i. FmocNHCH2CHOHCH2OH, /?-TsOH, 100 °C, 24 h; ii. 20% 
piperidine/DMF; iii. Fmoc-AA-OH, DIG, HOBt; iv. Deprotection and coupling; v. TFA; vi. NaIO4, 
20% acetic acid, 2 min.
In a slightly different approach, Yao and Xu78 have prepared peptide aldehydes 
directly on acetal resin (Scheme 37). This was achieved by treatment of Fmoc- 
alaninal 139 with 6w-trimethylsilyl ether to give the acetal 140 after purification by 
flash chromatography. Acetal 140 was coupled to aminomethylated resin using 
BOP, HOBt and DIPEA coupling conditions. Elongation by classical Fmoc- 
synthesis provided the peptide acetal 142 on solid support. Various cleavage 
conditions were examined for the removal of peptide aldehyde 143: acid (50% 
TFA/DCM or 95% TFA/H2O), temperature (50 °C or room temperature), and 
reaction time (from 5 min to 12 h). The optimum cleavage conditions were 95% 
TFA/H^O, three times over 15 min, at room temperature. Peptide aldehydes 143 


















Scheme 37: Reagents and conditions: i. TMSOTf, 0 °C; ii. polymer-CH2NH2, BOP, HOBt, DIPEA; 
iii. 20% piperidine/DMF; vi. Fmoc-Val-OH, BOP, HOBt, DIPEA; v. 20% piperidine/DMF; vi. Fmoc- 
Ile-OH, BOP, HOBt, DIPEA; vii. 95% TFA/H2O, 3x15 min.
Recently, Lelievre et. a/. 79'80 reported the synthesis of large peptide aldehydes 
(33-mer) from solid support through nucleophilic displacement (Scheme 38). 
Aminolysis of the ester bond between the peptide and phenylacetamidomethyl 
(PAM) resin 144 led to a peptide aldehyde 146 masked as an acetal, which could be 
converted to aldehyde by acid hydrolysis. Alanine was chosen as the amino acid 
attached to the PAM resin to minimise steric hindrance between the 









Scheme 38: Reagents and conditions: i. DMF, 18 h, 40 °C.
This report studied a variety of parameters for optimum cleavage of the peptide 
acetal 146 from solid support including; solvent, temperature, peptide length, workup 
procedure and the nature of the polymer matrix for optimum cleavage of the peptide 
acetal from solid support. It was found that a polar matrix for nucleophilic
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displacement improved cleavage yields since the matrix was compatible with the 
unprotected amino acid residues of the peptide chain. Among the solid supports 
tested (polystyrene, NovaGel, TentaGel and PEGA), PEGA resin afforded the best 
cleavage yield. This finding illustrates that the solid support should be considered as 
a co-solvent rather than an inert carrier.
1.3.2 Summary of solid-phase peptide aldehyde synthesis
The demand for linker groups, which are stable under a variety of reaction 
conditions and allow release of desired products from polymer supports under very 
mild conditions, has increased with the advent of combinatorial and parallel 
synthesis of compound libraries. From the previous review, it can be seen that there 
are several methods for the solid phase synthesis of peptide aldehydes from solid 
support which can be cleaved using chemical methods;64'65'67'68'71 '73 '75'76'78 however, 
such conditions often limit the applicability of the method. Enzymatic methods have 
been successfully employed in organic synthesis for a multitude of transformations 
with explicit chemo-, regie- and stereoselectivity. In principle, the use of enzymatic 
transformations opens up alternative strategies for the cleavage of aldehydes, namely 
peptide aldehydes, from solid support.
1.4 Aims of project
The aim of the project was to develop a suitable linker for the synthesis of 
peptide aldehydes on solid support, which could be cleaved using enzymatic 
hydrolysis. As mentioned previously, work carried out by Flitsch et. fl/. 50 focussed 
on a linker 87 suitable for the immobilisation of alcohols and amines (Scheme 39).
O 1
Linker 87 was constructed using Katritzky methodology by condensation of an 
aldehyde 147, benzotriazole and phenylacetamide with azeotropic removal of water. 
Displacement of benzotriazole with a thioethyl group was carried out to facilitate 
attachment of alcohols. Thus, treatment of 148 with sodium ethanethiolate followed
44
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by reduction of the azide group afforded 149. Amine 149 was coupled to 




Scheme 39: Reagents and conditions: i. phenylacetamide, benzotriazole, TsOH, toluene, reflux, 
Dean-Stark, 16 h, 67%; ii. sodium ethanethiolate, THF, r.t., 4 h, 96%; iii. triphenylphosphine, H2O, 
THF, r.t., 16 h, 96%; iv.carboxymethyl-TentaGel, TBTU, HOBt, DIPEA, DMF, 16 h, 25 °C.
Linker 87 can be cleaved using mild acid or base hydrolysis; in addition to, 
enzymatic hydrolysis with penicillin acylase (50% cleavage). The utility of linker 87 
was demonstrated by the synthesis of glycopeptides. 82
It is envisaged that aminal linker 87 could be extended to allow for the 
synthesis of peptide aldehydes 152 on solid support by simply tethering the linker 87 
to solid support through a benzotriazole moiety to give aminal linker 150 (Scheme 
40). Subsequent, peptide elongation followed by treatment with mild acid/base or 
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Scheme 40: Reagents and conditions: i. acid or base; ii. penicillin acylase.
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2 Results and discussion - Synthesis of amino aldehydes
2.1 Reported methods for the synthesis of amino aldehydes
In order to construct the aldehyde linker 150 using Katritzky methodology81 
(Scheme 40), a suitable method for the solution synthesis of amino aldehydes was 
required. A recent review by Jurczak et. al.*3 highlighted the methods available 
for the preparation of amino aldehydes.
2. 1 . 1 Oxidative methods for the preparation of amino aldehydes.
The most commonly used method for the synthesis of aldehydes is the 
oxidation of alcohols.84 In 1978, Omura and Swern85 reported the use of 
dimethylsulfoxide, activated with oxalyl chloride, as an oxidant for alcohols 153 
(Scheme 41). Despite the problems associated with this method, including the 
production of dimethylsulfide (stench) and toxic gaseous side products (phosgene 
and carbon monoxide), this method has gained increasing importance. There are 
many reasons for the popularity of this reaction and these include the use of mild 
conditions, volatile by-products and lack of over-oxidation to carboxylic acids. This 
method has become a well established procedure for the oxidation of primary,
Qf.




Scheme 41: Reagents and conditions: i. oxalyl chloride, dimethylsulfoxide, anhydrous 
dichloromethane, triethylamine, -60 °C.
The use of tetrapropylammonium perruthenate, TPAP was first introduced in 
1987 by Griffith and Ley. 87 TPAP is a commercially available, organic soluble 
oxidant which has been used to effect oxidation in complex molecules without 
disturbing other functional groups (Scheme 42). 88 Aldehydes bearing a labile a- 
stereogenic centre can be prepared without scrambling of stereochemistry. One
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advantage of TPAP is that it can be used as a catalyst in conjunction with an excess 
of A^methylmorpholine-W-oxide (NMO). Hinzen and Ley89 have developed a 
polymer supported perruthenate reagent that can be used in the same way as TPAP 




Scheme 42: Reagents and Conditions: i. TPAP, NMO, 4 A molecular sieves, dichloromethane, r.t, 
Ar(g), 1 h, 70%.
In 1983, Dess and Martin90 discovered that l-hydroxy-l,2-benziodoxol-3(l//)- 
one, IBX could be transformed into the more soluble periodinane, 1,1,1-triacetoxy- 
l,l-dihydro-l,2-benziodoxol-3(l//)-one 158. Since then, the Dess-Martin 
periodinane 158 has been used for the selective transformation of alcohols 157 into 




Scheme 43: Reagents and conditions: i. dichloromethane, 12 h, 58%.
159
2.12 Reductive methods for the preparation ofamino aldehydes.
Another useful method for the synthesis of aldehydes is via Weinreb amides 
161.66 These are prepared from commercially available 7V,O-dimethylhydroxylamine 
and the corresponding acid chloride 160 or other activated derivative. Reduction of 
161 with lithium aluminium hydride furnishes the desired aldehyde 162 (Scheme 
44). This method has gained popularity due to the fact that over-reduction and
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racemization of the a-stereocentre do not occur. C-terminal peptide aldehydes have 
been prepared using this method.92
O .. O
FT N fT H 
160 ' 162UMs
161
Scheme 44: Reagents and conditions: i. N, 0-dimethylhydroxylamine hydrochloride, 
pyridine, 0 °C; ii. LiAlH4, THF, -78 °C, N2 .
2.2 Attempted synthesis of 9-fluorenylmethoxycarbonyl-phenylalaninal
Since it was the intention to tether the protected amino aldehyde to a solid 
support, it was crucial that the amine protecting group was compatible with the 
conditions required for solid phase synthesis. That is, the protecting group must be 
easily removed at the end of the synthesis using mild conditions, which have no 
adverse effects on the rest of the structure. A^-Fluorenylmethoxycarbonyl (Fmoc) is 
one of the most common protecting groups in solid phase chemistry. Generally, the 
Fmoc group is relatively stable under acidic conditions, but can be easily removed 
under basic conditions (20% piperidine in DMF). Fmoc-protected amino acids are 
cheap, commercially available compounds making them ideal as possible starting 
materials for the synthesis of amino aldehydes.
The first method attempted for the synthesis of amino aldehydes was via 
reduction of Weinreb amides. (5)-Fmoc-phenylalanine 163 was readily converted to 
the corresponding Weinreb amide 164 in good yield (80%), by coupling with N,O- 
dimemylhydroxylamine hydrochloride in the presence of base using HBTU as a 
coupling reagent. Subsequent reduction of 164 using lithium aluminium hydride in 
tetrahydrofuran (THF) afforded only small amounts of desired aldehyde 165 
(Scheme 45). This suggested that the stabilised tetrahedral intermediate formed by 
coordination of the methoxy group to the metal, was not being suitably quenched in 
acidic KHSO4 (HSO4 "; pKa = 1.92). In hindsight, a stronger acid (e.g. H2SO4 ; pKa = 
-3) might facilitate complete conversion to the aldehyde 165. Several other Fmoc-
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Weinreb amides (i.e. glycine, valine, alanine and leucine) were reduced using the 
same method; however this yielded limited success. In some cases, the loss of the 
Fmoc protecting group was observed.
o
ii.
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Scheme 45: Reagents and conditions: i. AfO-dimethylhydroxylamine hydrochloride, 
diisopropylethylamine, HBTU, dichloromethane, 1 h, r.t, 80%. ii. LiAlH4, THF, -20 °C, 50 min.
2.3 Synthesis of allyloxycarbonyl-phenylalaninal via a Weinreb amide.
Since the Fmoc group appeared to be unstable, a more durable protecting group 
was sought. The allyloxycarbonyl (Alloc) group is sufficiently robust to withstand 
the basic conditions of the removal of Fmoc groups and the acidic conditions of Boc
removal. 93 However, it can be removed from the solid phase with
tetra^z'5(triphenylphosphine)palladium (0), in the presence of a scavenger. The 
scavenger prevents re-addition of the allyl unit onto the amine. Various scavengers
94have been used including dimedone and amine/borane complexes.95
There are two main reagents used for TV-Alloc protection: allylchloroformate or 
diallyl pyrocarbonate. The latter does not require an additional base and the only by- 
products, carbon dioxide and allyl alcohol, are volatile. Both methods were used, 
depending on which starting materials were available at the time.
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CS)-(-)-Phenylalanine 166 was protected using allylchloroformate in the 
presence of 4M sodium hydroxide (86%) or diallyl pyrocarbonate at reflux to give 
167 (61%) (Scheme 46). The former method was used to prepare racemic Alloc- 
protected phenylalanine 169 in good yield (80%). The amino acids, 167 and 169 
were obtained in sufficient purity to be used without further purification.




Scheme 46: Reagents and conditions: i. allyl chloroformate, 4 M NaOH, 0 °C for 15 min, then r.t for 
15 min, ii. diallyl pyrocarbonate, H2O/dioxane (3:2), reflux, 30 min.
170 was prepared using the same method as Fmoc-amino acid 164 (Section 2.2) 
(Scheme 47). Chiral HPLC (Section 8.2.9) confirmed the enantiomeric purity of the 
Weinreb amide (>99% e.e.). Aldehyde 171 was generated by reduction of Weinreb 
amide 170 with lithium aluminium hydride. The crude aldehyde 171 was used 
without further purification, since silica gel is known to epimerize cc-amino 
aldehydes83 . The chiral integrity (98% e.e.) of the aldehyde 171 was confirmed by 
reduction to the corresponding alcohol with sodium borohydride (Section 8.3.18), 
followed by chiral HPLC (Section 8.2.9). Racemic Alloc-protected phenylalaninal 
173 was prepared using the same method.
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Scheme 47: Reagents and conditions: i. A^O-dimethylhydroxylamine hydrochloride, 
diisopropylethylamine, HBTU, dichloromethane, 1 h, r.t. ii. LiAlH4 , THF, -20 °C, 50 min.
Results and Discussion 
2.4 Synthesis of allyloxycarbonyl-phenylalaninal via oxidation of alcohol
In an alternative strategy, (^-Alloc-phenylalaninol 174 was generated by 
reacting (S)-Alloc-phenylalanme 167 with isobutylchloroformate to form the mixed 
anhydride, followed by reduction with sodium borohydride to give the alcohol 17496 
(33% yield, 98% e.e. by chiral HPLC (Section 8.2.9) (Scheme 48). The alcohol was 









Scheme 48: Reagents and conditions: i. isobutyl chloroformate, W-methylmorpholine, 1,2- 
dimethoxyethane, -15 °C, then NaBH4 in H2O. ii. Dess-Martin Periodinane, water-saturated 
dichloromethane, r.t., 40 min.
D3X, l-hydroxy-l,2-benziodoxol-3(l//)-one 177 was prepared from 2- 
iodobenzoic acid 176 by oxidation with oxone (2KHSO5-KHSO4-K2SO4)97 (Scheme
OR
49). Dess-Martin periodinane 158 was obtained using the modified Ireland 
procedure, in which 177 was treated with acetic anhydride in catalytic p-toluene 
sulfonic acid to afford the periodinane 158 in good yield (80%). Treatment of (S)- 
Alloc-phenylalaninol 174 with Dess-Martin periodinane 158 in water-saturated 
dichloromethane" afforded the desired aldehyde 171 in good yield (79%) and >99% 
e.e., as determined by reduction with sodium borohydride (Section 8.3.18) followed 
by chiral HPLC (Section 8.2.9). Again, racemic Alloc-phenylalaninal 173 was 








Scheme 49: Reagents and conditions: i. oxone, H2O, 70 °C, 1 h, 96%; ii. acetic anhydride, /?-TsOH, 
80 °C, 2 h, 80%.
2.5 Summary and conclusions
Initial attempts to synthesize Fmoc-protected amino aldehydes 165 via Weinreb 
amides 164 were hampered by incomplete conversion to the aldehyde 165 and in 
some cases, loss of the Fmoc protecting group occurred (Scheme 45). These 
problems were overcome by the use of allyloxycarbonyl as a protecting group. (S)- 
Allyloxycarbonyl-phenylalaninal 171 was prepared in good yield and chiral purity 
using two methods:
1. via a Weinreb amide 170 (76% overall yield, 98% e.e.).
2. via oxidation of the corresponding alcohol 174 (56% overall yield, >99%
e.e.).
Racemic allyloxycarbonyl-phenylalaninal 173 was also prepared in good yield 
(72-86% overall yield) using both methods, 1. and 2.
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3 Results and discussion - Synthesis of 1 H-benzotriazole resins
To allow for the attachment of the allyloxycarbonyl-phenylalaninal 171/173 to 
a solid support, an efficient method for the preparation of polymer bound \H- 
benzotriazole was essential.
3.1 Reported syntheses of polymer bound 1 H-benzotriazole
In 1999, Katritzky et. a/. 100 published the first preparation of solid-phase bound 
l#-benzotriazole. Treatment of Merrifield resin 178 with sodium salt 179 (Scheme 
50) afforded the corresponding resin-bound nitroaniline 180. The nitro group was 
reduced using stannous chloride to give 181. Subsequent treatment of 181 with 
isoamyl nitrite afforded the benzylether-17/-benzotriazole resin 182. The gel phase 
13C NMR spectrum of 182 was unresolved, even after lengthy acquisition. However, 
the FTIR spectrum of 182 showed a very broad band (2700-3400 cm" 1 ), which was 
attributed to the NH group of the hetero ring (broadening is explained by the 
equilibrium between the I//, 2H and 3//-isomers in the benzotriazole backbone. The 
NH bond in each isomer varies in length and strength and will therefore show a range 










Scheme 50: Reagents and conditions: i. 7V,yV-dimethylacetamide (DMA), 80 °C, 6 h; ii. stannous 
chloride, DMA, 60 °C, 5 h, then r.t for ~16 h; iii. Dioxane, acetic acid, HC1, isoamyl nitrite, r.t., 24 h, 
then 50-60 °C for 0.5 h.
Longer, more flexible linkers for the attachment of benzotriazole were 
investigated by Schiemann and Showalter. 101 Polystyrene-supported benzotriazole 
188 and 192 with mono- and diether anchors were prepared (Scheme 51). These 
linkers 188 and 192 showed sufficient swelling (>7 mL g" 1 for 192) in DMF, THF 
and toluene. The swelling properties can be attributed to the use of hydrophilic ether 
tethers and lower polymer cross-linking; thus 192 was more accessible to solvation 
than 188. However, it was found that resins with better swelling properties did not 



















1.01 mmol g" 1 loading
192
0.99 mmol g" 1 loading
Scheme 51: Reagents and conditions: i. NaH, TrtCl, THF, 95%; ii. LiAlH4, THF, reflux, 98%; iii. 
CBr4, PPh3 , DIPEA, THF, 0 °C, 95%; iv. HO(CH2)6OH, KOf-Bu, TBAI, DMSO, 75%, v. KH, TBAI, 
THF, reflux; vi. HC1, MeOH, THF, 100%; vii. NaH, TBAI, THF, reflux; viii. Cone. HC1, MeOH, 
THF, 100%.
Two papers by Paio et. a/. 102' 103 reported the preparation of 1/f-benzotriazole 
resins tethered through both an ether and an amide moiety. In the first paper, 102 N- 
Boc protected 5-hydroxy-benzotriazole 197 was anchored onto hydroxymethyl- 
polystyrene resin 193 using Mitsunobu solid phase conditions and onto chloromethyl 
polystyrene 194 using nucleophilic substitution conditions, obtaining compounds 199 
and 200 respectively. Compound 198 was tethered onto aminomethyl polystyrene
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195 and onto Argogel-NH2 196 using conventional peptide coupling conditions to 
obtain 201 and 202 respectively (Scheme 52). These reactions were monitored by 
FT-IR. Treatment of 199-202 with acid removed the Boc protecting group to give 
deprotected polymer bound benzotriazoles 203-206.
X +
Boc
197; Y = OH 
198;Y = COOH
193; hydroxymethyl polystyrene (HMB-PS) 
194; chloromethyl polystyrene (CM-PS) 
195; aminomethyl polystyrene (AM-PS) 
196; Argogel™-NH2 (AG-NH2 )
199; Z = O,P = HMB-PS 
200; Z = O, P = CM-PS 
201; Z = NHCO,P = AM-PS 
202; Z = NHCO, P = AG-NH2
203; Z = O, P = HMB-PS 
204; Z = O, P = CM-PS 
205; Z = NHCO, P = AM-PS 
206; Z = NHCO, P = AG-NH2
Scheme 52: Reagents and conditions: i. 30% TFA/DCM.
In the later paper, 103 benzotriazole-5-carboxylic acid 207 was bound to 
polystyrene resins 195 and 196 without the need for protection at the reactive 
nitrogen (Scheme 53). Commercially available benzotriazole-5-carboxylic acid 207 
was reacted with the appropriate polystyrene resin 195 or 196 in the presence of 
diisopropylcarbodiimide (DIG) and 1-hydroxybenzotriazole (HOBt) in DMF. 
Quantitative coupling was observed using the colourimetric Kaiser test. 104 Supported 




195; aminomethyl polystyrene (AM-PS) 
196; Argogel -NH2 (AG-NH2 ) 
Scheme 53: Reagents and conditions: i. DIG, HOBt, DMF, r.t., 18 h.
205; P = AM-PS 
206;P = AG-NH 2
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In 2001, Katritzky et. at. 105 examined the attachment of benzotriazole directly 
to a polymer support via a carbon-carbon bond (Scheme 54). This employed the use 
of a Suzuki coupling reaction. Upon treatment of benzotriazole with bromo- 
chloroethane in the presence of sodium hydride, followed by direct bromination, the 
desired 5-bromo compound 210 was isolated. Compound 210 was heated with 
polymer bound boronic acid 209 in the presence of palladium catalyst at 90 °C for 24 














Scheme 54: Reagents and conditions: i. Br2 , benzene; ii. BuLi, benzene, B(OMe)3, THF, H+; iii. 
Pd(OAc)2, (0-Tol)3P, DMF/Et3N; iv. HC1 (6 N), reflux.
3.2 Synthesis of polymer bound 1 M-benzotriazole adducts
The synthetic scheme outlined (Scheme 53) allows the generation of polymer- 
bound 1//-benzotriazole 205/206 in one step from commercially available 
benzotriazole-5-carboxylic acid 207. A range of these adducts on different polymers 
were prepared to allow for the comparison in physical properties and compatibility 
with enzyme hydrolysis conditions.
Polymer-bound 1//-benzotriazole adducts 217-220 were obtained by reaction of 
benzotriazole-5-carboxylic acid 207 with the appropriate amino-resin 213-216 in the 
presence of DIG and HOBt (Scheme 55). Tethering of benzotriazole-5-carboxylic 
acid 207 to the solid support resulted in the appearance of brown resin beads/gel
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which provided a useful visual indication of reaction success. The 2,4,6- 
trinitrobenzene sulfonic acid (TNBS) test could not be used as a colourimetric test, 
since the colour of brown resin beads and the red colour of a positive TNBS test 
were indistinguishable. The Kaiser test (Section 8.2.5.1) confirmed quantitative 
coupling of 217-220 in all cases.
207
213; amino-tentagel HL 
214; amino-methylated polystyrene HL 
215; aminomethyl polystyrene MP 
216; PEGA1900
Scheme 55: Reagents and conditions: i. DIG, HOBt, DMF, r.t., 16 h.
217; amino-tentagel HL 
218: amino-methylated polystyrene HL 
219; aminomethyl polystyrene MP 
220; PEGA1900
In most cases, 217-219 the appearance of amide stretches at -1650 and 1540 








Figure 10: FT-IR spectrum of a) aminomethylated polystyrene 214 (KBr disc) and b) 218 (KBr disc).
In the PEGAiQoo resin 220, there was overlap of the amide stretches from the 
polymer backbone and the new amide linkage formed. In this case, loss of the Nib 
stretch at 3621 cm' 1 in the FT-IR, together with the series of broad signals observed 
in the aromatic region (7.60-8.50 ppm) of the magic angle spinning (MAS) 'H NMR 
spectrum, provided sufficient evidence for polymer bound l//-benzotriazole 220 
(Figure 11). In the case of 218, only one signal from the benzotriazole (7.84 ppm) 
was apparent in the MAS ! H NMR spectrum, as the rest of the aromatic signals were 










Figure 11: High resolution MAS 'HNMR spectrum of a) unfunctionalised PEGA,900 216 and b) 220.
A MAS H NMR spectrum was not obtained for 217, as no nanoprobe was 
available at the time of production of this intermediate. Additionally, MAS 1 H NMR 
was unobtainable for macroporous-polystyrene bound benzotriazole, 219. 
Macroporous resin consists of a permanent network of pores which does not swell in 
any solvent. The poor swelling and rigidity of this resin means that only a small 
percentage of the attached substrate (i.e. exterior sites) is available to be detected by 
NMR which results in negligible signals in the MAS ! H NMR spectrum.
In the case of aminomethyl-polystyrene and amino-methyl-polystyrene 
macroporous adducts, 218 and 219 respectively, gel phase carbon-NMR was 
unproductive. Similar problems in acquiring gel phase carbon-NMR were 
encountered by Schiemann and Showaiter. 101 They reported that attempts to gather 
gel-phase 13 C NMR data on polymer supported benzotriazole 221 were unsuccessful, 
yet they were able to obtain spectra for the more flexible linkers 222 and 223 (Figure 
12). Similarly, Katritzky et. al. 10° could not obtain a resolved gel phase 13C spectrum 
for benzylic ether linked 1//-benzotriazole 182, even after a lengthy acquisition 
(Scheme 50). It is thought that the lack of mobility in the polystyrene bound \H- 
benzotriazole moiety of 218 and 219 inhibits the ability to obtain good quality gel
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phase C NMR. In the case of macroporous polystyrene adduct 219, the mobility 
effect is magnified as macroporous resin is non-swelling in all common organic 
solvents. One drawback of gel-phase 13C NMR on resin bound material is the low 
sensitivity which results from the small amount of compound attached to the resin. 
For this reason, gel-phase 13C NMR was unattainable for low loading PEGAi 90o 
bound l#-benzotriazole 220 (max; 0.2 mmol g" 1 ).
©L ) = 221 = -CH2-222 = -CH2-O-CH 2-
223 = -CH2 -O-(CH2 )6-O-CH2-
Figure 12: Various linker lengths for polymer bound IH-benzotriazole 221-223.
The lack of good analytical methods for resin bound samples has been a long- 
standing problem. 141 For example, conventional NMR techniques require samples to 
be relatively concentrated and homogeneous in order to achieve good spectral 
resolution. In order to try to overcome the difficulties associated with 
inhomogeneous samples, resin bound samples are pre-swollen in solvent. This 
technique is called 'gel-phase' NMR. Gel-phase proton NMR is limited in that poor 
resolution is obtained due to very broad linewidths (> 100-300 Hz) which hamper any 
attempt to analyse resin bound samples. Gel phase 13 C NMR has inherent problems 
associated with insensitivity of the technique due to the low abundance of the 13 C 
nuclei; in addition, it also exhibits broad linewidths (e.g. 25-75 Hz). None the less, 
the wide range of chemical shifts associated with 13 C NMR (0-220 ppm) means that 
some structural information can usually be gained from the higher loading swelling 
resins (e.g. polystyrene) and the lower loading swelling/non-swelling resins (e.g. 
PEGA, Tentagel) are difficult to analyse by gel-phase 13 C NMR without 
incorporating 13 C labels. 142
The advent of magic angle spinning (MAS) NMR has overcome some of the 
problems associated with obtaining ! H and 13 C NMR spectra of heterogeneous 
samples. In theory, significant line narrowing (e.g. 4 Hz) can be achieved for resin
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bound samples using MAS NMR since the effects of heterogeneous samples are 
lessened by spinning the sample at an angle to the applied magnetic field (54°). In 
practice, variable quality spectra are obtained depending on the resin and solvent 
used. Resins that offer the bound compounds the greatest mobility, such as PEG 
based and low cross-linked resins, produce the narrowest !H NMR linewidths. 143 In 
addition, the choice of solvent is crucial to the success of MAS spectra since the 
resin and bound compound is required to be swollen in the solvent.
3.3 Summary and conclusions
Polymer bound l//-benzotriazole adducts 217-220 were prepared using normal 
coupling procedures (i.e. diisopropylcarbodiimide, HOBt). The couplings were 
monitored by visual inspection (brown beads/gel indicated coupling) and the 
colourimetric Kaiser test. The presence of amide stretches in the FT-IR spectra of 
217-219 indicated the formation of the amide bond; however, in the case of 
PEGAi9oo adduct, 220 the polymer backbone amide stretches overlapped with the 
new amide bond. Therefore, magic angle spinning ! H NMR spectrum indicated the 
formation of 220. Problems were encountered when attempting to aquire gel phase 
13C NMR of polystyrene resins 218-219 and gel phase carbon-NMR spectra were 
unobtainable due to the lack of mobility in these resins. The low loading of 
resin 220 hampered attempts to obtain a gel-phase carbon-NMR spectrum.
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4 Results and discussion - Generation of aminal linkers
4.1 Reported syntheses of 1 -(benzotriazol-1 -yl)alkyl aminals
In 1988, Katritzky et. a/. 81 described the formation of l-(benzotriazol-l-yl)alkyl 
aminals 227 by condensation of an amide 225 with an aldehyde 226 and 
benzotriazole 224. This was achieved by refluxing in dry toluene with azeotropic 
removal of water (Scheme 56), in yields ranging from 52-78%.




R 1 = Me, Ph
R2 = i-Pr, Ph, 4-MeC6H4 , H, n-Pr, n-C5H^, fl-C8H 17
227
Scheme 56: Reagents and conditions: i. anhydrous toluene, reflux, Dean-Stark apparatus, 52-78%.
The preparation of condensation products from an amide 225, aldehyde 226 and 
benzotriazole 224 was initially thought to be limited to primary amides 227. 
However, in a later report by Katritzky et. al. m, it was found that the use of catalytic 
amounts of p-toluene sulfonic acid, or carrying out the reaction in acetic acid 







R! = H or Me
R2 = Me, Et, PhCH2 , Ph
R3 =H,/-Pr) Ph,A7-C8H 17
229
Scheme 57: Reagents and conditions: i. AcOH, reflux, Dean-Stark apparatus; ii. /?-TsOH, toluene, 
Dean-Stark apparatus.
Previous work in our group 107, used the methodology described above (Scheme 
57) to generate a novel linker 231 suitable for the attachment of alcohols to solid
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support (Scheme 58). Moderate loading yields were reported (50%), which was 
probably due to the forcing conditions needed for removal of water i.e. azeotropic 
removal with Dean-Stark apparatus. Preliminary enzyme hydrolysis experiments 
using penicillin acylase met with limited success (10%). However, only TentaGel 




Scheme 58: Reagents and conditions: i. Phenylacetamide, benzotriazole, p-toluene sulfonic acid, 
reflux under Dean-Stark Conditions, 18 h.
Initial studies concentrated on the syntheses and enzyme hydrolyses of 1- 
(benzotriazolyl)alkyl aminal linkers since the methodology for synthesis of these 
linkers was established, 107 albeit in a inverted manner (Scheme 58).
4.2 Synthesis of polystyrene-bound 1-(benzotriazol-1-yl)alkyl aminals
The synthetic schemes outlined above (Scheme 56/Scheme 57) allow the 
generation of a range of 1-(benzotriazole-l-yl)alkyl aminals 227/229 simply by 
manipulating the aldehyde 226 or amide 225/228 used. In view of the work by 
Flitsch et. at. 50, it seemed reasonable that this chemistry could be transferred directly 
to solid phase to produce polymer bound 1-(benzotriazole-l-yl)alkyl aminals. A 
range of these aminals were prepared on a benzotriazole solid support and subjected
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to various investigative tests. In addition, the resin bound aminals were incubated 
with penicillin acylase to determine if the enzyme can cleave the aldehyde from solid 
support.
Polystyrene-bound 1-(benzotriazole-l-yl)formyl aminal 232, was produced 
from the condensation of benzotriazole resin 218, benzamide and formaldehyde to 
give 232 in moderate loading (58%) (Scheme 59). The azeotropic removal of water 
was achieved through the use of Dean-Stark apparatus. Formation of linker 232 was 
confirmed by a signal at -5.4 ppm in the ] H MAS NMR spectrum corresponding to 




Scheme 59: Reagents and conditions: i. formaldehyde (37% in H2O/MeOH), benzamide, /Moluene 
sulfonic acid, anhydrous toluene, 48 h, reflux, Dean-Stark apparatus, 58% loading.
The cleavage of the linker 232 was observed using two acidic cleavage 
methods; trifluoroacetic acid/dichloromethane/water (9:10:1) and 95% trifluoroacetic 
acid in water. This was optimised by measuring the amount of benzamide released, 






















75 105 135 165 195 225 255 285 
Time (min)
Figure 13: Cleavage optimization of aminal linker 232.
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From Figure 13, it can be seen that both cleavage methods, TFA/DCM/H2O and 
95% TFA/H2O, follow a similar trend. In both cases, similar cleavage rates are 
observed and quantitative cleavage is obtained in 255 minutes (4.25 hours). This is 
in spite of the fact that, the hydrophobic polystyrene resin swells better in 
TFA/DCM/H2O (9:10:1) than 95% TFA/H2O. The anomalous results (e.g. at 45 min 
for 95% TFA cleavage) are possibly caused by inhomogeneous loading on the 
polymer matrix. Each measurement was made on different samples of resin 232. 
On-line monitoring of acidic cleavage using a Gilson SK233 robot and Water HPLC 
system produced unreliable results due to concentration gradients in the reaction
T\/T T*1V>f
mixture. This was caused by insufficient mixing inside the Iron can. Iron cans 
are small porous vessels which are used in combinatorial chemistry for the 
containment of resins. In light of the increased swelling ability, the TFA/DCM/H2O 
(9:10:1) cleavage mixture was chosen for future aminal linker cleavage.
The synthesis of polystyrene bound aminal linkers 233 and 234, was carried 
out; with a view to, demonstrating the ability to synthesise peptide aldehydes on 
solid support.
218
233; R 1 = Ph, 
234; R 1 = CH 2 Ph,
Scheme 60: Reagents and conditions: i. (5)-171, benzamide or phenylacetamide, p-toluene sulfonic 
acid, anhydrous toluene, reflux, Dean-Stark apparatus.
Condensation of polystyrene-bound benzotriazole 218, benzamide or 
phenylacetamide and (^-allyloxycarbonyl-phenylalaninal 171 in the presence of 
catalytic /?-toluenesulfonic acid under Dean-Stark conditions afforded the coupled 
linkers 233 and 234. During refluxing, a white solid precipitated overnight which 
was difficult to remove by washing due to the insolubility in most organic and
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aqueous solvents; DMF, DCM, DMSO, H2O, MeOH/H2O, (CH3)2CO, Et2O, EtOAc, 
CHsCN. Only prolonged washings with copious amounts of solvents; DMF, MeOH, 
DCM (-200 mL), in combination with sonication, removed the unwanted solid. 
Since, this was not observed when formaldehyde was employed as the aldehyde 
component in 232, it was reasonable to assume that the solid was associated with 
allyloxycarbonyl-phenylalaninal 171. Initially, 171 was soluble in toluene; however 
only after reflux overnight in the presence of the rest of the reagents, did the 
insoluble white solid become evident. It was thought that the presence of the p- 
toluene sulfonic acid caused the allyloxycarbonyl-phenylalaninal 171 to polymerise. 
Nonetheless, FT-IR confirmed the presence of the urethane carbonyl (-1700 cm" 1 ) in 
both cases 233 and 234. Additionally, MAS ! H NMR of 233 showed the Alloc 
protecting group at 4.30-4.67 ppm and 4.90-5.24 ppm.
O-}
In 2000, the mechanism for the formation of 148 was proposed by Rice and
1 OS
Burgess (Scheme 61). The first step involves nucleophilic attack of the 
benzotriazole nitrogen on the aldehyde carbon 147, followed by acid catalysed loss 
of water. Benzotriazole possesses both electron-donor and -acceptor properties and 





Scheme 61: Proposed mechanism for the formation of 148.
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The cleavage of 233 in TFA/DCM/H2O (9:10:1), followed by chiral HPLC 
(Section 8.2.9), was performed to ascertain whether C$)-allyloxycarbonyl- 
phenylalaninal 171 was generated from the solid support with retention of the chiral 
purity. The chiral HPLC of the cleaved and reduced product (i.e. allyloxycarbonyl- 
phenylalaninol 174) was compared to a sample of chemically prepared racemic 
allyloxycarbonyl-phenylalaninol 175 to allow for the accurate determination of chiral 
purity. Initially, a small sample of resin 233 (30 mg) was cleaved; however, it was 
found that the resolution of the chiral HPLC method was not sufficient to allow for 
an accurate determination of enantiomeric excess. Therefore, a large sample of resin 
233 (238 mg) was treated with TFA/DCM/H2O for 4 h. The residue obtained was 
reduced with sodium borohydride and analysed by chiral HPLC. The chiral HPLC 
trace showed one peak at a retention time of 30.5 min corresponding to (S)- 
allyloxycarbonyl-phenylalaninol 174 with 97% enantiomeric excess. This 
demonstrates the potential for cleaving amino aldehydes 171 from the aminal linker 
233 with complete retention of chiral purity, using an acidic cleavage method 
(TFA/DCM/H2O 9:10:1).
4.3 Enzymatic hydrolysis of polymer-bound 1-(benzotriazolyl)propyl aminals.
Polystyrene-based supports are used in a variety of classical solid phase organic 
reactions; however, due to the hydrophobic nature of this polymer, polar reagents fail 
to enter the matrix. Polystyrene can be modified by grafting poly(ethylene glycol) to 
the hydrophobic core to produce a polymer that swells in both non-polar and polar 
solvents. Among these PEG-grafted polystyrene supports, TentaGel has been used 
extensively in solid phase synthesis because of the mechanical stability of the beads 
and the good swelling properties in organic and aqueous media. However, TentaGel 
is based on the short cross linking agent divinylbenzene at a level of 1-2%, which 
prevents access to most enzymes20 . Waldmann et. a/. 43 showed that only the outer 
surface of the TentaGel bead is accessible to the biocatalyst (penicillin G acylase 80 
kDa) (Scheme 62). Recently, Bradley et. al. ]4 have shown that even small enzymes 
(12 kDa) are not accessible to TentaGel beads, hi contrast, a support based on
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poly(ethylene glycol) as the major component of the resin, is more compatible with 
aqueous media36 and should allow access to enzymes. PEGA consists of a co- 
polymer of 6zs-2-acrylamidoprop-l-yl polyethylene glycol and the rapid diffusion of 
even large biomolecules in the interior of the PEGA polymer network, has recently 





Scheme 62: Reagents and conditions: i. penicillin G acylase suspension, 10% methanol, 37 °C, 10% 
cleavage.
The problem of solvent compatibility is significantly reduced with the advent of 
rigid macroporous supports. Access of liquid reagents to the reaction sites occurs by 
rapid diffusion through the rigid, open pore structure rather than through a swollen 
gel phase. Additionally, accessibility of reaction sites is independent of solvent type. 
The macroporous polystyrene-co-divinylbenzene (MP) resins were invented in the 
1950's 109 and since then, have been further developed to provide MP resins with 
larger pore sizes (>1000 A), suitable for the diffusion of macromolecules. Another 
macroporous resin available is controlled pore glass (CPG). As mentioned already
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(Section 1.2.5), it seems that a large pore size of CPG (>100 nm) is crucial to the 
success of biotransfomations on solid support. 14 Waldmann et. at 44 described the 
use of CPG with a pore size of 50 nm in combination with a large enzyme (80 kDa), 
but only minor cleavage (10%) of a model compound from this support was detected 
(Scheme 62).
Two enzyme labile aminal linkers 237 and 238 were prepared and their 
compatibility with enzymatic hydrolysis tested.
4.4 Synthesis of enzyme-labile polymer bound 1-(benzotriazole-1-yl)propyl aminals.
Macroporous polystyrene and TentaGel bound l-(benzotriazole-l-yl)alkyl 
aminals 237 and 238 were obtained using the procedure described for polystyrene 
resin 233 and 234 (i.e. Scheme 60) (Figure 14).
237; P = macroporous aminomethyl polystyrene 
238; P = TentaGel
Figure 14: Enzyme labile aminal linkers 237 and238.
The FT-IR of macroporous resin, 237 was inconclusive since the urethane 
carbonyl stretch (-1720 cm" 1 ) was masked by anomalous polymer backbone 
carbonyl stretches. In addition, Gel phase 13C and MAS ] H NMRs were unattainable 
due to the non-swelling character of the macroporous support. In this case, the 
linker 237 was carried through to the next step. In the case of TentaGel resin 238, 
the presence of a urethane carbonyl stretch at 1717 cm" 1 confirmed the success of the 








Figure 15: FT-IR spectrum of a) unfunctionalised amino tentagel (KBr disc) and b) 238 (KBr disc).
4.5 Enzyme hydrolysis studies
The compatibility of resins 237 and 238 towards penicillin acylase mediated 
hydrolysis was assessed. Enzyme hydrolysis experiments were performed by Dr 
Rein Ulijn at Edinburgh University. The resins 237 and 238 were treated with 
penicillin acylase in phosphate buffer pH 7.4 for 16 hours and the amount of 
phenylacetic acid released was analysed by reverse phase HPLC (Section 8.2.9). As 
expected, the hydrolysis of TentaGel bound linker 238 with penicillin acylase only 
resulted in surface sites being cleaved (i.e. <12% cleavage). This is in agreement 
with studies carried out by Barany et. at.,24 who reported that only the surface sites 
on TentaGel resin were accessible to biomolecules. It was expected that enzyme 
hydrolysis on macroporous polystyrene linker 237 would be more successful due to 
the large rigid pores. However, penicillin acylase mediated hydrolysis on 
macroporous resin 237 was very disappointing and the maximum cleavage yield was 
<5%. This result suggests that the hydrophobic aromatic backbone of macroporous
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polystyrene resin repels the hydrophilic enzyme; therefore, inhibiting access of the 
enzyme to the interior of the macroporous resin.
4.6 Summary and conclusions
The synthesis of various aminal linkers 232-234 and 237-238 has been 
demonstrated. Cleavage optimization of polystyrene linker 232 was performed. It 
was discovered that the best cleavage conditions were TFA/DCM/FkO (9:10:1) for 
4.25 hours. The potential for cleaving amino aldehydes from these aminal linkers 
was demonstrated by acidic cleavage of 233 which afforded (£)-allyloxycarbonyl- 
phenylalaninal 171 in 97% enantiomeric excess.
Enzymatic hydrolysis of macroporous polystyrene and TentaGel aminal linkers, 
237 and 238 was carried out. Penicillin acylase mediated hydrolysis of TentaGel 
resin 238 only resulted in surface sites being cleaved (<12% cleavage). Whereas, 
<5% hydrolysis was observed for macroporous aminal linker 237.
73
Results and Discussion
5 Results and discussion - Solid-phase peptide aldehyde synthesis
on aminal linker.
5.1 Reported synthesis of tetrapeptide.
It was thought that, the synthesis of a simple tetrapeptide would be a 
straightforward and rapid way of demonstrating the scope of the linkers, 233 and 
234. Thompson et. al. 55 reported the solution phase synthesis of the tetrapeptide 
aldehyde, acetylprolylalanylprolyl-phenylalaninal 244 via diethyl acetyl masked 
phenylalaninal 242 (Scheme 63).
o
244
Scheme 63: Reagents and conditions: i. l-ethyl(3,3-dimethylaminopropyl)carbodiimide 
hydrochloride, DMSO, 2 M solution of anhydrous phosphoric acid in DMSO, 3 h; ii. /^-toluene 
sulfonic acid, triethylorthoformate, ethanol, 30 min; iii. Sodium hydroxide (1 M), methanol, 45 min, 
H2O, r.t.; iv. acetylprolylalanylproline, 7V-methylmorpholine, acetonitrile, -20 °C, 
isobutylchloroformate, then r.t for 4 h; v. Dowex AG50W resin (H+ form), r.t., 2.5 h.
The peptide aldehyde, prolylalanylprolylphenylalaninal 244 was chosen for 
solid phase synthesis using the aminal linkers 233 and 234. Due to the relatively 
poor enzymatic cleavage yields for 237 and 238, it was decided to target chemical 
methods for the cleavage of the peptide aldehyde from solid support; for this reason,
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aminomethylated polystyrene resins, 233 and 234, were chosen for the synthesis of 
the peptide aldehyde.
5.2 Solid-phase peptide aldehyde synthesis on aminal linker.
Deprotection of allyloxycarbonyl from 233 and 234 was achieved with borane- 
dimethylamine complex and soluble palladium catalyst to afford 245 and 246 
(Scheme 64). This combination allows the rapid deprotection (10 min) of allyl 
carbamates under nearly neutral conditions and without any side-formation of 
allylamine. The reaction was monitored by the Kaiser test (Section 8.2.5.1) and the 
FT-IR spectrum of resin bound free amine 245, showed complete disappearance of 
the carbonyl urethane stretch at -1700 cm" 1 .
Coupling of Fmoc-proline to the free amine resins 245 and 246 was carried out 
using the common coupling reagents, HBTU and HOBt in the presence of DIPEA as 
base. Complete coupling was achieved when a negative Kaiser test (Section 8.2.5.1) 
was observed after 4 hours, for 247 and 248. Fmoc deprotection was accomplished 
with 20% piperidine in DMF. The amino acid coupling procedure described above 
was repeated with Fmoc-alanine, followed by Fmoc deprotection. The final amino 




233; R 1 = Ph, 
234; R 1 = CH 2 Ph,
245; R 1 = Ph 
246; R 1 = CH2 Ph
'Fmoc
249; R 1 - Ph, 247; R 1 = Ph 
250; R 1 - CH 2 Ph, 248; R 1 = CH 2 Ph
Scheme 64: Reagents and conditions: i. borane-dimethylamine complex, Pd(PPh3)4 , anhydrous DCM, 
10 min, r.t; ii. Fmoc-Pro-OH, DMF, DIPEA, 0.45M HBTU/HOBt solution in DMF, 4 h, r.t.; iii. 20% 
piperidine in DMF, 20 min; iv. Fmoc-Ala-OH, DMF, DIPEA, 0.45 M HBTU/HOBt solution in DMF, 
4 h, r.t.; v. 20% piperidine in DMF, 20 min; vi. Fmoc-AA-OH, DMF, DIPEA, 0.45 M HBTU/HOBt 
solution in DMF, 4 h, r.t.
Loading of the tetrapeptide aldehydes 249 and 250 was calculated at 0.16 (27%) 
and 0.28 mmol g" 1 (48%) respectively using Fmoc analysis (Section 8.2.6.1). These 
loading yields were unexpected. The loading of benzamide linker 249 was expected 
to be higher than the phenylacetamide linker 250. This may be explained by the 
differences in nucleophilicities of the amides. In the construction of linkers, 233 and 
234), nucleophilic amide reacts with benzotriazole imine 236 (Scheme 61). In the 
case of phenylacetamide (Route a; Figure 16), the lone pair of electrons on the amide
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nitrogen can be delocalized onto the carbonyl to decrease the nucleophilicity of the 
nitrogen; however, in benzamide (Route b; Figure 16), there is less delocalization of 
the amide nitrogen electrons due to competing delocalization of the aromatic 
electrons onto the carbonyl. This renders the amide nitrogen on benzamide more 
nucleophilic than the phenylacetamide nitrogen. These loading yields suggest that 
steric hindrance is more important than electronic effects since the aryl ring is closer 
to the reactive amine in benzamide than phenylacetamide. Therefore, the aryl ring 
on benzamide hinders nucleophilic attack on benzotriazole imine 236.
a)
Figure 16: Delocalization of electrons onto carbonyl carbon for a) phenylacetamide and b) 
benzamide.
At the time of production of these resins 249 and 250, the use of MAS ! H NMR 
to analyse these resins was impossible due to the lack of a MAS probe within the 
department. Nonetheless, MAS ! H NMR of 249 and 250 was carried out at a much 
later date. It should be noted that these amide linkers decompose slowly over about 
12 months even at 4 °C. The spectrum of both, showed mainly broad signals which 
were too weak to assign confidently. Many of the proton signals were masked by the 
methine, methylene and aromatic signals from the polystyrene backbone. However, 
in both cases, two benzotriazole aromatic signals were evident at -7.6 - 7.8 ppm, as 
was the methine aminal proton at -6 ppm (Figure 17).
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Figure 17: MAS JH NMR spectrum of a) aminomethyl polystyrene 214 and b) 249.
Cleavage of both linkers 249 and 250 was carried out using TFA/DCM/HbO 
(9:10:1) (Section 8.2.7.1), followed by LC-MS analysis (Section 8.2.8). In the case 
of 250, the mass spectrometry clearly shows the desired MH+ ion at 637 m/z at a 
retention time of 26 min (Figure 18). Further treatment with acid resulted in no 
further cleavage of peptide aldehyde indicating that cleavage was quantitative. 
Insufficient material was obtained for analysis by !H NMR, even at 600 MHz. Only 
broad unresolved peaks were obtained probably due to the nature of the peptide and 
insufficient material. Attempts were made to purify the peptide aldehyde using an 
automated mass directed fraction collector and Micromass ZMD mass spectrometer. 
This was unsuccessful due to insufficient material and problems with insensitivity of 
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Figure 18: ES-MS of 250 cleavage mixture.
Unfortunately, cleavage of 249 (Scheme 64), resulted in no peptide aldehyde 
being detected by electrospray mass spectrometry. This suggested that one of the 
amide couplings was not successful since Fmoc was clearly present from the UV 
trace after piperidine cleavage; although, there were no MH+ ions in the mass 
spectrum of 249 corresponding to depletions in the peptide backbone.
At this point, it was thought that the synthesis of a dipeptide aldehyde would 
simplify the analysis. Hence, dipeptide aldehyde linker 251 was synthesized using 
the same coupling procedures as used for the tetrapeptide aldehyde (Scheme 64). In 
this case, racemic allyloxycarbonyl-phenylalaninal 173 was used.
Acidic cleavage of 251 (Scheme 65), followed by purification using semi- 
preparative TLC (Rf = 0.33) and electrospray mass spectrometry (Figure 19) revealed 
the presence of the desired [M+Na] + ion at 491 m/z and another impurity which has 
been postulated to be the imine intermediate, [M+H]+ and [M+CHaCN]* ions at 572 
and 612 m/z respectively. This imine intermediate can undergo nucleophilic attack
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by liberated benzamide 253 to generate the benzamide aminal adduct, [M+H] and 
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Figure 19: ES-MS of purified dipeptide 252.
Insolubility of the dipeptide aldehyde 252 in many common deuterated solvents 
hampered attempts to obtain ! H NMR analysis. Eventually, a mixed solvent system 
(CDC13/CD3OD) was found that sufficiently solvated the dipeptide aldehyde 252. ! H 
NMR of the peptide aldehyde 252 was broad and unresolved even when run on a 600 
MHz instrument. However, signals were evident at 9.63 and 9.95 ppm 
corresponding to the diastereomeric aldehyde protons.
In view of the low/moderate yields of polystyrene bound-peptide aldehydes 249 
and 250, it was decided to optimize the peptide coupling yields. One way of 
achieving this, may be by changing the connectivity of the benzotriazole to the 
polystyrene.
In the case of linkers 249 and 250, benzotriazole is bound to the polystyrene 
backbone through an amide moiety. The conjugated amide would render the 
benzotriazole proton slightly more acidic and hence, the nitrogen less basic (Figure 
20). Therefore, the coupling reaction would be slightly more difficult to perform on 




Figure 20: Weak conjugation into amide 218.
With this in mind, the synthesis of a benzotriazole resin 254 attached through a 
reversed amide functionality was carried out, using DIG coupling procedures 
(Scheme 66). Although other methods of attachment of benzotriazole were possible, 




Scheme 66: Reagents and conditions: i. (5)-171, benzamide, /?-toluene sulfonic acid, anhydrous 
toluene, 48 h, reflux, Dean-Stark apparatus.
The aminal linker 255 was generated using the same coupling procedures as 
before (Scheme 66). FT-IR confirmed the presence of the urethane carbonyl at 1715 
cm" 1 . MAS *H NMR was not carried out due to lack of MAS probe at the time. 
Peptide synthesis was carried out as before (Section 5.2) to give the polystyrene 
bound aldehyde 256 with a loading yield of 15%. This loading is slightly lower than 
the loading obtained for the conjugated amide linker, 249 (27%). One possible 
reason for this could be that, the now relatively basic benzotriazole nitrogen 
neutralizes the catalytic />-toluene sulfonic acid needed for the removal of water
o^
(Scheme 61). Work performed previously by Rice indicated that 50% was the 
maximum yield obtainable for solution phase couplings using phenylacetamide 
(Scheme 61). Therefore, 48% loading seemed quite acceptable and no further work 
was carried out in this area.
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Again, acidic cleavage of the peptide aldehyde 256 was performed (TFA/DCM/H2O 
9:10:1) (Scheme 67) and electrospray mass spectrometry (Figure 21) confirmed the 
presence of tetra-peptide aldehyde 257. Insufficient aldehyde 257 was obtained for 
analysis by *H NMR, due to the low loading of the resin (0.091 mmol g" 1 ).
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Figure 21 : ES-MS of 256 cleavage mixture.
5.3 Summary and conclusions
Tetra-peptide aldehyde 257 was synthesized on polystyrene aminal linkers 250 
and 256 and cleaved using acid to release 257. Electrospray mass spectrometry of 
the cleavage mixtures gave the appropriate molecular ions for the tetrapeptide 
aldehyde 257. Unfortunately, no ] H NMR data could be obtained for the released 
tetrapeptide aldehyde. Tetra-peptide aldehyde 257 was also synthesized using 
polystyrene hemiaminal linker 328 (Chapter 7). Acidic cleavage of 328, followed by 
purification using semi-preparative HPLC and electrospray mass spectrometry of the 
purified fraction also gave similar [M+H]+, [M+Na]+ and [M+K]+ ions. The 
presence of similar molecular ion adducts from the cleavage of the three different 
linkers, 250, 256 and 328 strengthens the evidence for the synthesis of tetrapeptide 
aldehyde 257 on polystyrene resin.
The synthesis of diastereomeric dipeptide aldehyde 252 was carried out on 
polystyrene aminal linker 233. Electrospray mass spectrometry and high resolution 
'H NMR analysis of the acidic cleavage mixture indicated the presence of the 
diastereomeric dipeptide aldehyde 252 on linker 233.
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6 Results and discussion - Generation of hemiaminal linkers
As mentioned previously (Section 4.2), the synthesis of the aminal linker 233 
resulted in polymerisation of the allyloxycarbonyl-phenylalaninal 171. This was 
caused by the forcing conditions required for construction of the linker 233 (i.e. 
reflux in toluene for 48h with azeotropic removal of water). One way to avoid these 
problems would be through the use of milder reaction conditions for the generation 
of the linker 233. This was envisaged through an analogous hemiaminal linker 258, 
which can be generated under mild conditions110 (Figure 22).
rv-
v_x
Figure 22: Proposed structure of hemiaminal linker 258.
6.1 Solution-phase synthesis of hemiaminal linkers
The synthesis of the hemiaminal linker 258 was first carried out in solution, 
with a view to eventually generating the linker on solid phase.
6.1.1 Reported syntheses of 1-(benzotriazol-1-yl)alkyl hemiaminals
In 1957, Gaylord and Naughton111 reported the synthesis of benzoyloxymethyl- 
1 //-benzotriazole 260 by direct treatment of 1-hydroxymethyl benzotriazole 259 with 




Scheme 68: Reagents and conditions: i. benzoyl chloride or benzoic anhydride, base.
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A similar approach was taken by Ono and Itoh112 who prepared the levulinate 
262 and acetate 263 hemiaminals, by reaction of the appropriate anhydride with 5- 




Scheme 69: Reagents and conditions: i. pyridine, DMAP, THF, r.t.
In 1991, Katritzky et. a/. 113 reported the synthesis of l-(benzotriazole-l-yl)alkyl 
hemiaminals 266 by the displacement of chlorine from 1-(1- 














Scheme 70: Reagents and conditions: i. thionyl chloride, chloroform, reflux, 30 min; ii. DMSO, 50 
°C, 5 h.
In a later report by Katritzky et. al.,m the synthesis of benzotriazole 
hemiaminals 266 and 269 by the reaction of JV-acyl benzotriazoles 268 with either 










R1 = C6H5) 4-MeOC6H4 , CICH2 , CI(CH2 )3 , Me, f-Bu, 2-furyl 
R2 = Et, Pr, f-Bu, 2-furyl, 4-NO2C6 H4 , 4-MeO2CC6 H4) 
4-NCC6H4 , 4-MeC6H4) C6H5 269
Scheme 71: Reagents and conditions: i. Et3N, anhydrous DCM, 0 °C, 30 min: ii. acetonitrile, base.
Aliphatic aldehydes and electron deficient aromatic aldehydes 226 were found 
to give benzotriazole hemiaminals in quantitative yields at room temperature. In 
contrast, electron rich aromatic aldehydes 226 required elevated temperatures and 
prolonged reaction times. In general, most hemiaminals were obtained as the 1' 
isomer 266 however, some products contained small amounts (8-18%) of the 2' 
isomer 269. It was also found that various bases could be used without any serious 
detrimental effects on the yields of hemiaminal obtained (e.g. potassium carbonate, 
tnethylamine). However, formation of the 2' isomer 269 could be minimized by 
using triethylamine as a base. The implications of this will be discussed in more 
detail in Section 6.1.5.
6.1.2 Solution synthesis of model hemiaminal linkers from N-acyl 
benzotriazoles
Variation of the R2 group on aldehyde 226 allows the generation of a range of 
benzotriazole hemiaminals 266 and 269 from readily synthesized 7V-acyl 
benzotriazole 268 (Scheme 71). Using this route, a range of hemiaminals 270-272 
were prepared and subjected to enzymatic hydrolysis to investigate whether they are 
substrates for lipases/esterases/penicillin acylase and that they fragment, according to 




N-acyl benzotriazoles 270-272 were generated from the reaction of 
benzotriazole 224 with the corresponding acid chlorides in anhydrous DCM with 
triethylamine as base (Scheme 72). Benzoyl chloride and phenylacetyl chloride were 
commercially available; however 4-phenylbutyryl chloride was obtained from 4- 





Scheme 72: Reagents and conditions: i. benzoyl chloride, Et3N, DCM, 56%: ii. phenylacetyl 
chloride, Et3N, DCM, 73%: iii. 4-phenylbutyryl chloride, Et3N, DCM, 71%.
7V-acyl benzotriazoles 270-272 were converted to the 1' hemiaminals 273-275 
by reacting with formaldehyde 277 in acetonitrile with triethylamine; the 2' 
hemiaminals were not detected in the reaction mixtures (Scheme 73). The yields 
obtained for 273-275 were lower than the quantitative yields reported by 
Katritzky, 110 possibly due to the presence of methanol and water in the formaldehyde 






Scheme 73: Reagents and conditions: i. formaldehyde (37% in MeOH/H2O, Et3N, acetonitrile, r.t., 
60 min, 66%; ii. formaldehyde (37% in MeOH/H2O, Et3N, acetonitrile, r.t, 16 h, 45%; iii. 
formaldehyde (37% inMeOH/H2O, Et3N, acetonitrile, r.t., 16 h, 63%.
6.1.3 Enzymatic hydrolysis of model hemiaminal linkers
The suitability of l-(benzotriazole-l-yl)formyl hemiaminals 273-275 as 
substrates for lipase, esterase and penicillin acylase had to be ascertained. This was 
achieved by performing small scale hydrolysis reactions (0.3 (imol of each substrate) 
using 7 Upases, 1 esterase and penicillin acylase (Table 1). The substrates 273-275 
were treated with each enzyme at room temperature in 10% acetonitrile/potassium 
phosphate buffer pH 7.4 for 16 hours and the amount of corresponding acid released 
276 (Scheme 74), determined by reverse phase HPLC. Experimental conditions are 





Pseudomonas fluorescens lipase (PFL)










































Table 1: Quantitative conversion ofhemiaminal substrates 273-275 with enzymes.
The quantitative results displayed in Table 1 indicate that all of the 
benzotriazole hemiaminals 273-275 were hydrolysed, at least to some extent, by all 
of the enzymes tested. With 273, PFL, PPL, Chromobacterium viscosum, 
Penicillium roqueforti lipases and Thermoanaerobium brockii esterase all exhibit 
near quantitative conversion to the acid. In the case of 274, PFL, PPL, 
Chromobacterium viscosum lipases and Thermoanaerobium brockii esterase all show 
near quantitative cleavage. As expected, Penicillin acylase shows quantitative 
conversion of 274. In general, all the lipases cleaved 275 in almost quantitative 
yield, as did Thermoanaerobium brockii esterase. However, the conversion of 275 
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Figure 23: Reverse phase HPLC trace of 273 cleavage with Pseudomonas fluorescens lipase.
In addition to the corresponding acids 276, benzotnazole 224 was detected by 
HPLC (Figure 23) for all these substrates indicating that the hemiacetal product 259 




R = Ph, CH2Ph, CH2CH2CH2 Ph
Scheme 74: Fragmentation of 259 to formaldehyde 277 and benzotnazole 224.
These results (Table 1) show that all of the benzotnazole hemiaminals 273-275 
are substrates for the lipases, esterase and Penicillin acylase tested. Ultimately, these 
benzotriazole hemiaminals will be used as linkers for attachment of aldehydes, 
namely amino aldehydes. At this point, it was decided to generate benzotriazole 
hemiaminals 278-280 from (*S)-allyloxycarbonyl-phenylalaninal 171, to test whether 
these were substrates for the enzymes. It was crucial to establish that these 
benzotriazole hemiaminals 278-280 were substrates for these enzymes, as they 
contain two chiral centres and therefore, can exists as four possible diastereomers; 
unlike the achiral hemiaminals generated from formaldehyde 273-275.
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Synthesis of diastereomeric 1-(benzotriazol-1-yl)propyl hemiaminals
With this in mind, 7V-acyl benzotriazoles 270-272 were converted to the 
diastereomeric 1' hemiaminals 278-280 by reacting with (*S)-Alloc-phenylalaninal 
171 in acetonitrile or dichloromethane with triethylamine; the 2' hemiaminals were 
not isolated from the reaction mixtures (Scheme 73). The diastereomeric mixtures, 





Scheme 75: Reagents and conditions: i. (S)-171, Et3N, acetonitrile/dichloromethane, r.t., 16 h, 55%; 




Examination of the proton NMR for each mixture, 278-280 revealed that two 
diastereomers a and b were formed during the aldehyde insertion step. Both 
diastereomers of substrates 278-280 were observed in the RP-HPLC. In addition, 
small amounts (<3%) of the 2' isomers of each diastereomer were observed in the 
HPLC. Other bases can be used for the aldehyde insertion (i.e. potassium carbonate); 
however, Katritzky et. al uo reported that the use of triethylamine minimized the 
formation of the 2' isomer 269 (Scheme 71). This is favourable to limit the amount 
of potential isomers exposed to the enzyme and hence, allow for a more accurate 
substrate specificity study. The diastereomeric excess for each substrate 278a/b, 
279a/b and 280a/b was 45%, 21% and 22% d.e. respectively. This suggests that the 
aldehyde insertion step (Scheme 75) does not necessarily generate a 1:1 mixture of 
diastereomers. It was not deemed necessary to separate the diastereomers a and b, 
since no control would be possible over the diastereomeric excess of the solid phase 
bound analogues of these hemiaminals. Since, these diastereomers were not isolated, 
it is not known which diastereomer a or b is in excess.
6.1.5 Enzymatic hydrolysis of diastereomeric 1-(benzotriazole-1yl)propyl 
hemiaminals.
The suitability of diastereomeric l-(benzotriazole-l-yl)propyl hemiaminals 
278-280 as substrates for lipase, esterase and penicillin acylase cleavage was 
ascertained. This was achieved by performing small scale hydrolysis reactions (0.9 
jumol of each substrate) using 7 Upases, 1 esterase and penicillin acylase (Table 2). 
The substrates 278-280 were treated with each enzyme at room temperature in 10% 
acetonitrile/potassium phosphate buffer pH 7.4 for 16 hours and the amount of 
corresponding acid released determined by reverse phase HPLC. Experimental 





Pseudomonas fluorescens lipase (PFL)











































Table 2: Conversion of diastereomeric benzotriazole hemiaminals 278-280 with enzyme.
In all reactions where hydrolysis was observed, both (^-Alloc-phenylalaninal 
171 and benzotriazole 224 were observed in the reverse phase-HPLC traces (Rt = 4.4 
min and 9.6 min respectively). From Table 2, it can be seen that neither of the 
diastereomers of benzotriazole hemiaminal 278a/b were hydrolysed by any of the 
enzymes tested. In the case of 279a/b, Hog pancreas lipase and Penicillin acylase 
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Figure 25: Reverse phase HPLC trace of280a/b cleaved with Hog pancreas lipase.
The control experiment exhibited a diastereomeric excess of 21% for 
unhydrolysed 279a/b; whereas, in the presence of Hog Pancreas lipase a 
diastereomeric excess of 62% was obtained for unhydrolysed 279a/b. This showed 
that Hog pancreas preferencially hydrolyses one diastereomer over the other. On the 
other hand, Penicillin acylase did not seem to exhibit any diastereoselectivity (i.e. 
20% d.e. c.f. 21% d.e. in control). For 280a/b, only Hog Pancreas lipase cleaved the 
hemiaminal in good yield (i.e. 72%) (Figure 25) and was shown to be selective for 
the minor diastereomer (i.e. diastereomeric excess of the unhydrolysed material 
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Figure 26: Reverse phase HPLC trace of a) Control containing 279a/b and b) 279a/b cleaved with 
Hog pancreas lipase.
6.1.6 Summary and conclusions
Model l-(benzotriazol-l-yl)alkyl hemiaminals 273-275 were synthesized using 
methodology developed by Katritzky et. al. UQ (45-66% yield). Enzymatic screening 
revealed that all of the benzotriazole hemiaminals 273-275 were substrates for all of 
the lipases and the esterase. In general, hemiaminal 275 was the best substrate for 
the lipases and hemiaminal 274 was the best substrate for penicillin acylase.
Diastereomeric 1-(benzotriazole-l-yl)propyl hemiaminals 278a/b-280a/b were 
prepared in order to study the effect of the diastereomeric centres on the substrate 
specificity of the enzymes, hi the case of 278a/b, none of the lipases or the esterase
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hydrolysed the diastereomeric hemiaminal 278a/b. This is in sharp contrast to the 
achiral benzotriazole hemiaminal equivalent 273 where nearly all the lipases/esterase 
hydrolysed the substrate 273 in excellent yield (>90% conversion). Only penicillin 
acylase and Hog pancreas lipase hydrolysed the diastereomeric hemiaminal 279a/b 
in 27 and 20% respectively. In addition, Hog pancreas preferentially hydrolyses one 
diastereomer over the other (62% d.e.). For 280a/b, only Hog pancreas lipase 
cleaved the hemiaminal in good yield (72%) and diastereomeric excess (64% d.e.).
To conclude, it can be seen that the presence of the allyloxycarbonyl-amino-3- 
phenyl-propyl group in substrates 278-280 dramatically decreases the substrate 
specificity of all the enzymes tested, compared to the methyl hemiaminals 273-275.
6.2 Solid phase synthesis of hemiaminal linkers
With the results of the enzymatic hydrolysis of the solution phase analogues 
273-275 and 278-280 in mind, the synthesis and enzymatic hydrolysis of the solid 
support bound equivalents were undertaken.
6.2.1 Solid phase synthesis N-acyl benzotriazole resins
Polymer bound 7V-acyl benzotriazoles 281-286, were prepared by acetylation 
of benzotriazole adducts 218-220 with the corresponding acid chlorides in anhydrous 
dichloromethane with triethylamine as base (Scheme 76). 
o
218; P = aminomethylpolystyrene
III' P = aminomethylpolystyrene MP ^ . p = amjnomethy| po ,ystyrene , R = Ph
^u, K KtUA 1900 282; p = aminomethy| polystyrene MP, R = Ph
283; P = aminomethyl polystyrene MP, R = CH2Ph
284; P = PEGA1900 , R = Ph
285; P = PEGA1900 , R = CH 2 Ph
286; P = PEGA 1900 , R = CH 2 CH 2CH2Ph
Scheme 76: Reagents and conditions: i. benzoyl chloride, phenylacetyl chloride, or 4-phenylbutyric 
chloride, Et3N, anhydrous dichloromethane, 20 h, r.t.
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Formation of the W-acyl bond resulted in a strong carbonyl stretch at -1700 
cm"1 in the FT-IR for all polymer bound substrates 281-286. For substrates 281 and 
284-286, additional aromatic signals can be seen in the MAS ! H NMR spectra which 
can be attributed to the extra phenyl rings present in the polymer bound N-acyl 
benzotriazole (Figure 27). 
a)__




The polymer bound W-acyl benzotriazoles 281-286 were found to be relatively 
unstable at room temperature decomposing over a few weeks but could be stored for 
several months below 0 °C.
6.2.2 Solid-phase synthesis of model hemiaminal linker
The preparation of polymer-bound benzotriazole hemiaminals 287-290 was 
carried out by reacting N-acyl benzotriazole resin 281, 284-286 with formaldehyde 





287; P = amino-methyl polystyrene, R = Ph
288; P = PEGA1900 , R = Ph
289; P = PEGA1900 , R = CH2 Ph
290; P = PEGA-,900, R = CH2CH2CH2 Ph
Scheme 77: Reagents and conditions: i. polymer-bound N-acy\ benzotriazole, formaldehyde, EtsN, 
acetonitrile, 20 h, r.t.
The loading for substrate 287 was much improved over the aminal linker 
analogue 232 (i.e. 77%, c.f. 58% loading). This was probably due to the milder 
conditions required for the synthesis of 287 compared to conditions required for the 
condensation of benzotriazole, formaldehyde 277 and benzamide for the synthesis of 
232. It should be noted that PEGAi 90o linker 288 was obtained with a loading of 
34%, which is substantially less than the equivalent polystyrene linker 287 (77%). 
This was probably caused by a greater affinity of the organic reagents/solvents for 
the hydrophobic polystyrene resin 287.
For each substrate 287-290, the complete disappearance of the W-acyl carbonyl 
stretch at 1700 cm" 1 and the emergence of an ester carbonyl stretch at -1730 cm" 1 in 
the FT-IR indicated complete insertion of the formaldehyde 277 into the N-acy\ 
bond. Additionally, an extra peak at -6-7 ppm was evident in all MAS 'H NMR
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spectra which was assigned to the hemiaminal methylene of substrates 287-290 
(Figure 28).
Figure 28: High resolution MAS 'HNMR spectrum of 287.
It is assumed that a mixture of 1', 2' and 3' hemiaminals were formed, although
it was thought that the 1' hemiaminal was the predominant form (Figure 29).
R
N
1' isomer 3' isomer
Figure 29: 1', 2' and 3' isomers of benzotriazole hemiaminals 287-290.
6.2.3 Evaluation of chemical cleavage methods for model hemiaminal linker
The ability to cleave polymer bound benzotriazole hemiaminals 287-290 is 
central to their application as effective aldehyde linkers. The cleavage was 
envisaged through base induced hydrolysis of the ester 287, followed by 
fragmentation of the mixed hemiacetal moiety 291 (Scheme 78). Polystyrene-bound
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A selection of bases were screened for their effectiveness in the cleavage of 
polystyrene bound benzotriazole hemiaminal 287. The substrate was treated with 
each base according to the experimental procedures detailed in Section 8.6.27 and 













TableS: +(0-25%), ++(26-50%), +++(51-75%), ++++(76-100%).
The qualitative results displayed in Table 3 indicate that methanolic ammonia, 
hydrazine hydrate and sodium hydroxide cleave the ester 287, in almost quantitative 




Ultimately, the benzotriazole hemiaminal linker 287 was to be used for the 
attachment, manipulation and subsequent release of amino aldehydes into solution. 
Therefore, it was essential to ensure that the cleavage methods (Table 3) were 
suitable for the release of aldehydes into solution.
6.2.4 Solid phase synthesis of diastereomeric hemiaminal linkers
With the results of the base cleavage of 287 in mind, the synthesis of Alloc- 
protected phenylalaninal coupled benzotriazole resin 293 was undertaken. This was 
achieved by reacting 7V-acyl benzotriazole resin 281 with (^-allyloxycarbonyl- 




Scheme 79: Reagents and conditions: i. (5)-171, Et3N, acetonitrile, 20 h, r.t.
Analysis of 293 by FT-IR revealed the formation of an ester carbonyl stretch at 
1730 cm" 1 . In addition, the MAS ! H NMR spectrum of 293 showed characteristic 
signals at 4.54, 5.06 and 5.75 ppm consistent with the protons of the 
allyloxycarbonyl-protecting group (Figure 30).
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Figure 30: High resolution MAS 'HNMR of 293.
With 293 in hand, base cleavages were repeated as before and the samples 
analysed by electrospray mass spectrometry according to Section 8.2.8. It was found 
that although the bases listed in Table 3 cleaved linker 293, to release the 
corresponding acid derivative, only methanolic ammonia and sodium hydroxide 
released the desired allyloxycarbonyl-phenylalaninal 171/173 into solution. It should 
be noted that allyloxycarbonyl-phenylalaninal 171/173 was unstable in sodium 
hydroxide since treatment with a solution of 1 M sodium hydroxide in dioxane for 2 
hour resulted in a mixture of allyloxycarbonyl-phenylalaninal 173, self-condensation 







Scheme 80: Reagents and conditions: i. 1 M NaOH/dioxane (3:2), 2 h.
An aliquot of the cleaved allyloxycarbonyl-phenylalaninal 173 was reduced 
using sodium borohydride (Scheme 81) and analysed by normal phase chiral HPLC 
according to Section 8.2.9.
OH
173 175
Scheme 81: Reagents and conditions: i. Sodium borohydride, EtOAc, r.t, 30 min.
Not surprisingly, it was found that the cleaved allyloxycarbonyl-phenylalaninal 
173 was completely epimerized (0% e.e.) during sodium hydroxide and methanolic 
ammonia cleavage. One way of avoiding the problem of epimerization of the 
cleaved aldehyde could be through the use of hydrolytic enzymes.
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6.2.5 Enzymatic hydrolysis of model enzyme labile PEG A 1900-bound hemiaminal 
linkers
As discussed previously in Section 6.2.2 (Scheme 77), PEGAi 900-bound 
benzotriazole hemiaminals 288-290 were prepared and enzyme cleavage studies 
were carried out by Dr. Rein Ulijn at Edinburgh University. Small scale hydrolysis 
reactions were carried out (20 mg of resin) using 5 lipases. Each substrate was 
treated with each enzyme at room temperature in 10% acetonitrile/potassium 
phosphate buffer pH 7.4 for 16 hours and the amount of corresponding acid released 
was quantified by reverse phase HPLC (Section 8.2.9). All experimental details are 
described in Section 8.6.37. Although, most of the lipases selected for this 
experiment were different to those chosen to cleave the solution phase analogues 
273-275 (Scheme 73); they were selected to give a range of enzymes with different 
molecular weights. The results for Hog pancreas lipase cleavage were compared 
(Table 4). In all of the solution phase analogues, Hog pancreas lipase cleaved 
substrates 273-275, in excellent yield (>90%). With the PEGAi 900-bound substrates, 
only 288 was hydrolysed by Hog pancreas lipase in moderate yield (42%); whereas, 
289 and 290 were not cleaved to any significant extent by Hog pancreas lipase (5 and 
0% respectively). It would seem that enzymatic cleavage in the solution phase does 
not guarantee enzymatic cleavage from the solid-phase analogues and therefore, 
direct comparisons between solution- and solid-phase analogues cannot be made in 
the case of enzymatic hydrolyses yields.
From Table 4, it can be seen that there is no obvious correlation between the 
molecular weight of the enzyme and the cleavage yield obtained. For example, for 
substrate 288, Hog pancreas lipase (50kDa) gives a greater cleavage yield (42%) than 





Candida antarctica lipase (CA)
Mucor Meihei lipase (MM)
Hog Pancreas lipase (PPL)
Candida Cylindracea lipase (CCL)
Mucor javanicus lipase (MJ)






























Table 4: Results of enzymatic cleavage of substrates 288-290.
6.2.6 Solid phase synthesis of diastereomeric hemiaminal linkers on PEGA 190o 
resin
PEGAi9oo-bound linkers 295-297 were synthesized using methodology 
developed previously (Section 6.2.4) (Scheme 82). For all resins, 295-297 evidence 
was found for the presence of the allyoxycarbonyl protecting group in the MAS H 
NMR spectra.
284-286
295; R-, = Ph 
296; R! = CH 2 Ph 
297; R 1 = CH 2CH2CH2 Ph 
Scheme 82: Reagents and conditions: i. (S)-171, Et3 N, acetonitrile, 20 h, r.t.
6.2.7 Enzymatic hydrolysis of PEGA 1900-bound hemiaminal linkers
Small scale hydrolysis reactions were carried out (500 mg of resin) using 
various lipases, an esterase and penicillin acylase. Each substrate 295-297 was 
treated with the appropriate cleavage mixture (Table 5) for 16 hours and the amount
106
Results and Discussion























































Table 5: Results of enzyme cleavages of 295-297.
The results shown in Table 5 show that only the phenylacetate linker 296 is a 
substrate for the enzymes, with Penicillin acylase showing the best cleavage yields 
(31%) followed by Mucor javanicus lipase (18%). All substrates were re-treated 
with the corresponding cleavage mixture, however no further cleavage was observed. 
Further treatment of the substrates previously treated with an enzyme, with 
methanolic ammonia resulted in cleavage of the remaining aldehyde (SJ-lll. In all 
substrates, 295-297 small amounts of cleavage were observed in the 
acetonitrile/buffer control (3, 10 and 4% respectively). In all cases, 295-297 the 
appropriate breakdown figures (3, 10 and 4% respectively) were subtracted from the 
cleavage yields to give the actual cleavage yields for 295-297. Allyloxycarbonyl- 
phenylalaninal 171/173 and corresponding acid 276 were observed in a ratio of 1:1.4 
respectively in the reverse phase HPLC traces of all substrates 295-297, as calculated 
by external standards. 70% of cleavage can be attributed to breakdown of the 
hemiaminal 295-297, while 30% was generated from the TV-acyl benzotriazoles 284-
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286. Presumably, the 7V-acyl benzotriazoles 284-286 were present due to incomplete 
coupling and these are known to be unstable in solution (Scheme 83). Reducing the 
cleavage time (2 hours) did not reduce the amount of breakdown observed; however, 







Scheme 83: Reagents and conditions: i. 10% acetonitrile/phosphate buffer pH 7.4, 2-16 h, r.t.
From the solution phase transformations of 278-280, it can be seen that the 
lipases/esterase exhibit some diastereoselectivity. Therefore, it was reasonable to 
assume that the solid supported lipase/esterase hydrolysis would also show some 
diastereoselectivity; hence, it should be noted that the lipase/esterase hydrolysis of 
295-297 might be limited to <50% conversion. Since this was impossible to 
determine, the diastereoselectivity of the solid phase enzymatic transformations, the 
yields were stated out of a theoretical 100% conversion.
Linkers 295-297 were stable in methanol since no acid 276 or aldehyde 171/173 
was observed in the methanol control. In contrast to the behaviour of 295-297, the 
corresponding solution phase analogues 278-280 were stable in buffer/acetonitrile 
solution; possibly because they do not possess the weakly electron withdrawing 
amide moiety (Scheme 84).
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Scheme 84: Reagents and conditions: i. 10% acetonitrile/potassium phosphate buffer 10 mM, 16 h, 
r.t.
It has been reported 114 that lowering the pH can reduce the contribution from 
non-enzymatic hydroxide-induced hydrolysis (Scheme 84). Therefore, a study was 
carried out to determine whether the stability of the linker in buffer could be 
improved by carrying out the reaction in buffers of lower pH. Resin 296, was 
treated with phosphate buffer (50 mM) at a variety of different pH values. The 
amount of phenylacetic acid released was quantified by reverse phase HPLC. The 
results shown in Graph 2, show that the largest cleavage was observed for buffer pH 
7.4 (10.5%), however unacceptable cleavage yields were obtained for all other pHs 
tested (8.5-10%). It should be noted, that the linker 296, was stable in water and 
methanol. To conclude, no significant pH dependence was observed for the stability 
of the phenylacetate linker 296.
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Graph 2: pH dependence of 296 cleavage
In order to determine the enantiomeric excess (e.e.) of the allyloxycarbonyl- 
phenylalaninal 171 released during enzymatic cleavage of 296,171/173 was reduced 
to the allyloxycarbonyl-phenylalaninol 174/175 using sodium borohydride. 
Unfortunately, the determination of the e.e. of (^-allyloxycarbonyl-phenylalaninal 
171 was hampered by the poor cleavage yields and lack of resolution of the chiral 
HPLC method. Eventually, a gradient elution method was developed that separated 
the enantiomers of the racemic allyloxycarbonyl-phenylalaninol 175 standard Figure 
31. Only resin 296 cleaved by Mucor javanicus lipase and penicillin acylase 
provided enough alcohol 171/174 for analysis by chiral HPLC. Figure 32 and Figure 
33 show the chiral HPLC traces of the Mucorjavanicus lipase and penicillin acylase 
cleavage mixtures. It can be seen that both enzymes cleave the linker to give (S)- 
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Figure 31 : Chiral HPLC trace ofracemic allyloxycarbonyl-phenylalaninol 1 75.
o.oo 5.00
Minutes










30.00 35.00 40.00 45.000.00
-l——i——i
5.00 10.00 15.00 20.00 25.00
Mnute»
Figure 33: Chiral HPLC trace of 296 cleavage by penicillin acylase.
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As mentioned previously (Section 1.2.5), CPG has been successfully utilised for 
enzymatic transformations; however, the pore size of CPG (i.e. 100 nm) is crucial for 
the accessibility of enzymes. With this in mind, CPG (pore size; 100 nm) was 
utilized as a support for the hemiaminal linker 301 and subsequent enzymatic 
cleavage was carried out. Initially, benzotriazole was coupled to aminopropyl-CPG 
(80.3 jamol g" 1 , pore size; 101 nm) using diisopropylcarbodiimide and HOBt. 
Unfortunately, these reagents were unsuitable for the formation of 299. Optimisation 
of the coupling conditions led to the use of HBTU and HOBt for the formation of 
299 (73 ^imol g" 1 , 92% loading from N analysis). The propyl spacer only allows a 
short distance between the silica backbone and the reactive amine; therefore, it was 
thought that the silica backbone could sterically hinder the amide coupling. This 
theory led us to postulate that by using a longer alkyl spacer, the contribution from 
steric hinderance could be minimized and penetration of the linker into the enzyme 
could be maximized. Long-chain alkyl-amine CPG 301 (15 carbon extension arm, 
pore size; 108 nm) was purchased from CPG Inc (now Millipore Ltd) and coupled to 
benzotriazole 5-carboxylic acid 207 to give 299 with moderate loading yields (63% 
from N analysis) (Scheme 85). The decrease in loading yields can be attributed to 
the high flexibility of the 15-carbon extension arm compared to the relatively 
inflexible propyl alkyl spacer arm. Time restraints prevented optimization of this 
yield; however, longer reaction times may provide better loading yields. The 
controlled pore glass bound benzotriazole 298 was characterized by FT-IR. The 
MAS ] H NMR of resin 299, was unattainable for the same reason as the 
macroporous-polystyrene bound benzotriazole 219 (Scheme 55). Additionally, gel- 
phase 13 C NMR spectra of CPG resin 299, was impossible due to the non-swelling 
properties of the CPG resin. The acetal linker 301 was constructed using the method 
developed previously (Scheme 85) with an overall loading of 40.0 ^imol g" 1 (53%).
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Scheme 85: Reagents and condtions: i. HBTU, HOBt, DIPEA, benzotriazole 5-carboxylic acid, 
DMF, 16 h, r.t.; ii. phenylacetyl chloride, Et3N, anhydrous DCM, 20 h, r.t; iii. (5)-171, Et3N, 
acetonitrile, 20 h, r.t.
Enyzyme hydrolysis experiments were carried out using Mucorjavanicus lipase 
and penicillin acylase as before (Section 6.2.5). These enzymes were chosen due to 
their moderate success with PEGAi 90o resin. Unfortunately, it was found that no 
enzymatic hydrolysis of 301 was observed for either of the enzymes tested. One 
possible reason for this could be that the hydrophobic 15-carbon spacer is too 
flexible or may aggregate under the aqueous conditions required for enzymes. 
Therefore, the use of a more hydrophilic or rigid spacer may improve the enzyme 
cleavage.
It was proposed that if benzotriazole was bound to the resin using an alkyl 
amine 302 (Scheme 86), the linker may be stable in phosphate buffer pH 7.4. The 
formation of the secondary amine 302 was envisaged using Mitsunobu chemistry. 115 
Generally, this procedure requires that the primary amine 298 is converted into a 
derivative in which the NH is strongly acidic. This can be achieved through the
16 17formation of toluenesulfonamide, trifluoroacetamide, trifluoromethane-
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sulfonamide, 118 2,2,5 J,8-pentamethylchroman-6-sulfonyl (pmc) 119 and 2- 
nitrobenzenesulfonamide (Nbs) 120 derivatives. The method of choice for the linker 
synthesis was the 2-nitrobenzenesulfonamide (Nbs) derivative since this can be
_ 101




P = Protecting group
303
Scheme 86: Retrosynthetic analysis ofalkyl amine linked benzotriazole 302.
The synthesis of Nbs-protected amine 304 was attempted using 2-nitrobenzene 
sulfonyl chloride in DMAP as base (Scheme 87); however, this coupling was 
unsuccessful even after 3 repeated couplings for 1.5 h, 3h and 16h, at room 
temperature. This was presumably due to the 2-nitrobenzene sulfonyl chloride being 
unstable under such conditions. Yang and Chiu121 reported optimum conditions for 
this coupling, using 2-nitrobenzene sulfonyl chloride and diisopropylethylamine in 
THF for 3 h. Unfortunately, these conditions were also unsuccessful in forming 304 











Scheme 87: Attempted synthesis of Nbs-protected amine; Reagents and conditions; i. 2-nitrobenzene 
sulfonyl chloride (4eq.), DMAP (6eq.), THF/DCM (2:1).
6.2.8 Molecular modelling
Molecular modelling was performed in an attempt to explain the low yields 
obtained for the penicillin acylase cleavage of allyloxycarbonyl-phenylalaninal 171 
from solid support 296 (31%) and in solution 279 (27%).
The crystal structure of penicillin G acylase was obtained from the Protein Data
1 "7'7 10^
Bank ' and the structure prepared for energy minimization using the CHARMm 
forcefield with Insightll on a Silicon Graphics workstation. The water and penicillin 
G were separated from the protein and an assembly was created. The amino acid 
residues, Glul and Gln2 were missing from the a-subunit. Since, these residues 
were situated at the termini of the a-subunit, it was decided that these were 
unimportant in the binding of the substrate within the active site. Therefore, these 
residues were omitted from the penicillin acylase structure. The bond order was 
turned on and hydrogen atoms were added to the crystal structure. Potentials and 




One stereoisomer of the linker, (R,S)-296 was constructed in 2D, converted to 
3D and energy minimization calculations were carried out to obtain the approximate 
energy minimum configuration. Manual docking was performed to position the 
linker within the binding site of the enzyme. Models of the linker 296/penicillin 
acylase complex were compared to penicillin G bound to the active site of penicillin 
acylase (Appendix B and C). On examination of the penicillin G/enzyme complex, it 
could be seen that favourable aromatic interactions exist between the 
phenylacetamide of the penicillin G and the enzyme phenylalanine P24 and a 146 
residues. In addition, phenylalanine P57 is situated at the bottom of the hydrophobic 
cleft and although the distance between the substrate and this residue is too long for a 
direct interaction (4.9 A). This residue may be important for maintaining the 
structure of the binding site. From Appendix B and C it can be seen that 
phenylalanine p71 has a favourable interaction with the hydrophobic p-lactam 
nucleus. The phenylalanine (324 and a 146 residue interactions are shared in the 
molecular models of the linker 296/enzyme complex (Appendix D-G). It appeared 
that the phenyl moiety fits into the hydrophobic pocket which was lined with many 
hydrophobic side chains such as isoleucine P177, alanine P69 and proline P22. In 
addition, phenylalanine P71 seemed to have a favourable hydrophobic interaction 
with the benzyl group on the linker. From the space filled and Connelly electron- 
density models (Appendix G and D), it seemed that the (^,5)-stereoisomer of the 
linker 296 would fit in the active site of the enzyme. On the other hand, it seems that 
the active site would be much more crowded with linker 296 bound to the active site, 
compared to Penicillin G in the active site (Appendix B). Examination of the two 
diastereoisomers of the linker 296 (Appendix H) showed that the position of the 
benzyl and Alloc groups in the (S,S)-296 would be reversed compared to the (R,S)- 
296. In this case, the benzyl substituent would point into the hydrophobic cleft and 
the Alloc group would be positioned away from the hydrophobic cleft, hi this 
position the benzyl group would still favourably interact with the phenylalanine p71 
within the hydrophobic cleft. This suggested that both diastereomers of 296 were 
likely to be suitable for penicillin acylase hydrolysis. This is in agreement with the 
results of the solution phase study of benzotriazole hemiaminal 279, hydrolysis by 
penicillin acylase, which showed no preference for either diastereomer (Table 2). It
116
Results and Discussion
was difficult to predict whether the solid support bound linker would fit in the active 
site, since the solid support cannot be modelled to any degree of accuracy; therefore, 
the influence the solid support would have on the active site binding was impossible 
to determine.
To conclude, molecular modelling explained the limited success of the enzymatic 
cleavage of 279 and 295. Although 279/295, seemed to interact favourably with the 
active site; it seemed that steric hinderance between the linker 279/295 and penicillin 
acylase limited the enzymatic hydrolysis yields.
6.2.9 Lipase/Penicillin acylase inhibition assays
Since peptide aldehydes are known inhibitors of serine proteases, it seemed 
possible that the (,S)-allyloxycarbonyl-phenylalaninal 171 cleaved during the 
hydrolysis, could inhibit the Upases/penicillin acylase (i.e. product inhibition) 




Scheme 88: Reagents and conditions: i. When X = O, lipase, esterase or penicillin acylase, pH 7.4 
buffer; When X = NH, penicillin acylase, pH 7.4 buffer.
The hydrolysis of the carboxylic ester of /?flra-nitrophenol 307 leads to the 
release of /7-nitrophenol 308. 308 can be monitored continuously and quantitatively 
using a spectrophotometric method (Scheme 89). The appearance of the yellow 
coloured/?ara-nitrophenol 308 (pKa 7.15) can be monitored by reading the increase 
in absorbance at 400 nm 124 ' 125 .
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Scheme 89: Reagents and conditions: i. lipase or esterase, pH 7.4.
The reaction rate of the lipases/esterase hydrolysis of />flra-nitrophenylbutyrate 
307 was determined using a method by Pencreac'h and Baratti 126 . For each enzyme, 
a suspension of/rara-nitrophenylbutyrate 307 (10 mM) (1 mL) in 10 mM phosphate 
buffer pH 7.4 was placed in a 3 mL cuvette. The desired concentration of 
allyloxycarbonyl-phenylalaninal 171 was added (150 juL) [0, 0.5, 1 and 5 mM], 
followed by 150 pL of stock enzyme suspension [(1 mg mL" 1 ) in 10 nM phosphate 
buffer pH 7.4] and the absorbance of the /rara-nitrophenol 308 was read at 400 nm 
against a blank without enzyme. This was repeated for each concentration of 
allyloxycarbonyl-phenylalaninal 171 [0, 0.5, 1 and 5 mM]. The maximum 
concentration of allyloxycarbonyl-phenylalaninal 171 (5 mM) was chosen so that the 
concentration of 171 in the assay exceeded the maximum concentration of 171 that 
could be cleaved from PEGA bound linker with a 0.2 mmol g' 1 loading (i.e. 50 mg 
resin = 1 mM). Initial rates were calculated from the slope of the line of the data 
points obtained when plotting absorbance versus the time. Graph 3 shows a plot of 
initial rates versus allyloxycarbonyl-phenylalaninal 171 concentration. If 171 was an 
inhibitor, a significant decrease in initial rate should occur with increasing 
concentrations of 171. In general, it can be seen that none of the lipases or the 
esterase are inhibited by the allyloxycarbonyl-phenylalaninal 171 to any considerable 
extent, at the concentrations tested (0-5 mM). It should be noted that, as the initial 
rates of the enzyme reactions increase the errors become larger. This could account 
for the large fluctuations in points for the two fastest acting enzymes, 
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Graph 3: Initial rate vs. 171 concentration for lipase/esterase.
A similar method was employed for monitoring the inhibition of penicillin 
acylase. The hydrolysis of 5-(2-phenylacetamido)-2-nitrobenzoic acid 309 with 
penicillin acylase results in the release of 5-amino-2-nitrobenzoic acid 310 which can 




Scheme 90: Reagents and conditions: i. Penicillin acylase, pH 7.4.
To a solution of 5-(2-phenylacetamido)-2-nitrobenzoic acid 309 in phosphate 
buffer pH 7.4 (1 mL) in a 3 mL cuvette, was added the required concentration of 17
1 
(150 jaL) (0, 0.5, 1 and 5 mM) in buffer, followed by penicillin acylase [(1 mg mL"
1 ) 
in 10 nM phosphate buffer pH 7.4] (150 |uL). The absorbance of 5-amino-2
- 
nitrobenzoic acid 310 was recorded at 400 nm against a blank without enzyme. This
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was repeated for each concentration of 171 (0, 0.5, 1 and 5 mM). Initial rates were 
calculated as before and a graph of initial rate versus allyloxycarbonyl- 
phenylalaninal 171 concentration was plotted (Graph 4). Graph 4 illustrates that 171 
















Graph 4: Initial rate vs. 171 concentration for penicillin acylase
6.2.10 Solid phase synthesis of safety catch linker
Molecular modelling suggested that the enzymatic hydrolysis of the linkers 
295-297, may be hampered by unwanted steric or electronic interactions between the 
linker/substrate and the biocatalyst. Therefore, the substrate tolerance of the 
biocatalyst may be limited. The use of a spacer unit between the site of attack and 
the asymmetric carbon should maximize the substrate tolerance of the enzyme, hence 
possibly improve the enzymatic cleavage yields. From the proposed scheme 
(Scheme 91), it is obvious that the cleaved linker would need to fragment further to 













Scheme 91: Proposed mechanism for release of aldehyde 171 from extended linker 311.
In a report published in 2001, Waldmann et. al ni used an enzyme labile 
phenylacetoxy benzyloxycarbonyl (PhAcOZ) group for the TV-protection of 
nucleotripeptides 315 (Scheme 92). Penicillin G acylase cleavage of the 
phenylacetyl group 314, followed by spontaneous fragmentation released the 
nucleotripeptide 315 in 69% yield. It should be noted that only solution phase 
cleavage was reported. The high selectivity of penicillin G acylase for the 








AcO AcO „ 314 315Scheme 92: Reagents and conditions: penicillin G acylase, 50 mM phosphate buffer, MeOH (20 vol%), 0.1 M KI, pH 6.8, 24 h, r.t, 69%.
In 2000 and 2001, Waldmann et. a/. 43 '44 reported an enzyme-labile safety catch 
linker 316 for synthesis on a soluble polymer support (Scheme 93). Penicillin 
acylase hydrolyses the phenylacetamide 316, the benzylamine 317 cylises to polymer 
bound lactam 318 and releases the corresponding target molecule 319. It is thought 
that the phenyl ring assists in the cyclization by bringing the reactive ends into closer 
proximity of each other, therefore reducing the entropy difference (AS*) and the 
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Scheme 93: Reagents and conditions: i. Penicillin G acylase
In view of the ease of synthesis of the Waldmann linker44 (Scheme 93), it was 
thought that a modified version of this linker might provide a simple spacer for the 
acetal linker 320. (Scheme 94). The proposed linker involves a phenylacetamide 
moiety, which on cleavage with penicillin acylase liberates a free amine 
functionality. Although this linker 320 did not possess the phenyl ring as mentioned 
above (Scheme 93), it was anticipated that the linker would cyclize to generate 










Scheme 94: Proposed safety catch linker 320 for enzymatic cleavage.
The synthesis of the proposed safety catch linker 320 was envisaged using 
Katritzky methodology110 as before (Scheme 95). Pentanoic acid 323 was prepared 
from 2-aminovaleric acid and phenylacetyl chloride in sodium hydroxide, in 50% 
yield. Treatment of pentanoic acid 323, with oxalyl chloride and catalytic 
dimethylformamide, afforded the pentanoyl chloride 324 in moderate yield (30%). 
Coupling of the pentanoyl chloride 324 to PEGAi9oo benzotriazole resin 220 was 
carried out in base to give 325. Subsequent aldehyde 171 insertion was achieved in 








Scheme 95: Reagents and conditions: i. oxalyl chloride, cat. DMF, anhydrous DCM, 30%; ii. Et3N, 
anhydrous DCM, 20 h^r.t; iii. (5)-171, triethylamine, acetonitrile, 20 h, r.t, 24% loading.
Two small scale hydrolysis reactions were performed (-60 mg of 320), along 
with two control reactions. Linker 320 was treated for 16 hours with the appropriate 
cleavage mixture (Table 6). The hydrolysis experiments were repeated twice more 
and the amount of phenylacetic acid/phenylacetamide released was quantified by 
reverse phase HPLC.
Cleavage method
Control (10% acetonitrile/buffer pH 7.4)








Table 6: Results of hydrolysis experiments of 320.
From the results shown in Table 6, it can be seen that the safety catch linker 320 
is a poor substrate for penicillin acylase (5%). The catalytic domain of penicillin
i "7 o
acylase is located at the base of a large cavity, therefore, the phenylacetyl moiety 
must be able to penetrate into this cavity. The pentyl spacer may aggregate due to
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the high flexibility of the carbon chain and hence, render it incapable of penetrating 
into the deep cavity. It should be noted that, again the linker 320 was unstable in the 
phosphate buffer/10% acetonitrile control (10%; however, this was considered when 
calculating the enzyme hydrolysis yield. In all hydrolysis mixtures, 
allyloxycarbonyl-phenylalaninal 171 was detected in similar quantities to 
phenylacetic acid/phenylacetamide, which indicated that the safety catch linker 
fragmented as predicted (Scheme 94).
6. 2.11 Summary and conclusions
Linkers 287-290 and 293 were prepared on solid support, by aldehyde insertion 
into the corresponding Af-acyl benzotriazole moiety. Polystyrene bound 1- 
(benzotriazol-l-yl)alkyl hemiaminal 287 was prepared in 77% loading, which was 
much improved over the aminal linker analogue 232 (58%). An investigation into 
the chemical cleavage of the hemiaminal linkers 287 and 293 indicated that only 
sodium hydroxide/dioxane and methanolic ammonia were suitable for aldehyde 
cleavage; however, both methods completely epimerized the oc-stereocentre of the 
cleaved aldehyde 173. In addition, sodium hydroxide cleavage of 293 resulted in the 
formation of unwanted by-products.
The enzymatic hydrolysis of model PEGAIgoo-bound hemiaminal linkers 288- 
290 were studied in order to gain an insight into what influence the solid support 
would have on the substrate specificities of the enzymes. In the case of The 
PEGAigoo support was found to have a major detrimental effect on the substrate 
specificity of Hog pancreas lipase. In the case of 288, 42% conversion yield was 
obtained for Hog pancreas lipase. In the solution phase analogue 273, Hog pancreas 
lipase hydrolysed 273 in 95% yield. To conclude, it would seem that direct 
comparison between solution- and solid-phase analogues cannot be made in the case 
of enzymatic hydrolyses yields.
PEGAi9oo-bound benzotriazole hemiaminals 295-297 were synthesized in a 
manner similar to the polystyrene benzotriazole linker 293. Enzymatic hydrolysis
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screening was carried out with a variety of enzymes. The best enzymatic cleavage 
yield was obtained with hemiaminal 296 and penicillin acylase (31%). This yield is 
comparable with the enzymatic cleavage of solution phase analogue, 279 (27%). 
This suggests that the substrate specificity of the enzyme plays a vital role in the 
enzymatic hydrolysis reactions. Mucor javanicus lipase hydrolysed linker 296 in 
18% yield, which was much improved over the solution phase analogue cleavage 279 
(1.4%). Pseudomonas fluorescens, Hog pancreas, Chromobacterium viscosum and 
Penicillium roqueforti lipase all hydrolysed 296 with minimal success (11-14%). 
Since, most of the enzymes screened showed some cleavage of 296, this suggests 
that only a small amount of the support bound linker was accessible to the enzyme. 
Recleavage of the 296 with more enzyme did not result in any further hydrolysis. 
This implied that diffusion was not a limiting factor in the hydrolysis by enzymes. 
One possible use for the low enzymatic hydrolysis yields might be in biological 
screening. For example, in a two stage cleavage strategy, where 10-31% of the 
linker can be cleaved by biocatalysts and the remaining substrate on the linker can be 
cleaved using chemical methods for the identification of possible substrates for 
enzymes. A similar strategy has been exploited by Barany et. al 24 who exploited 
the differences in properties of surface and interior sites of TentaGel resin to cleave 
only 10-15% of the substrate with enzyme, with the remaining sites available for 
identification of the active ligands.
Mucor javanicus lipase and penicillin acylase cleaved the linker 296 to afford 
(S)-allyloxycarbonyl-phenylalaninal 171 with enantiomeric excess of >98%.
The use of controlled pore glass (100 nm) as a support for the hemiaminal 
linker 301 resulted in no enzymatic hydrolysis with either Mucor javanicus lipase or 
penicillin acylase. This implied that the choice of resin was critical to the success of 
the enzymatic cleavage and that the resin should be treated as a co-solvent rather 
than as an inert carrier.
Product inhibition was dismissed as a possible problem in the hydrolysis of 
these linkers 295-297. Allyloxycarbonyl-phenylalaninal 171 was screened for
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inhibition against the enzymes and it was found that 171 was not inhibiting any of 
the enzymes used.
The synthesis of a safety catch linker 320 was performed in order to minimize 
possible unwanted steric or electronic interactions between the linker/substrate and 
the biocatalyst; however, subsequent enzymatic hydrolysis with penicillin acylase 
did not improve the hydrolysis yields. This suggested that steric hinderence between 
the chiral centre of 295 and the solid support was not hindering the enzymatic 
hydrolysis.
To conclude, these results suggest that the hydrolysis of 296 was limited to 
some extent by the substrate specificity of the enzyme. It was also probable that, 
steric or electronic hinderance between the PEGAi9oo resin and enzyme is a major 
contributing factor in the low cleavage yields obtained. As a consequence of these 
unwanted interactions, the choice of solid support was crucial to the success of 
enzymatic hydrolysis; with PEGAigoo offering the best enzymatic cleavage yields. 
Improved enzymatic hydrolysis yields might be obtained by tailoring of the resin to 
the enzyme. For example, by the use of charged PEGA supports. This concept was 
recently investigated by Ulijn et. al., ]29 who reported on the introduction of 
permanent positive or negative charges into the acrylamide backbone. They 
discovered that electrostatic repulsion between adjacent chains increased the swelling 
of the polymer, therefore increasing the pore size. In the case of PEGA+ resin, a 
significant enhancement in penicillin acylase hydrolysis yields (<50% conversion) 
were obtained, compared to neutral PEGA (<15% conversion). This effect was 
explained by the increased protein accessibility due to better swelling and 
electrostatic attraction between the negatively charged penicillin acylase and the 
positive resin. Further work might include a study of these positively charged resins 
for the enzymatic hydrolysis of the hemiaminal linkers 295-297.
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7 Results and discussion - Solid-phase peptide aldehyde synthesis
on hemiaminal linker
Allyloxycarbonyl protected resin 293 was treated with a combination of borane- 
dimethylamine complex and palladium catalyst. The deprotected resin 326 was 
coupled to (5)-Fmoc-proline using HBTU/HOBt in the presence of base. Two cycles 
of Fmoc deprotection and Fmoc-amino acid coupling resulted in the synthesis of a 




Scheme 96: Reagents and conditions: i. borane-dimethylamine complex, Pd(PPh3 )4 , anhydrous DCM, 
10 min, r.t; ii. (5>Fmoc-Pro-OH, DMF, DIPEA, 0.45 M HBTU/HOBt solution in DMF, 4 h, r.t.; iii. 
20% piperidine in DMF, 20 min; iv. (5)-Fmoc-Ala-OH, DMF, DIPEA, 0.45 M HBTU/HOBt solution 
in DMF, 4 h, r.t.; v. 20% piperidine in DMF, 20 min; vi. Fmoc-AA-OH, DMF, DIPEA, 0.45 M 
HBTU/HOBt solution in DMF, 4 h, r.t.
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The presence of tetrapeptide aldehyde 257 was confirmed by basic cleavage (1 M 
NaOH/dioxane) of 328, followed by reverse phase HPLC and electrospray mass 
spectrometry analysis. In the HPLC trace (Figure 34), only two main products were 
observed; benzoic acid (7.3 min) and Fmoc-peptide aldehyde (9.0 min).
1.00 2.00 11.00 12.00
Figure 34: Reverse phase HPLC trace of cleavage mixture of 328.
Semi-preparative HPLC was carried out to obtain a sample of peptide aldehyde 
257 and the identity was confirmed by electrospray mass spectrometry (Figure 35). 
The desired molecular ion was observed at 637 m/z, along with MNa+ and MK+ ions 
at 659 and 675 m/z respectively. It was assumed that sodium hydroxide would 
completely epimerize the a-stereocentre of the peptide aldehyde 257, therefore the 
ideal cleavage method would involve the use of enzymes.
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Figure 35: Electrospray mass spectrometry of peak at 9.0 min in reverse phase HPLC trace (Figure 
34).
In order to study the use of hydrolytic enzymes for cleavage of these linkers, the 
solid support must be compatible with the specific conditions required for the 
biocatalyst. As mentioned previously, macroporous resins consist of a rigid open 
pore structure and access of liquid reagents to reaction sites occurs by rapid diffusion 
through the rigid, open pore structure rather than through a swollen gel phase.
Macroporous polystyrene-bound peptides 329 and 330, were constructed in the 
same way as the polystyrene peptide 328 (Figure 36). The loadings achieved were 
35% and 22% respectively.
Fmoc
o





Enzyme hydrolysis experiments were carried out by Rein Ulijn at Edinburgh 
University. Each substrate was treated with the appropriate enzyme (1 mg mL" 1 ) in 
phosphate buffer pH 7.4 for 16 hours and the amount of phenylacetic acid released 











Table 7: Enzyme hydrolysis yields for 329 and 330.
From Table 7, it can be seen that the best cleavage was obtained with the 
phenylacetyl linker 330 and penicillin acylase. Benzoic linker 329 was not a 
substrate for penicillin acylase or Mucor Meihei lipase. It was concluded that 
macroporous polystyrene resin was not suitable as a support for the enzymes tested. 
It is probable that the hydrophobic polystyrene backbone repels the hydrophilic 
enzyme, thus limiting access to the active site of the enzyme.
7.1 Summary and conclusions
Tetrapeptide aldehyde 257 was synthesized on polystyrene linker 328 and 
cleaved from the solid support using sodium hydroxide. Purification of tetrapeptide 
aldehyde 257 by semi-preparative HPLC followed by electrospray mass 
spectrometry indicated the presence of tetrapeptide aldehyde 257. In support of this 
evidence, tetra-peptide aldehyde 257 was also synthesized on polystyrene aminal 
linkers 250 and 256 and cleaved using acid to release 257. Electrospray mass 
spectrometry of the cleavage mixtures gave the appropriate [M+H] + and [M+Na] + 
ions for the tetrapeptide aldehyde 257.
Enzymatic hydrolyses of macroporous bound peptide aldehydes 329 and 330 
were performed. Although, 329 was not hydrolysed by Mucor meihei lipase or 
penicillin acylase, 330 was cleaved by penicillin acylase in 18% yield. This 
relatively low hydrolysis yield was explained by the inability of hydrophilic enzyme 
to penetrate into the hydrophobic resin. Further work might include a study of
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! H and 13C NMR spectra were recorded on Bruker AC200, Bruker AC250, 
Varian Gemini 200 and Varian Inova 600 instruments. Chemical shifts (8H , 6C) are 
reported in p.p.m. and coupling constants (J) are in hertz (Hz), ./values are quoted to 
within one decimal place. J values for coupled protons are expected to match, 
however the small inconsistancies to be found in these results are due to the 
inaccuracy of the NMR machine and are within the expected error limits (±0.5). 
Magic angle spinning *H NMR was recorded on a Varian Inova 600 instrument.
Electrospray mass spectrometry (ES-MS) was performed using a Micromass 
platform II instrument with MassLynx software. Fast Atom Bombardment (FAB) 
mass spectrometry was performed using a Kratos MS50TC instrument.
Infrared spectroscopy (IR) was performed using a Perkin Elmer Paragon 1000 FT-IR 
spectrometer with the frequencies (v) measured in wavenumbers (cm" 1 ). Solution 
samples were measured as thin films or neat. Solid samples were measured as nujol 
mulls or KBr discs. Solid resins were measured either swollen in DCM or as KBr 
discs.
Reaction optimization experiments were carried out on a Gilson SK233 system 
and analysed by reverse phase HPLC.
Optical rotations were measured on an Optical Activity AA-1000 polarimeter 
(Sodium 589 nm detection). Sample concentration was measured in g/100 mL and 
[a] 20D values are quoted in 10" 1 deg cm" .
134
Experimental
Melting points were recorded on a Gallenkamp melting point apparatus and 
were uncorrected.
A 360° Stuart scientific SB1 blood rotator and a New Brunswick Scientific 
Gyrotory water bath shaker were used for resin agitation at room temperature.
Elemental analysis was performed using a Perkin-Elmer 2400 CHN Elemental 
Analyser. Elemental analysis of resin bound compounds was carried out by Medac 
Ltd.
8.1.2 Chromatography
Analytical thin layer chromatography (TLC) was performed using Merck 
aluminium backed plates coated with silica gel 60F2 54. Identification was carried out 
using U.V. fluorescence (254 nm),/7-anisaldehyde, ammonium molybdate, potassium 
permanganate and ninhydrin dips. Flash column chromatography was carried out 
with a variety of glass columns using BDH silica gel (40-63 (am) or a Biotage pre- 
packed cartridge system.
8.1.3 Reagents and solvents
All reagents were standard laboratory grade and used as supplied unless 
otherwise stated. Phenylacetamide was obtained and used as supplied from 
Maybridge pic. For HPLC methods: U.V. grade acetonitrile and water, HPLC grade 
j'so-propanol, hexane and trifluoroacetic acid were used. Where a solvent has been 
described as anhydrous, it was either purchased as anhydrous grade or was distilled 
prior to use. Tetrahydrofuran was pre-dried over sodium wire and distilled from 
sodium benzophenone ketal. Peptide synthesis grade, dimethylformamide (DMF), 





All enzymes were purchased from Fluka or Sigma and the specific activities are 
shown below. Penicillin amidase was obtained from Sigma as a solution in 0.1 M 




























8.2 General experimental - solid phase
8.2. 1 Resins
All resins were obtained from Novabiochem, Advanced Chemtech, Polymer 
Laboratories or CPG Inc (now Millipore Corporation).
8.2.2 Solid phase reactions
Solid phase reactions were carried out in 3, 10, or 25 mL plastic isolute SPE 
filtration columns with caps, luer tip caps and 20 jum porosity frits, purchased from 
Jones Chromatography and spun on a 360° blood rotator. Large scale reactions (>1 g 
resin) were performed in standard glass round bottom flasks and a New Brunswick 
Scientific Gyrotory® water bath shaker was used to agitate the resin. In general,
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reactions were allowed to proceed for >15 h, before filtering and washing as 
described in Section 8.2.3
8.2.3 General washing protocol
All resins were washed according to the following procedure, unless otherwise 
stated: THF (x2), DMF (x2), DMF/MeOH (1:1) (x2), DMF (x2), THF (x2), DCM 
(x2). Resins were agitated during washing using plastic pipettes to minimize loss of 
polystyrene resin, which adheres to glass. Isolute tubes were filtered using a 
VacMaster 10 workstation, otherwise a standard sinter funnel and water pump were 
used. Resins were dried in a vacuum oven before being analysed as illustrated in 
Section 8.2.4. PEGAigoo was stored swollen in MeOH or DCM, as drying was 
detrimental to the internal structure of the resin.
8.2.4 On-resin analysis of polymer-supported intermediates
8.2.4.1 IR spectroscopy
In general, samples were prepared by taking a pre-washed and dried aliquot of 
resin (-5-10 mg), swelling in DCM and pressing between a pair of NaCl plates. The 
broad C-C1 stretch from DCM masks any diagnostic peaks below vmax ~820 cm" 1 , but 
signals in the carbonyl region are generally very apparent. Some resins were 
prepared by taking a small aliquot (-5-10 mg), grinding with KBr (FT-IR grade) and 
pressing into a pellet.
8.2.4.2 Gel phase 13 C NMR spectroscopy
Samples were prepared by loading dry resin into an NMR tube and adding 
CD2C12 dropwise until the resin had swollen. Care must be taken to avoid any air 
bubbles or foreign matter which may give rise to distortions in the NMR spectrum. 
Due to the nature of gel phase spectra, quaternary carbons are often too weak or 
broad to be assigned correctly. Also, many polymers give rise to broad peaks which 
can usually be attributed to signals from the backbone (e.g. aromatic or benzylic), 
often obscuring any weaker signals in the vicinity. Therefore, where gel phase NMR
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data has been quoted in the experimental section, peaks have been assigned as far as 
possible, often with the aid of relevant solution spectra. Where atoms are not 
assigned, it is assumed that the corresponding peaks have either been obscured or are 
too weak to assign confidently.
8.2.4.3 Magic angle spinning (MAS) }HNMR 121
Samples were prepared by loading dry resin into a zirconium rotor (4mm 
diameter and slowly adding CDC^. This served two purposes. Firstly, the solvent 
caused the resin to swell, increasing the mobility of the attached molecule, giving 
sharper signals. Secondly, to allow locking of the deuterium signal to regulate the 
field position. When the sample is in place, it is tilted to the magic angle (0= 54.7) 
and is spun at rates up to 5 kHz. Due to the nature of some resins, some peaks are 
often very broad or are obscured by the polymer backbone. Therefore, peaks have 
been assigned as far as possible. Where atoms are not assigned, it is assumed that 
the corresponding peaks have either been obscured or are too weak to assign 
confidently. Unless otherwise stated, if magic angle spinning ! H NMR has not been 
quoted, then the nanoprobe was not available at the time of production of the resin.
8.2.5 Qualitative detection of resin-bound free amines
8.2.5.1 Kaiser test104
A small sample of washed and dried resin (~2 mg) was treated with two drops 
of each reagent: A, B and C. The resin suspension was heated (-100 °C) for 2-5 min 
and any colour change noted. A dark blue/black colour indicated the presence of free 
amine, whereas a straw brown colour verified complete coupling. Due to the 
sensitivity of the test (5 jumole/ g free amine) if a pale blue colour developed after 
5min it was assumed that the reaction had reached virtual completion, nevertheless, 
the test was used in conjunction with the TNBS test. (Section 8.2.5.2). 
Reagents: A; ninhydrin (500 mg) in EtOH (10 mL)
B; phenol (80 g) in EtOH (20 mL)




A small portion of washed and dried resin was treated with one drop of each 
solution: D and E. Red beads, viewed under a microscope, indicated the presence of 
free amine. 
Reagents: D; 10%DIPEAinDMF
E; 1% 2,4,6-trinitrobenzenesulfonic acid in DMF.
8.2.6 Determination of loading
8.2.6.1 Fmoc analysis
A minimum of two samples of dry resin (4-10 mg) were weighed directly into 5 
or 10 mL volumetric flasks and made up to the volumetric level with a solution of 
20% piperidine in DMF. The samples were sonicated at room temperature for 2 min, 
before recording the U.V. spectrum of the supernatant between 280 and 320 nm. 
Where absorbances with A,max > 1 were measured, the sample was diluted with blank 
20% piperidine in DMF, until an absorbance of Xmax < 1 was achieved, in accordance 
with the Beer-Lambert Law. Equation 1 below was used to calculate the resin 
loading:
mmol/ g = (A x v)/(sxl O"3 x wt) (1)
[A = absorbance at 301 nm (A,max); v = volume (mL); e = extinction coefficient of N-(9- 
fluorenylmethyl)piperidine 132 (e (301 nm) = 7800 M" 1 cm" 1 )]
Due to the errors incurred from weighing small samples and carrying out 
repeated dilutions, the loadings obtained are only considered to be accurate to 
~±0.05 mmol g" 1 and are merely intended to give an indication of the success of the 
reaction. In terms of starting loadings for reactions, although the loading of the resin 
to be derivatised was calculated where possible, in order to account for 
inconsistencies, reagents were often added with respect to the manufacturer loading.
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8. 2. 6. 2 Calculation of loading and yield of resin bound substrates
When determining the yield of a solid phase reaction, the weight gain/loss 
during the reaction must be accounted for, when calculating the maximum theoretical 
yield. The maximum theoretical loading (L^x) can be calculated using equation 2.
Lmax (mmol g'1 ) = Lsm/[l + (Lsm x MWt)] x 1000 (2)
[where Lsm = loading of the starting material (mol g" 1 ); MWt = molecular weight added to the resin 
(g)]
When the loading of a precursor is unknown, it is possible to calculate backwards to 
get the calculated loading of the starting material (Lcaic) using equation 3.
Lmax (mmol g- 1 ) = Lprod/[l - (Lprod x MWt)] x 1000 (3)
[where Lprod = loading of the product resin (mol g")]
The increase or decrease in weight of a resin upon reaction can also be used to 
ascertain the loading. The coupling efficiency (C.E.)/yield can be calculated as 
described in equation 4.
C.E.=[actuaI weight increase(g)/expected weight increase(g)] x 100 (4)
[where, expected weight increase (g) = Lsm x MWt x initial weight of resin]
Elemental analysis can be used to determine the loading of a resin using equation 5. 
Elements such as carbon, hydrogen, nitrogen, sulfur, chlorine, bromine and iodine 
can be evaluated in this way.
Loading (mmol g' 1 ) = [(%A/NA) x 10]/MWtA (5)
[where,%A = % of element (A) found by elemental analysis; NA = expected number of elements (A)
on resin; MWtA = molecular weight of element A]
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8.2.7 Product release and subsequent analysis
8.2.7.1 General procedure for acidic cleavage
An aliquot of dry resin was treated with a solution of TFA/DCM/H2 O (9:10:1) for 
2 h. The resin was filtered, washed with DCM and the filtrates and washings 
combined and concentrated.
8.2.7.2 General procedure for basic cleavage
An aliquot of dry resin was treated with a solution of 7 N NH3/MeOH or 1 M 
NaOH/dioxane (1:3) for 2 h. The resin was filtered, washed with CH3CN/H2O (1:1) 
(-10 mL) and the filtrates and washings combined and concentrated.
8.2.8 ES-MS/LC-MS
After cleavage (Sections 8.2.7.1/8.2.7.2), the crude product was dissolved in a 
solution of CH3CN/H2 O. An aliquot was withdrawn and analysed by ES-MS using a 
direct infusion set-up, Micromass  Platform II spectrometer with MassLynx version 
2.3 software. When required, LC-MS analysis was carried out using a Waters  2690 
separations module and a Waters  486 tunable absorbance detector measuring at 
210nm. A Phenomenex Luna 3 ja C18(2) 50 x 1 cm column was used as the 
stationary phase eluting with CH3 CN/H2 O at a flow rate of 0.1 mL min" 1 . Retention 
























8.2.9 Reverse phase HPL C/'normal phase chiral HPL C
After cleavage (Sections 8.2.7.1/8.2.7.2), the crude product was dissolved in a 
known amount of CH3 CN/H2O or zsopropanol for normal phase HPLC. Analytical 
high performance liquid chromatography (HPLC) was performed using a Waters  
tunable 486 absorbance detector, Waters  autosampler and a Waters  600 pump 
and controller or a Waters Alliance 2690 separations module with a Waters tunable 
486 absorbance detector. These were managed by the Waters Millennium 
Chromatography software package. A Phenomenex Sphereclone 25 cm x 0.46 cm 
5 )um ODS2 column was used for all reverse phase HPLC and either a Diacel 
Industries Chiracel OD 25 cm x 0.46 cm, OD-H 25 cm x 0.46 cm or Chiralpak AD 
25 cm x 0.46 cm column were used for all normal phase chiral HPLC. Unless 
otherwise stated, all columns were operated at room temperature. In all cases, a flow 
rate of 1 mL min" 1 was used and detection was at 210 nm for reverse and normal 
phase HPLC. Due to the number of methods developed the exact mobile phase 
composition is documented within the analytical data for the specific compound of 
interest. In the case of quantitative results being required, two standard solutions 
were run for each compound to construct a standard concordance test. Retention 
times (Rt) are quoted in minutes.
8.3 Synthesis of amino aldehydes
8.3. 1 General procedure for the preparation of Alloc-protected amino acids
Two methods were employed for the allyloxycarbonyl-protection of amino 
acids.
8.3.1.1 Allyl chloroformate method131
To a solution of the appropriate amino acid (leq.) in 4 M sodium hydroxide was 
added in eight portions, allyl chloroformate (leq.) in 4 M sodium hydroxide with 
stirring at 0 °C. The reaction was kept alkaline throughout. After the last addition, 
the reaction mixture was stirred for 15 min, and then allowed to stand at room
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temperature for 15 min. After this time, the mixture was extracted with diethyl ether 
and the aqueous layer acidified with concentrated hydrochloric acid. A solid 
precipitated after standing at room temperature for 40 min. The solid was collected 
and dried over phosphorous pentoxide in vacua for overnight.
8.3.1.2 Diallylpyrocarbonate method132
To a solution of the appropriate amino acid (leq.) in t^O/Dioxane (3:2) at 
reflux, was slowly added diallyl pyrocarbonate (leq.). After 30 min, the mixture was 
extracted with diethyl ether. The ethearal extracts were washed with brine, dried 
over magnesium sulfate and concentrated to give the product.
8.3.2 2-(S)-Allyloxycarbonylamino-3-phenyl-propionic acid 167131,132,140
H
O
The general procedure 8.3.1.1 was followed with (*S)-(-)-phenylalanine 166 
(50.1 g, 303 mmol) in 4 M NaOH (77.5 mL), allyl chloroformate (32 mL, 0.30 mol) 
in 4 M NaOH (77.5 mL) to provide the title compound as a colourless solid (64.9 g, 
86%). Alternatively, general procedure 8.3.1.2 was followed with G$)-(-)- 
phenylalanine 166 (0.44 g, 2.7 mmol), diallyl pyrocarbonate (0.50 g, 0.4 mmol) in 
water/dioxane (3:2) (6 mL) to give the desired product as a colourless oil (0.41 g, 
61%). Both methods afforded product of sufficient purity to be used without any 
further purification. Analysis was comparable for both methods. 
Mpt 91-96 °C, Lit 131 Mp 83-84 °C; Rf 0.73 [methanol/chloroform (2:1)]; umax (nujol)/ 
cm' 1 3320 (OH), 3061 (CH, aryl), 2725, 2670 (OH, carboxylic acid), 1695 (CO, 
carboxylic acid and urethane), 1603 (C=C, arom), 1541 (CO, amide II), 1495 (C=C, 
arom); 5 H (CDC13 ; 250 MHz) 3.15 (1H, dd, 7=13.9, 6.3 Hz, C//aCHbPh), 3.26 (1H, 
dd, 7=13.8, 5.3, CHaC//bPh), 4.61 (2H, d, 7=5.5 Hz, C//2O), 4.75 (1H, m, C//CH- 
aCHb), 5.26 (1H, dd, 7=11.2, 1.3 Hz, CHcisCHlrans), 5.32 (1H, dd, 7=18.6, 1.4 Hz, 
CUcisCHtrans), 5.91 (1H, ddt, 7=19.0, 11.0, 5.7 Hz, C//=CH2 ), 6.25 (1H, d, 7=7.8 Hz, 
N//), 7.13-7.25 (5H, m, Ph); 5C (CDC1 3 ; 63 MHz) 37.6 (CH2Ph), 55.6 (CHCH2 ), 65.7
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(CH20), 117.6 (CH2=CH), 126.7 (CHar0m), 128.4 (CHarom x 2), 129.2 (CHarom x 2), 
132.4 (CH=CH2), 136.4 (Carom), 156.2 (OOurethane), 176.8 (OOacid); [ct] D22+34.5° 
(0.01, CHC13), Lit [a] D22+35.8° (0.01, CHC13 ); FAB-MS, Found: MH+ 250.1071, 
Ci 3Hi 6NO4 requires MH+ 250.1072.




The general procedure 8.3.1.1 was followed with (^/^-phenylalanine 168 (3.0 
g, 18 mmol) in 4 M NaOH (5 mL), allyl chloroformate (1.9 mL, 18 mmol) in 4 M 
NaOH (5 mL) to provide the desired compound as a colourless solid (3.6 g, 80%). 
The product was obtained in sufficient purity to be used without further purification. 
Analysis comparable to 8.3.2 except Mp 77-80 °C Lit 131 Mp 83-84 °C
8.3.4 General procedure for the preparation of Weinreb amides
Diisopropylethylamine (1.2eq.) was added to a solution of Alloc-protected 
phenylalanine (leq.) in dimethylformamide. HBTU (l.leq.) and HOBt (l.leq.) was 
added and after a few minutes, A^O-dimethyl-hydroxylamine.hydrochloride (1.5eq.) 
was added with diisopropylethylamine (1.4eq.). After 90 min, water (40 mL) was 
added and the reaction mixture was extracted with diethyl ether (3 x 50 mL). The 
organic extracts were combined and washed with water (2 x 50 mL), 2M HC1 (3 x 50 
mL), saturated NaHCO3 (3 x 50 mL) and brine (2 x 50 mL). The organic layer was 
dried over magnesium sulfate and concentrated to give the title compound.
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The general procedure 8.3.4 was followed with diisopropylethylamine (0.89 
mL, 5.1 mmol, 1.2eq.), (6)-Alloc-protected phenylalanine 167 (1.1 g, 4.3 mmol, 
leq.) in dimethylformamide (20 mL), HBTU (1.9 g, 4.7 mmol, l.leq.) and HOBt 
(0.63 g, 4.7 mmol, l.leq.); then N, 0-dimethyl-hydroxylamine.hydrochloride (0.62 g, 
6.4 mmol, 1.5eq.) and diisopropylethylamine (1.1 mL, 5.9 mmol, 1.4eq.). The 
product was obtained as a pale yellow oil (0.93 g, 75%). The compound was found 
to be enantiomerically pure (>99% e.e) by chiral HPLC, eluting using an isocratic 
Hexane/IPA/TFA (90:10:0.01) over 31 min at 5 °C; C$)-enantiomer at Rt = 19.3 min. 
Rf 0.67 [ethyl acetate/hexane (2:1)]; umax (film)/ cm" 1 , 3086, 3062 (CH, arom), 3028, 
2978, 2940 (CH, sat), 1720 (CO, urethane), 1651 (CO, amide I), 1604 (C=C, arom), 
1531 (CO, urethane, amide II); 5H (CDC13 ; 250 MHz) 2.89 (1H, dd, .7=14.0, 7.4 Hz, 
C//aCHbPh), 3.05 (1H, dd, .7=14.0, 6.1, CHaC//bPh), 3.16 (3H, s, NC#3), 3.66 (3H, s, 
OCT/s), 4.50 (2H, dd, .7=5.5, 1.4 Hz, OCH2), 4.96-5.01 (1H, m, C//CHaCHb), 5.16 
(1H, dd, .7=10.4, 1.3 Hz, Cflc&CH, ,), 5.24 (1H, dd, .7=17.0, 1.4 Hz, CHcisCHlrans), 
5.39 (1H, d, .7=8.5 Hz, NH), 5.86 (1H, ddt, .7=17.0, 10.4, 5.3 Hz, C//CH2), 7.13-7.31 
(5H, m, Ph); 8C (CDC13 ; 63 MHz) 31.9 (NCH3), 38.5 (CH2Ph), 51.9 (CHCH2), 61.4 
(OCH3), 65.5 (OCH2), 117.5 (CH2=CH), 126.8 (CHarom), 128.3 (CHarom x 2), 129.3 
(CHarom x 2), 132.5 (CH=CH2), 136.2 (Carom), 155.5 (C=Ourethane), 171.8 (C=Oamide); 









The general procedure 8.3.4 was followed with diisopropylethylamine (2.77 
mL, 15.9 mmol, 1.2eq.), (^/S)-Alloc-protected phenylalanine 169 (3.30 g, 13.2 
mmol, leq.) in dimethylformamide (66 mL), HBTU (5.79 g, 14.8 mmol, l.leq.) and 
HOBt (1.97 g, 14.8 mmol, l.leq.); then TV,0-dimethyl-hydroxylamine.hydrochloride 
(1.94 g, 19.8 mmol, 1.5eq.) and diisopropylethylamine (3.23 mL, 18.4 mmol, 
1.4eq.). The product was obtained as a colourless solid (3.3 g, 86%). The racemic 
compound (1:1 mixture of enantiomers) was analysed by chiral HPLC eluting using 
an isocratic Hexane/EPA/TFA (90:10:0.01) over 31 min at 5 °C; (JR)-enantiomer at Rt 
= 14.7 min, (^-enantiomer at Rt = 19.3 min. 
Analysis comparable to 8.3.5
8.3.7 General procedure for the preparation of Alloc-protected amino aldehydes
To a solution of lithium aluminium hydride (3eq.) in tetrahydrofuran was added 
drop-wise a solution of Weinreb amide (leq.) in tetrahydrofuran at -20 °C over 5 
min. The reaction was stirred at -20 °C for 45 min. After this time, saturated KHSO4 
was added dropwise until effervescence ceased and a grey solid was produced. The 
mixture was stirred at room temperature for 50 min before removing the grey solid 
by filtration. The mother liquors were washed with saturated KHSO4 and brine and 
dried over magnesium sulfate, then concentrated to yield the desired product.
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8.3.8 Allyl (S)-1-formyl-2-phenylethylcarbamate 171 138
General procedure 8.3.7 was followed with lithium aluminium hydride (0.65 g, 
17 mmol) in tetrahydrofuran (22 mL) and Weinreb amide 170 (1.65 g, 5.65 mmol) in 
anhydrous tetrahydrofuran (11 mL). The title compound was obtained as a pale 
yellow solid (1.0 g, 78%). The aldehyde was reduced to the corresponding alcohol 
using procedure 8.3.18 and was found to be enantiomerically pure (98% e.e.) by 
chiral HPLC, eluting using an isocratic Hexane/IPA (98:2) over 50 min at 10 °C; (S)- 
enantiomer at Rt = 30.5 min.
Rf 0.75 [ethyl acetate/hexane (2:1)]; umax (film)/ cm' 1 , 3086, 3062 (CH, arom), 3028, 
2940 (CH, sat), 1694 (CO, aldehyde), 1647 (CO, urethane), 1604 (C=C, arom), 1528 
(CO, amide II); 8H (CDC13 ; 250 MHz) 3.13 (2H, d, .7=6.1 Hz, C#2Ph), 4.50-4.53 
(IH, m, C//CH2), 4.56 (2H, dd, 7=5.6, 1.4 Hz, OO72), 5.21 (IH, dd, 7=10.4, 1.4 Hz, 
CHcisCHtrans), 5.28 (IH, dd, 7=18.6, 1.4 Hz, CHcisCHtrans), 5.89 (IH, ddt, 7=18.5, 
10.6, 5.3 Hz, C/7CH2 ), 7.11-7.34 (5H, m, Ph), 9.50 (IH, s, C7/O); 6C (CDC13 ; 63 
MHz) 35.3 (CH2Ph), 60.9 (CHCH2), 65.8 (OCH2), 117.9 (CH2=CH), 127.1(CHarom), 
128.7 (CHarom x 2), 129.2 (CHarom x 2), 132.3 (CH=CH2), 135.2 (Carom), 155.6 
(00urethane), 198.8 (C=Oa,dehyde); [a] D22 +80.0° (0.01, CHC13); FAB-MS, Found: 
MH+ 234.1130, Ci 3Hi 6NO3 requires MH+ 234.1130.
8.3.9 Allyl (S/R)-1-formyl-2-phenylethylcarbamate 173138
General procedure 8.3.7 was followed using lithium aluminium hydride (0.40 g, 
11 mmol) in tetrahydrofuran (13.3 mL) and Weinreb amide 172 (1.0 g, 3.6 mmol) in
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tetrahydrofuran (6.7 mL). The title compound was obtained as a pale yellow solid 
(0.73 g, 87%). The aldehyde was reduced to the corresponding alcohol using 
procedure 8.3.18 and analysed by chiral HPLC (1:1 mixture of enantiomers), eluting 
using an isocratic Hexane/IPA (98:2) over 50 min at 10 °C; (S)-enantiomer at Rt = 
30.5 min, (^)-enantiomer at Rt = 35.5 min. 
Analysis comparable to 8.3.8.
968.3.10 General Procedure for the preparation of amino alcohols
To a cold (-15 °C) solution of Alloc-protected amino acid (leq.) in 1,2- 
dimethoxyethane (DME), were successively added TV-methyl morpholine (leq.) and 
isobutyl chloroformate (leq.). After 5 min, the precipitated TV-methyl morpholine 
hydrochloride was removed by filtration, washed with DME (3x5 mL) and the 
filtrate and washings were combined in a large flask in an ice-salt bath. A solution of 
sodium borohydride (1.5eq.) in water was added at once, producing a strong 
evolution of gas, followed by water. The mixture was extracted with ethyl acetate; 
then the combined organic extracts with washed with water and brine, then dried 
over magnesium sulfate to afford the title compound.
8.3.11 Allyl (S)-1-hydroxy-3-phenylpropan-2-ylcarbamate 174138
The general procedure 8.3.10 was followed with (^-Alloc-protected 
phenylalanine 167 (2.03 g, 8.14 mmol) in DME (6.8 mL); and TV-methyl morpholine 
(0.89 mL, 8.1 mmol) and isobutyl chloroformate (1.05 mL, 8.14 mmol). Then, 
sodium borohydride (0.46 g, 12 mmol) and water (3.3 and 168 mL) was added. The 
crude product was purified on a Biotage 40M cartridge eluting with ethyl 
acetate/hexane (2:1) to afford the pure compound as a colourless solid (0.63 g, 33%).
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Chiral HPLC using an isocratic hexane/IPA (98:2) at 10 °C, confirmed the 
enantiomeric purity (98% e.e.) of the pure product; (S)-enantiomer at Rt = 33 min. 
Rf 0.55 [ethyl acetate/hexane (2:1)]; Mp 54-55 °C; umax (film)/ cm' 1 3300 (OH), 3082, 
(CH, arom), 3029, 2951, 2856 (CH, sat), 1687 (CO, urethane), 1602 (OC, arom), 
1546 (CO, amide II); 6H (CDC13 ; 250 MHz) 2.75 (2H, d, .7=7.2 Hz, C/72Ph), 3.45 
(1H, dd, .7=10.9, 5.0 Hz, C//aCHbOH), 3.55 (1H, dd, 7=10.9, 3.6 Hz, CHaC//bOH, 
3.81 (1H, m, C#CH2Ph), 4.42 (2H, dd, .7=5.6, 1.4 Hz, OC//2), 4.92 (1H, d, .7=7.9 
Hz, NH), 5.07 (1H, dd, y=10.4, 1.3 Hz, CHcisCHtrans), 5.15 (1H, dd, 7=17.3, 1.4 Hz, 
CHdsCHtrans), 5.75 (1H, ddt, 7=17.2, 10.4, 5.5 Hz, C//CH2), 7.08-7.20 (5H, m, Ph); 
6C (CDC13 ; 63 MHz) 37.8 (CH2Ph), 54.5 (CHCH2Ph), 64.4 (OCH2), 66.1 (CH2OH), 
118.2 (CH2=CH), 127.1(CHarom), 129.1 (CHarom x 2), 129.7 (CHarom x 2), 133.1 
(CH=CH2), 137.9 (Carom), 156.8 (C=Ourethane); [a]D22 36.0° (0.01, MeOH); m/z (ES- 
MS; +ve), 236 (50%, MH+), 258 (100%, MNa+); FAB-MS, Found: MH+ 236.1282, 
Ci 3Hi 8NO3 requires MH+ 236.1286. Found C, 66.14%; H, 7.08%; N, 5.83. Requires 
C, 66.35%; H, 7.29%; N, 5.95%.
8.3. 12 Allyl (R/S)-1-hydroxy-3-phenylpropan-2-ylcarbamate 175138
OH
The general procedure 8.3.10 was followed with (/?/S)-Alloc-protected 
phenylalanine 169 (1.00 g, 4.04 mmol) in 1,2-dimethoxyemane (DME) (6.8 mL); 
and Af-methyl morpholine (0.44 mL, 4.0 mmol) and isobutyl chloroformate (0.52 
mL, 4.0 mmol). Then, sodium borohydride (0.23 g, 6.1 mmol) and water (1.6 and 84 
mL). The crude compound was obtained as a colourless solid (0.80 g, 84%) and used 
without further purification. Chiral HPLC using an isocratic hexane/IPA (98:2) at 10 
°C, confirmed that the product was racemic; (5)-enantiomer at Rt = 33 min, (R)- 
enantiomer Rt = 36 min. 
Analysis comparable to 8.3.11.
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8.3.13 2-lodoxybenzoic acid (IBX) 17 f7
O 
CAUTION! IBX is explosive under impact or heating to > 200 °C
2-Iodobenzoic acid 176 (25 g, 0.11 mol, leq.) was added all at once to a 
solution of oxone [2KHSO5-KHSO4-K2 SO4] (185 g, 0.300 mol, 3eq.) in de-ionised 
water (1000 mL). The suspension was set at 70 °C; after Ih at this temperature a 
clear solution was obtained that delivered IBX upon cooling the solution to 0 °C for 
2h and filtering and washing the crystals with water (6 x 50 mL) and acetone (2 x 50 
mL). The colourless solid was dried in vacuo (29 g, 96%).
Rf baseline [ethyl acetate/hexane (8:2)]; Mp 228-230 °C decomposed, Lit97 Mp 233 
°C dec; i)max (film)/ cm' 1 , 1630 (CO); 6H (DMSO-4; 250 MHz) 8.10 (IH, t, .7=7.0 
Hz, C//b), 8.26 (IH, td, .7=7.0, 1.0 Hz, C/7C), 8.26 (IH, d, .7=7.3 Hz, C#a), 8.40 (IH, 
d, C/7d); Found C, 29.61%; H, 1.59%; N, 0%. Requires C, 30.03%; H, 1.80%; N, 
0%.
8.3. 14 Dess-Martin periodinane 15898
AcO OAc
O 
177 (1.8 g, 6.5 mmol, leq.) was added to a solution of acetic anhydride (7.27
mL, 77.4 mmol, 12eq.) and TsOH.H2 O (0.091 g, 0.48 mmol, 5 wt%). The flask was 
equipped with a drying tube and was heated at 80 °C for 2 h. After this time, the 
reaction mixture was cooled in an ice-water bath. The cold mixture was filtered and 
washed with anhydrous ether. The resulting colourless solid was quickly transferred 
to an argon filled flask and stored in the freezer (2.2 g, 80%).
Mp 128-131 °C, Lit98 Mp 134 °C; 8 H (DMSO-^6 ; 250 MHz) 2.08 (9H, s, C//3 ), 8.01 
(IH, t, .7=7.3 Hz, C//arom), 8.11-8.33 (3H, m, C/7arom); 5C (DMSO-4; 63 MHz) 21.9
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(CH3), 125.4 (CHarom), 130.9 (CHarom), 133.8 (CHarom), 134.3(CHarom), 147.4 (Carom x 
2), 168.4 (OOiactone), 172.9 (C=Oester).
8.3.15 General procedure for preparation of amino aldehydes from alcohol"
Dess-Martin periodinane 158 (2.1eq.) was added to a solution of Alloc- 
protected phenylalaninol (leq.) in water-saturated dichloromethane. The resulting 
suspension was stirred at room temperature and monitored by TLC. When no 
remaining alcohol was detected (-40 min), the reaction mixture was diluted with 
diethyl ether and a solution of sodium thiosulfate (lleq.) in saturated aqueous 
sodium bicarbonate was added. The mixture was stirred rapidly for 10 min, until 
both phases were clear. The layers were separated and the aqueous layer extracted 
with diethyl ether. The combined organic layers were washed with saturated 
aqueous sodium bicarbonate, water and brine, then dried over sodium sulfate. 
Concentration afforded the crude product.




General procedure 8.3.15 was followed with 158 (9.32 g , 21.9 mmol) and 174 
(2.46 g, 10.5 mmol) in water-saturated dichloromethane (9.5 mL); then a solution of 
sodium thiosulfate (17.6 g, 111 mmol) in saturated aqueous sodium bicarbonate (58 
mL) was added. Concentration afforded the crude product as a colourless solid (1.9 
g, 79%). The aldehyde was reduced to the corresponding alcohol using procedure 
8.3.18 and enantiomerically pure (>99% e.e.) alcohol was analysed by chiral HPLC, 
eluting using an isocratic Hexane/EPA (98:2) over 50 min at 10 °C; (^-enantiomer at 
Rt =35.4min.
Analysis comparable to 8.3.8 except Rf 0.60 [ethyl acetate/hexane (1:1)]; m/z (ES- 
MS; +ve), 234 (100%, MH+); [a] D22 +84.0° (c. 0.01, CHC1 3 ).
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8.3.17 Ally! (S/R)-1-formyl-2-phenylethylcarbamate 173138.139
H
O
General procedure 8.3.15 was followed with 158 (1.62 g, 3.82 mmol) and 175 
(0.43 g, 1.8 mmol) in water-saturated dichloromethane (3 mL); then a solution of 
sodium miosulfate (3.6 g, 23 mmol) in saturated aqueous sodium bicarbonate (12 
mL) was added. Concentration afforded the crude product as a colourless solid (0.26
Analysis comparable to 8.3.8.
8.3. 18 General procedure for reduction of amino aldehydes for analysis133
Alloc protected phenylalaninal (leq.) was dissolved in ethyl acetate. Sodium 
borohydnde (2eq.) was added and the solution stirred at room temperature for 30 
min. After this time, the reaction mixture was poured into water, the organic layer 
was separated and the aqueous layer was extracted with ethyl acetate. The combined 
organic layers were dried over magnesium sulfate and concentrated to yield the crude 
product which was used without further purification.
"138
8.3.19 Allyl (S)-1-hydroxy-3-phenylpropan-2-ylcarbamate 174
OH
General procedure 8.3.18 was followed with (<S)-Alloc-phenylalaninal 171. 
Chiral HPLC using an isocratic hexane/LPA (98:2) at 10 °C, confirmed the 





General procedure 8.3.18 was followed with (^/6)-Alloc-phenylalaninal 173. 
Chiral HPLC using an isocratic hexane/IPA (98:2) at 10 °C, confirmed that the 
product was racemic; (5)-enantiomer at Rt = 33 min, (^)-enantiomer Rt = 36 min.
8.4 Solution phase synthesis of linkers
8.4.1 4-Phenyl-butyryl chloride137
o
To a solution of 4-phenylbutyric acid (10.0 g, 61.0 mmol) in anhydrous 
dichloromethane (100 mL) was added oxalyl chloride (6.37 mL, 9.27 g, 73.0 mmol), 
followed by catalytic dimethylformamide (1 drop). The reaction was allowed to stir 
at room temperature for 1 h, evaporated to remove any excess oxalyl chloride, to 
provide the crude product as a moisture sensitive colourless oil. The crude product 
was purified by distillation at 120 °C/0.2 mm Hg (Lit 137 bp 80-85°C/0.2 mm Hg) to 
obtain the title compound as a colourless oil (7.9 g, 71%).
umax (DCM film)/ cm' 1 1799 (CO, acid chloride), 1603 (CH, aryl); 5H (CDC13 ; 250 
MHz) 2.11 (2H, tt, .7=7.2, 7.2 Hz, CH2C//2CH2), 2.76 (2H, t, J=7.3 Hz, 
CH2CH2C//2), 2.97 (2H, t, .7=7.2 Hz, C//2CH2CH2), 7.23-7.42 (5H, m, Ph); 8C 
(CDC13 ; 63 MHz) 26.7 (CH2), 34.4 (CH2), 46.4 (CH2), 126.5 (CHarom), 128.5 (CHarom 
x 2), 128.7 (CHarom x 2), 140.4 (Carom), 173.8 (CO);
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8.4.2 General procedure for the preparation of N-acyl benzotriazoles
To a solution of benzotriazole (leq.) in anhydrous dichloromethane was added 
triethylamine (1.2eq.), followed by the appropriate acid chloride (l.leq.). The 
reaction was stirred at room temperature for 0.5 h. After this time, the reaction 
mixture was washed with 1M HC1 and saturated NaHCO3 . The organic layers were 
dried over magnesium sulfate and concentrated to obtain the product.
8.4.3 Benzotriazol-1-yl-phenyl-methanone 270110
General procedure 8.4.2 was followed with benzotriazole 224 (1.0 g, 8.6 
mmol), benzoyl chloride (1.1 mL, 9.5 mmol), triethylamine (1.44 mL, 10.3 mmol) 
and dichloromethane (50 mL). Recrystallisation [Hexane/ethyl acetate (9:1)] 
afforded the title compound as a colourless solid (56%).
Rf 0.78 [ethyl acetate/hexane (3:7)]; Mp 106-108 °C Lit110 Mp 112-113 °C; umax 
(nujol mull)/ cm' 1 , 1710 (CO), 1597 (C=C, arom); 6H (CDC13 ; 250 MHz) 7.67-7.91 
(5H, m, Ph), 8.37 (IH, ddd, /=8.2, 8.1, 0.9 Hz, C//bt), 8.44 (IH, ddd, .7=8.3, 8.3, 1.0 
Hz, C#bt), 8.58 (IH, ddd, .7=7.6, 0.8, 0.8 Hz, C//bt), 8.76 (IH, ddd, 7=8.3, 0.9, 0.9 
Hz, C//bt); Sc (CDC13 ; 63 MHz) 115.2 (CHbt), 120.6 (CHbt), 126.7 (CHbt), 128.8 
(CHarom x 2), 130.8 (CHbt), 131.8 (Cbt), 132.1 (CHarom x 2), 132.7 (Cbt), 134.06 
(CHarom), 146.1 (Carom), 167.1 (CKWyi); FAB-MS, Found: MH+ 224.0819, 
C 13Hi 0N3 O requires MH+ 224.0824.
8.4.4 1~Benzotriazol-1-yl-2-phenyl-ethanone 271 135
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General procedure 8.4.2 was followed with benzotriazole 224 (1.54 g, 12.9 
mmol), phenylacetyl chloride (1.87 mL, 14.2 mmol), triethylamine (2.16 mL, 15.5 
mmol) and dichloromethane (75 mL). Recrystallisation [Hexane/diethyl ether (9:1)] 
afforded the title compound as a colourless solid (2.2 g, 73%). 
Rf 0.73 [ethyl acetate/hexane (3:7)]; Mp 67-70 °C, Lit 135 Mp 66-67 °C; umax (nujol 
mull)/ cm' 1 , 1733 (CO, 7V-acyl), 1593 (OC, arom); 6H (CDC13 ; 250 MHz) 4.96 (2H, 
s, CH2), 7.56-7.71 (5H, m, Ph), 7.73 (1H, ddd, 7=8.3, 8.1, 0.9 Hz, C#bt), 7.87 (1H, 
ddd, 7=7.1, 7.0, 1.0 Hz, C#bt), 8.42 (1H, ddd, 7=8.2, 1.0, 1.0 Hz, C//bt), 8.50 (1H, 
ddd, 7=8.8, 0.9, 0.9 Hz, C//bt); 5C (CDC13 ; 63 MHz) 41.9 (CH2), 114.4 (CHbt), 120.1 
(CHbt), 126.1 (CHbt), 127.5 (CHbt), 128.7 (CHarom x 2), 129.7 (CHarom x 2), 130.4 
(CHarom), 131.1 (Cbt), 132.4 (Cbt), 146.2 (Carom), 170.1 (CKWyi); FAB-MS, Found: 
MH+ 238.0984, Ci 4Hi 2N3 O requires MH+ 238.0980.
8.4.5 1-Benzotriazol-1-yl-4-phenyl-butan-1-one 272
O' 
General procedure 8.4.2 was followed with benzotriazole 224 (1.54 g, 12.9
mmol), 4-phenylbutyryl chloride (2.35 mL, 14.2 mmol), triethylamine (2.16 mL, 
15.5 mmol) and dichloromethane (75 mL). Recrystallisation [Hexane/ethyl acetate 
(9:1)] afforded the title compound as an off-white solid (2.5 g, 71%). 
Rf 0.73 [ethyl acetate/hexane (3:7)]; Mp 67-70 °C; umax (nujol mull)/ cm' 1 , 1741 (CO, 
A^-acyl), 1593 (C=C, arom); 5H (CDC13 ; 250 MHz) 2.27 (2H, tt, .7=7.6, 7.5 Hz, 
CH20/2CH2), 2.89 (2H, t, 7=7.2 Hz, CH2CH2C//2), 3.52 (2H, t, 7=7.4 Hz, 
C//2CH2CH2), 7.25-7.36 (5H, m, Ph), 7.56 (1H, ddd, 7=7.2, 7.2, 1.0 Hz, C#bt), 7.71 
(1H, ddd, 7=8.0, 8.0, 1.0 Hz, C//bt), 8.17 (1H, ddd, 7=7.4, 1.0, 1.0 Hz, C//bt), 8.33 
(1H, ddd, 7=8.2, 0.9, 0.9 Hz, C//bt); 8C (CDC13 ; 63 MHz) 25.7 (CH2), 34.7 (CH2), 
34.9 (CH2 ), 114.3 (CHbt), 120.0 (CHbt), 125.9 (CHarom), 126.0 (CHbt), 128.4 (CHarom 
x 2), 128.4 (CHarom x 2), 130.2 (CHbt), 130.9 (Cbt), 140.8 (Cbt), 146.0 (Carom), 172.2 
O/v-aci); FAB-MS, Found: MH+ 266.1300, Ci 6Hi 6N3 O requires MH+ 266.1293.
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8.4.6 General procedure for the preparation of benzotriazole hemiaminals
To a mixture of 7V-acyl benzotriazole (leq.) and desired aldehyde (l.leq.) in 
acetonitrile was added triethylamine (1.2eq.) with stirring. The reaction was stirred 
at room temperature. After TLC had indicated the reaction had gone to completion, 
the reaction mixture was evaporated, then diluted with DCM, washed with 1 M HC1, 
basified with NaHCO3 and dried over MgSO4 to give the crude product.
8.4.7 Benzole acid benzotriazole-1-ylmethyl hemiaminal 273113' 136
General procedure 8.4.6 was followed with 270 (0.40 g, 1.8 mmol), 
formaldehyde (37% in MeOH/H2 O, 0.05 mL, 2 mmol) and triethylamine (0.30 mL, 
2.1 mmol) in acetonitrile (8 mL) for 60 min. The crude product was purified on a 
40S Biotage system [(3:7) ethyl acetate/ hexane] to give the title compound as a 
colourless solid (0.30 g, 66%).
Rf 0.51 [ethyl acetate/hexane (3:7)]; Mp 84-87 °C Lit136 Mp 91-92 °C; umax (nujol 
mull)/ cm' 1 , 1733 (CO, ester), 1599 (OC, arom); 8H (CDC13 ; 250 MHz) 7.03 (2H, s, 
CH2 ), 7.57-7.77 (5H, m, Ph), 8.07 (1H, ddd, .7=8.3, 0.9, 0.9 Hz, C//bt), 8.20 (1H, ddd, 
.7=8.5, 8.3, 1.3 Hz, O/bt), 8.22 (1H, ddd, 7=8.5, 7.6, 0.7 Hz, C//bt), 8.76 (1H, ddd, 
,7=8.3, 0.9, 0.9 Hz, C//bt); 6C (CDC13 ; 63 MHz) 68.2 (CH2), 110.0 (CHbt), 119.9 
(CHbt), 124.5 (CHbt), 128.2 (Cbt), 128.4 (CHarom x 2), 128.4 (CHbt), 129.9 (CHarom x 
2), 132.7 (Cbt), 133.8 (CHarom), 146.0 (Car0m), 165.4 (COester); FAB-MS, Found: 
MH+ 254.0934, Ci4Hi 2N3 O2 requires MH+ 254.0929.
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8.4.8 Phenyl acetic acid benzotriazole-1-ylmethyl hemiaminal 274
General procedure 8.4.6 was followed with 271 (0.47 g, 2.0 mmol), 
formaldehyde (37% in MeOH/H2 O, 0.06 mL, 2 mmol) and triethylamine (0.33 mL, 
2.4 mmol) in acetonitrile (8 mL) for 16 h. The crude product was purified on a 40S 
Biotage system [(2:8) ethyl acetate/ hexane] to give the title compound as a 
colourless solid (0.24 g, 45%).
Rf 0.46 [ethyl acetate/hexane (3:7)]; Mp 88-90 °C; umax (nujol muliycm"1 , 1752 (CO, 
ester), 1600 (C=C, arom); 5H (CDC13 ; 250 MHz) 3.90 (2H, s, C//2Ph), 6.80 (2H, s, 
C//2O), 7.45-7.56 (5H, m, Ph), 7.70 (1H, ddd, 7=8.2, 8.2, 1.1 Hz, C#bt), 7.79 (1H, 
ddd, .7=8.2, 8.2, 1.1 Hz, C#bt), 7.95 (1H, ddd, J=8.3, 0.8, 0.8 Hz, O/bt), 8.34 (1H, 
ddd, J=8.3, 0.8, 0.8 Hz, C//bt); §c (CDC13 ; 63 MHz), 40.6 (CH2), 68.0 (CH2), 109.9 
(CHbt), 119.9 (CHbt), 124.4 (CHbt), 127.3 (CHbt), 128.3 (CHar0m), 128.6 (CHarom x 2), 
129.1 (CHarom x 2), 132.5 (Cbt), 132.6 (Cbt), 146.0 (Carom), 170.7 (C=Oester); m/z (ES- 
MS; +ve), 268 (30%, MH+), 290 (100%, MNa+); FAB-MS, Found: MH+ 268.1090, 
Ci 5H13N3 O2 requires MH+ 268.1086.
8.4.9 4-Phenylbutyric acid benzotriazole-1-ylmethyl hemiaminal 275
General procedure 8.4.6 was followed with 272 (0.47 g, 1.7 mmol), 
formaldehyde (37% in MeOH/H2O, 0.05 mL, 2 mmol) and triethylamine (0.28 mL, 
2.0 mmol) in acetonitrile (8 mL) for 16 h. The crude product was purified on silica 
[(3:7) ethyl acetate/ hexane] to give the title compound as a colourless oil (0.32 g,
63%).
Rf 0.55 [ethyl acetate/hexane (3:7)]; umax (DCM film)/ cm' 1 , 1749 (CO, ester), 1602
(C=C, arom); 5 H (CDC1 3 ; 250 MHz) 1.92-2.01 (2H, tt, J= 7.4, 7.4 Hz, CH2C//2 CH 2 ),
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2.44 (2H, t, .7=7.4 Hz, C#2CH2CH2), 2.63 (2H, t, J=7A Hz, CH2CH2C7/2), 6.61 (2H, 
s, C7/2O), 7.11-7.529 (5H, m, Ph), 7.48 (1H, ddd, J=8.3, 8.3, 1.1 Hz, O7bt), 7.61 
(1H, ddd, .7=8.3, 8.3, 1.0 Hz, C//bt), 7.81 (1H, ddd, J=8.3, 0.9, 0.9 Hz, C#bt), 8.14 
(1H, ddd, .7=8.3, 0.9, 0.9 Hz, C77bt); 8C (CDC1 3 ; 63 MHz), 25.9 (CH2), 32.9 (CH2), 
34.7 (CH2), 67.5 (CH2), 109.9 (CHbt), 119.9 (CHbt), 124.4 (CHbt), 125.9 (CHbt), 
128.3 (CHarom x 5), 132.6 (Cbt), 140.7 (Cbt), 145.9 (Carom), 172.4 (C=Oester); m/z (ES- 
MS; +ve), 296 (15%, MH+), 318 (100%, MNa+); FAB-MS, Found: MH+ 296.1392, 
Ci 7Hi 7N3O2 requires MH+ 296.1399.
8.4.10 (1R,2S)- and (1S,2S)-Benzoic acid 2-allyloxycarbonylamino-1-benzotriazol- 
1-yl-3-phenyl-propyl hemiaminals 278a/b
General procedure 8.4.6 was followed using 270 (0.40 g, 1.8 mmol), 171 (0.45 
g, 2.0 mmol) and triethylamine (0.30 mL, 2.1 mmol) in acetonitrile/ dichloromethane 
(90:10) (8 mL). The crude product was purified on a 40S Biotage system [(2:8) ethyl 
acetate/ hexane] to give the title compound as a diastereomeric mixture (0.45 g, 
55%).
Rf 0.45 [ethyl acetate/hexane (3:7)]; Mp 107-109.5 °C; umax (film)/ cm' 1 , 1730 (CO, 
ester and urethane), 1648 (CO, amide II), 1601 (C=C, arom); 6H (CDC13 ; 250 MHz) 
2.80 (1H, dd, .7=13.5, 8.3 Hz, C//aCHbPh, one diastereomer), 2.83 (2H, d, .7=5.0 Hz, 
CHaC7/bPh and C7/aCHbPh, two diastereomers), 3.20 (1H, dd, .7=14.1, 7.6 Hz, 
CHaC7/bPh, one diastereomer), 4.49 (2H, d, ,7=5.2 Hz, C7/2 O, one diastereomer), 
4.61 (2H, d, 7=5.5 Hz, C//2 O, one diastereomer), 5.06-5.31 (2 x 1H and 2 x 1H and 2 
x 1H, overlapping m, C7/CH2 , two diasteromers and CH=C7/c,,CHfrao,, two 
diastereomers and CH=CHC* CHtranst two diastereomers), 5.73 (2 x 1H, overlapping 
ddd, .7=22.4, 10.5, 5.3 Hz, C//=CH2 , 2 diastereomers), 6.45 (2 x 1H, N//, two
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diastereomers), 7.05 (2 x IH, m, OC//CH), 7.19-7.33 (2 x 10H, m, Ph, two 
diastereomers), 7.44-7.50 (2 x IH, m, C/4t, two diastereomers), 7.59-7.66 (2 x IH, 
m, C//bt, two diastereomers), 7.98-8.16 (2 x IH and 2 x IH, m, C//bt, two 
diastereomers); 5C (CDC13 ; 63 MHz) 35.3 (CH2Ph, two diastereomers), 53.1 
(CHCH2, major diastereomer), 54.5 (CHCH2 , minor diastereomer), 65.0 (CH2 O, two 
diastereomers), 76.4 (CHCH, minor diastereomer), 79.3 (CHCH, major 
diastereomer), 109.8 (CHbt, two diastereomers), 117.1 (CH2=CH, two 
diastereomers), 119.5 (CHbt, two diastereomers), 124.0 (CHbt, two diastereomers), 
126.4 (CHarom, two diastereomers), 127.5 (Cbt, two diastereomers), 127.9 (CHbt, two 
diastereomers), 128.1 (CHarom x 2, two diastereomers), 128.4 (CHarom x 2, two 
diastereomers), 128.6 (CHarom, two diastereomers), 129.5 (CHarom x 2, two 
diastereomers), 131.6 (CHar0m x 2, two diastereomers), 132.0 (Cbt, two 
diastereomers), 133.3 (CH=CH2 , two diastereomers), 134.9 (Carom, two 
diastereomers), 145.2 (Car0m, two diastereomers), 155.2 (C=Ourethane, two 
diastereomers), 164.3 (C=Oester, two diastereomers); FAB-MS, Found: MH+ 
457.1882, C26H25N4O4 requires MH+ 457.1875.
8.4.11 (1R,2S)- and (1S,2S)- Phenylacetic acid 2-allyloxycarbonylamino-1 
benzotriazol-1-yl-3-phenyl-propyl hemiaminals 279a/b
General procedure 8.4.6 was followed using 271 (0.40 g, 1.7 mmol), 171 (0.43 
g, 1.9 mmol) and triethylamine (0.35 mL, 2.5 mmol) in dichloromethane (10 mL). 
The crude product was purified on silica [(19:1) dichloromethane/ diethyl ether] to 
give the title compounds as a diastereomeric mixture (0.25 g, 32%).
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Rf 0.35 [ethyl acetate/hexane (3:7)]; umax (film)/ cm' 1 , 1754 (CO, ester), 1722 (CO, 
urethane),1647 (CO, amide II), 1603 (C=C, arom); 6H (CDC13 ; 250 MHz) 2.62 (1H, 
dd, .7=13.9, 7.9 Hz, C#aCHbPh, one diastereomer), 2.76 (2H, d, .7=4.8 Hz, 
and C//aCHbPh, two diastereomers), 2.91 (1H, dd, .7=13.8, 7.6 Hz,
, one diastereomer), 3.56 (2H, s, COC7/2Ph, one diastereomer), 3.57 (2H, 
s, COC7/2Ph, one diastereomer), 4.38 (2H, d, .7=5.0 Hz, C//2O, one diastereomer), 
4.45 (2H, d, .7=4.5 Hz, C7/2O, one diastereomer), 4.83 (2 x 1H, m, C//CH2 , two 
diastereomers), 5.07 (2 x 1H, overlapping dd, 7=10.4, 1.3 Hz, CH=C/7c/iCH//ww, two 
diastereomers), 5.18 (2 x 1H, overlapping dd, .7=15.9, 1.5 Hz, CH=CHc/5 CHtrans, two 
diastereomers), 5.65-5.85 (2 x 1H, overlapping ddt, 7=15.8, 10.5, 5.3 Hz, O7=CH2 , 
two diastereomers), 5.95 (2 x 1H, NT/, two diastereomer), 6.83 (2 x 1H, m, OC//CH, 
two diastereomers), 6.98-7.19 (2 x 1 OH, m, Ph, two diastereomers), 7.30-7.65 (6 x 
1H, m, C#bt, two diastereomers), 8.00 (1H, ddd, 7=8.2, 1.0, 1.0 Hz, C//bt , one 
diastereomer), 8.01 (1H, ddd, 7=8.2, 1.0, 1.0 Hz, C7/bt, one diastereomer); 5C 
(CDC13 ; 63 MHz) 35.9 (CH2Ph, minor diastereomer), 37.2 (CH2Ph, major 
diasteromer), 40.4 (CH2Ph, minor diastereomer), 40.6 (CH2Ph, major diasteromer), 
54.1 (CHCH2, minor diastereomer), 54.7 (CHCH2 , major diastereomer), 65.6 (OCH2 , 
minor diastereomer), 65.7 (OCH2 , major diastereomer), 77.5 (CHCH, minor 
diastereomer), 79.0 (CHCH, major diastereomer), 110.1 (CHbt, major diastereomer), 
110.3 (CHbt, minor diastereomer), 117.4 (CH2=CH, minor diastereomer), 117.8 
(CH2=CH, major diastereomer), 119.8 (CHbt , minor diastereomer), 120.0 (CHbt, 
major diastereomer), 124.5 (CHbt, major diastereomer), 124.6 (CHbt, minor 
diastereomer), 126.9 (CHbt , major diastereomer), 127.4 (CHbt, minor diastereomer), 
128.2 (CHarom x 2, major diastereomer), 128.4 (CHarom x 2, minor diastereomer), 
128.5 (CHarom x 2, one diastereomer), 128.6 (CHar0m x 2, one diastereomer), 128.8 
(CHarom x 4, one diastereomer), 129.1 (CHar0m x 4, one diastereomer), 129.1 (CHarom 
x 2, one diastereomer), 129.2 (CHar0m x 2, one diastereomer), 132.3 (CH=CH2 , minor 
diastereomer), 132.4 (CH=CH2 , major diastereomer), 132.6 (Cbt x 2, major 
diastereomer), 133.2 (Cbt x 2, minor diastereomer), 135.6 (Carom , minor 
diastereomer), 135.8 (Carom, major diastereomer), 145.0 (Carom, minor diastereomer), 
145.6 (Carom, major diastereomer), 155.4 (C=Ourethane, major diastereomer), 155.9
, minor diastereomer), 169.8 (C=Oester, major diastereomer), 170.0
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minor diastereomer); FAB-MS, Found: MH+ 471.2031, C27H27N4O4 
requires MH+ 471.2032.
8.4.12 (1R,2S)- and (1S,2S)-1-(4-Phenylbutyric acid) 2-allyloxycarbonylamino-1- 
benzotriazol-1-yl-3-phenyl-propyl hemiaminal 280a/b
General procedure 8.4.6 was followed using 272 (0.40 g, 1.5 mmol), 171 (0.38 
g, 1.7 mmol) and triethylamine (0.31 mL, 2.2 mmol) in dichloromethane (8 mL). The 
crude product was purified on silica [(19:1) dichloromethane/diethyl ether] to give 
the title compound as diastereomeric mixture (0.33 g, 44%).
Rf 0.30 [ethyl acetate/hexane (3:7)]; umax (film)/ cm" 1 , 1752 (CO, ester), 1722 (CO, 
urethane), 1647 (CO, amide II), 1603 (C=C, arom); 8H (CDC13 ; 250 MHz) 1.73-1.79 
(2H x 2, overlapping tt, .7=7.2, 7.2 Hz, CH2C//2CH2 , two diastereomers), 2.17-2.25 
(2H x 2, overlapping t, J= 7.4 Hz, CH2CH2C/72 , two diastereomers), 2.35-2.46 (2H x 
2, overlapping t, J= 7.4 Hz, C/72CH2CH2, two diastereomers), 2.50-2.62 (IH, dd, 
.7=13.9, 8.3 Hz, C//aCHbPh, one diastereomer), 2.76 (2H, d, 7=5.8 Hz, CHaC//bPh 
and C7/aCHbPh, two diastereomers), 2.86-3.00 (IH, dd, .7=14.1, 7.6 Hz, CHaC/7bPh, 
one diastereomer), 4.33 (2H, d, .7=5.4 Hz, C//2O, one diastereomer), 4.38 (2H, .7=5.5 
Hz, C7/2O, one diastereomer), 4.32-4.37 (2 x IH, overlapping m, C//CH2 , two 
diastereomers), 5.01 (2 x IH, overlapping dd, 7=11.0, 1.3 Hz, CH=CHclsCHtnins two
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diastereomers), 5.05 (2 x 1H, overlapping dd, .7=22.0, 1.4 Hz, CH=CHcisCHtrans, two 
diastereomers), 5.57-5.80 (2 x 1H, overlapping ddt, .7=22.5, 11.3, 5.4 Hz, O/=CH2 , 
two diastereomers), 5.94 (2 x 1H, N//, two diastereomers), 6.83 (2 x 1H, overlapping 
m, CHCH, two diastereomers), 6.98-7.23 (2 x 10H, m, Ph, two diastereomers), 7.30- 
7.65 (6 x 1H, m, C//bt, two diastereomers), 8.00 (1H, ddd, .7=8.2, 1.0, 1.0 Hz, C//bt, 
one diastereomer), 8.01 (1H, ddd, 7=8.2, 1.0, 1.0 Hz, C#bt, one diastereomer); 8C 
(CDCls; 63 MHz) 25.7 (CH2 , minor diastereomer), 25.9 (CH2 , major diastereomer), 
32.8 (CH2 , minor diastereomers), 34.6 (CH2 , major diastereomers), 35.9 (CH2Ph, 
major diastereomer), 37.5 (CH2Ph, minor diastereomer), 53.9 (CH2Ph, major 
diastereomer), 54.7 (CH2Ph, minor diastereomer), 65.5 (OCH2 , minor diastereomer), 
65.7 (OCH2 , major diastereomer), 76.8 (CHCH, minor diastereomer), 78.7 (CHCH, 
major diastereomer), 110.2 (CHbt, major diastereomer), 110.3 (CHbt, minor 
diastereomer), 117.4 (CH2=CH, minor diastereomer), 117.7 (CH2=CH, major 
diastereomer), 119.8 (CHbt, minor diastereomer), 120.1 (CHbt, major diastereomer), 
124.5 (CHbt, major diastereomer) , 124.6 (CHbt, minor diastereomer), 125.9 (CHbt, 
major diastereomer), 126.9 (CHbt, minor diastereomer), 128.3 (CHar0m x 4, one 
diastereomer), 128.3 (CHarom x 4, one diastereomer), 128.6 (CHar0m x 4, one 
diastereomer), 128.8 (CHarom x 4, one diastereomer), 129.1 (CHarom x 2, two 
diastereomers), 132.2 (CH=CH2 , minor diastereomer), 132.5 (CH=CH2 , major 
diastereomer), 132.6 (Cbt, major diastereomer), 133.2 (Cbt, minor diastereomer), 
135.6 (Carom, major diastereomer), 135.8 (Car0m, minor diastereomer), 140.6 (Cbt, two 
diastereomers), 145.0 (Car0m, minor diastereomer), 145.7 (Car0m, major diastereomer), 
155.5 (C=OUrethane> major diastereomer), 155.9 (C=Ourethane, minor diastereomer), 
171.7 (COester, two diastereomers); m/z (ES-MS; +ve), 521 (100%, MNa+); FAB- 
MS, Found: MH+ 499.2339, C29H3iN4O4 requires MH+ 499.2345.
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8.5 Enzymatic studies on benzotriazole substrates
8.5. 1 Screening of enzymes for hydrolysis of benzotriazole hemiaminals
Hydrolysis experiments were carried out in glass sample tubes (2 mL) with 
plastic stoppers. To the enzyme (-0.8 mg) was added 1 mL of stock substrate 
solution (made up with potassium phosphate buffer pH 7.4/acetonitrile (9:1), to give 
-0.3 jamol per reaction for 273-275 and 0.9 jLimol for 278a/b-280a/b. The solutions 
were rotated for 16 h at room temperature on a 360° blood rotator. An aliquot was 
removed for analysis by RP-HPLC. Control experiments contained all reagents 
except the enzyme.
HPLC conditions: Using equipment according to Section 8.2.9 with an isocratic 
method eluting with H2O/CH3CN/TFA (7:3:0.01).













Table 8: Specificity of HPLC method.
HPLC conditions for determination of diastereoselectivity: Using equipment
according to Section 8.2.9 with an isocratic method eluting with
(5:5:0.01).

















Table 9: Specificity ofHPLC method for determination of diastereoselectivity.
8.6 Solid phase synthesis of linkers
8.6.1 General procedure for the preparation of benzotriazole resins103
Benzotriazole-5-carboxylic acid 207 (lOeq.) and HOBt (lOeq.) were suspended 
in dimethylformamide. Diisopropylcarbodiimide (5eq.) was added and the mixture 
stirred at room temperature for 1 h. Appropriate resin (leq.) was added and the 
mixture shaken at room temperature for 16 h. After this time, the Kaiser test 8.2.5.1 
was carried out to confirm coupling, and the resin was filtered and washed according 
to the standard protocol 8.2.3.
8.6.2 1 H-Benzotriazole-5-carboxylic acid-methylamino polystyrene 218
General procedure 8.6.1 was followed with benzotriazole-5-carboxylic acid 207 
(4.11 g, 25.2 mmol), HOBt (3.40 g, 25.2 mmol), diisopropylcarbodiimide (1.97 mL, 
12.6 mmol) and amino-methylated polystyrene HL 214, 100-200 mesh (1.23 mmol 
g" 1 , 2.05 g, 2.5 mmol) in dimethylformamide (45 mL). The title compound was 
obtained as brown beads. Kaiser (8.2.5.1) test confirmed quantitative coupling. 
umax (DCM swell)/ cm' 1 , 1652 (CO, amide I), 1540 (CO, amide II); 6H (MAS-NMR; 
CDC1 3 ; 600 MHz) 7.84 (broad s, C//bt).
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8.6.3 1H-Benzotriazole-5-carboxylic acid-ammo tentagel 217
General procedure 8.6.1 was followed with benzotriazole-5-carboxylic acid 207 
(0.52 g, 3.2 mmol), HOBt (0.43 g, 3.2 mmol), diisopropylcarbodiimide (0.25 mL, 1.6 
mmol) and amino-TentaGel HL 213 (0.45 mmol g" 1 , 0.71 g, 0.32 mmol) in DMF (45 
mL). The title compound was obtained as a brown gel. Kaiser 8.2.5.1 test confirmed 
quantitative coupling.
umax (DCM swell)/ cm' 1 1650 (CO, amide I), 1540 (CO, amide II); 5C (CDC13 ; 63 
MHz) 167.0 (CO), 132.0 (CHbt), 124.8 (CHbt), H5.5 (CHbt).
8.6.4 1 H-Benzotriazole-5-carboxylic acid-aminomethyl polystyrene MP 219
General procedure 8.6.1 was followed with benzotriazole-5-carboxylic acid 207 
(3.88 g, 23.8 mmol), HOBt (3.22 g, 23.8 mmol), diisopropylcarbodiimide (1.86 mL, 
11.9 mmol) and aminomethyl polystyrene MP 215, particle size=50-70 ^im, pore 
size=1000 A (1.19 mmol g" 1 , 2.00 g, 2.4 mmol). The title compound was obtained as 
non-swelling brown beads. Kaiser 8.2.5.1 test confirmed quantitative coupling. 
umax (KBr disc)/ cm' 1 , 1645 (CO, amide I).
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.6.5 1H~Benzotriazole-5-carboxylic acid-amino-PEGA 1900 220
General procedure 8.6.1 was followed with benzotriazole-5-carboxylic acid 207 
(0.97 g, 6.0 mmol), HOBt (0.81 g, 6.0 mmol), diisopropylcarbodiimide (0.47 mL, 3.0 
mmol) and PEGAi9oo 216, particle size=300-500 fim, (0.2 mmol g" 1 , 3 g, 0.6 mmol) 
in dimethylformamide (35 mL). The coupled resin was obtained as a pale brown gel 
and stored in DCM until required for further elaboration. Kaiser 8.2.5.1 test 
confirmed quantitative coupling.
umax (KBr disc)/ cm' 1 , 1672 (CO, amide I), 1549 (CO, amide II); 5H (MAS-NMR; 
CDC13 ; 600 MHz) 7.60-8.50 (broad m, C//bt).
8.6.6 1H-Benzotriazole-5~amino-carboxypolystyrene 254
O
Carboxy-polystyrene HL, 100-200mesh (1.24 mmol g' 1 , 1.95 g, 2.4 mmol) and 
HOBt (3.27 g, 24.2 mmol) were suspended in dimethylformamide. 
Diisopropylcarbodiimide (1.53 g, 12.1 mmol) was added and the mixture agitated at 
room temperature for 1 h. 5-Aminobenzotriazole was added and the mixture agitated 
at room temperature for 16 h. The resin was filtered and washed according to the 
standard protocol 8.2.3 to obtain the title compound as colourless beads. In this case, 
double coupling was carried out to ensure complete coupling. 
umax (KBr disc)/ cm' 1 , 1658 (CO, amide I), 1580 (CO, amide II).
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8.6.7 1 H-Benzotriazole-5-carboxylic acid-am ino-propyl CPG
To a solution of benzotriazole-5-carboxylic acid 207 (0.19 g, 1.2 mmol, 5eq.) in 
dimethylformamide (2 mL) was added, HBTU (0.45 g, 1.2 mmol, 4.9eq.) and HOBt 
(0.16 g, 1.2 mmol, 5eq.), followed by diisopropylethylamine (0.43 mL, 0.31 g, 2.4 
mmol, lOeq.) with stirring. The coupling mixture was immediately added to the 
amino-propyl CPG (1011 A pore size, 29.9 m2 g" 1 , surface area 125-177 jum particle 
size) (80.3 jimol g" 1 , 3.00 g, 0.24 mmol, leq.). The reaction mixture was agitated on 
a blood rotator for 16 h to obtain brown beads (73.0 j^mol g" 1 , Lmax = 79.3 ^imol g" 1 , 
92% loading by elemental analysis). Kaiser 8.2.5.1 test confirmed coupling. 
umax (KBr disc)/ cm'1 , 1632 (CO, amide I).
8.6.8 1 H-Benzotriazole-5-carboxylic acid-long chain amino-propyl CPG 299
To a solution of benzotriazole-5-carboxylic acid 207 (0.25 g, 1.5 mmol, 5eq.) in 
dimethylformamide (5 mL) was added, HBTU (0.57 g, 1.5 mmol, 4.9eq.) and HOBt 
(0.21 g, 1.5 mmol, 5eq.), followed by diisopropylethylamine (0.55 mL, 0.40 g, 3.1 
mmol, lOeq.) with stirring. The coupling mixture was immediately added to the long 
chain amino-propyl CPG 298 (1088 A pore size, 34.4 m2 g" 1 surface area, 125-177 
fim particle size) (77.5 jamol g" 1 , 4.0 g, 0.31 mmol, leq.). The reaction mixture was 
agitated on a blood rotator for 16h to obtain brown beads (48.0 ^irnol g" 1 , 63% 
loading by elemental analysis). Kaiser test (Section 8.2.5.1) confirmed coupling. 




Attempted synthesis of 2-nitrobenzenesulfonamide coupled long chain 
amino-propyl CPG 304
To a suspension of 298 (1088 A pore size, 34.4 m2 g" 1 surface area, 125-177 |um 
particle size) (77.5 j^mol g" 1 , 0.45 g, 35 jumol, leq.) in THF/DCM (3 mL) and DMAP 
(26 |^L, 0.21 mmol, 6eq.), was added 2-nitrobenzene sulfonyl chloride (31 mg, 0.14 
mmol, 4eq.). The resulting suspension was agitated on a blood rotator at room 
temperature for 1.5 h. After this time, the Kaiser test (8.2.5.1) revealed incomplete 
coupling. The reaction mixture was filtered, washed with DCM and fresh reagents 
added. The reaction was repeated a further 4 times, however the Kaiser test showed 
a positive result each time. Sulfur analysis confirmed the failure of the 2- 
nitrobenzene sulfonyl coupling.
8.6.10 General procedure for preparation of aminal linkers106
Desired aldehyde (lOeq.), phenylacetamide (lOeq.) and ^-toluene sulfonic acid 
(0.5eq.) were dissolved in toluene. Benzotriazole resin (leq.) was added and the 
reaction mixture was heated under reflux for 48 h using a Dean-Stark apparatus for 
azeotropic removal of water. The resin was filtered and washed according to the 
standard protocol 8.2.3, unless otherwise stated.
8.6.11 l-(Benzoylamino-methyl)-1H-benzotriazole-carboxyamino-polystyrene 232
General procedure 8.6.10 was followed using formaldehyde (37% in 
H2O/MeOH) (0.66 mL, 0.73 g, 24 mmol), benzamide (2.94 g, 24.3 mmol),/?-toluene
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sulfonic acid (0.23 g, 1.2 mmol) and 218 (assume 1.23 mmol g' 1 , 1.98 g, 2.43 mmol) 
in anhydrous toluene (50 mL) to obtain the desired product as brown beads. 0.52 
mmol g" 1 by acid cleavage (Section 8.2.7.1), followed by quantitation of the 
benzamide released by reverse phase HPLC (Section 8.2.9), Lmax = 0.90 mmol g' 1 , 
58% loading.
umax (KBr disc)/ cm' 1 3057, 3023 (CH, aryl), 2919, 2850 (sat. CH), 1645 (CO, amide 
I), 1600 (CH, aryl), 1580 (CO, amide II). 5H (MAS-NMR; CDC13 ; 600 MHz) 5.43 
(C#2), 8.30 (C#bt), 7.80 (C#bt), 7.35 (O/arom), 7.24 (C//arom).
8.6.11.1 Optim isation of acid cleavage
The cleavage of 232 was carried out in plastic isolute tubes using either 
trifluoroacetic acid/dichloromethane/water (9:10:1) or 95% trifluoroacetic acid/water 
cleavage mixtures. For each cleavage mixture, 11 aliquots of resin 232 (-13 mg) 
were treated with the cleavage mixture (0.5 mL). After 30 min, the first sample was 
filtered, washed with acetonitrile/water (1:1) (5 mL), concentrated and dissolved in 
acetonitrile/water (1:1) (5 mL), then the amount of benzamide released was analysed 
by reverse phase HPLC. This was repeated every 15 min over 4.75 h. The amount 
of benzamide released against time was plotted for both cleavage methods. Controls 
contained all reagents except the acid and were allowed to run until the end of the 
experiment before being analysed.
HPLC conditions: Using equipment according to section 8.2.9 with an isocratic 
method eluting with H2O/CH3 CN/TFA (7:3:0.01). Benzamide standards were 







8.6.12 1-[1-({2S}-Allyloxycarbonylamino- 1-benzoylamino-3-phenyl-propyl)-1H- 
benzotriazolej-carboxyamino-polystyrene 233
General procedure 8.6.10 was followed using 171 (1.80 g, 7.80 mmol, 5eq.), 
benzamide (0.94 g, 7.8 mmol, 5eq.), p-to\uene sulfonic acid (70 mg 0.39 mmol) and 
218 (assume 1.23 mmol g" 1 , 1.27 g, 1.56 mmol, leq.) in anhydrous toluene (50 mL). 
The resin was filtered and washed with copious amounts of DMF and DCM (>300 
mL).
umax (KBr disc)/ cm' 1 , 3023 (CH aryl), 2923 (sat. CH), 1714 (CO, urethane), 1645 
(CO, amide I), 1539 (CO, amide II); 5H (MAS-NMR; CDC13 ; 600 MHz) 4.30-4.67 
(C//2CH= and O/CH2Ph), 4.90-5.24 (CH2=), 7.86 (C#bt).
8.6.12.1 Determination of enantiomeric purity of cleaved aldehyde
A large sample of resin 233 (238 mg) was treated with TFA/DCM/H2O (9:10:1) 
(0.5 mL) for 4 h. The resin was filtered, washed with acetonitrile/water (1:1) and 
concentrated. The residue was dissolved in ethylacetate and sodium borohydride 
(5.2 mg) was added. The solution was stirred at room temperature for 30 min. After 
this time, the reaction mixture was concentrated and dissolved in iso-propy\ alcohol
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before being analysed by normal phase chiral HPLC and compared to a sample of 
racemic allyloxycarbonyl-phenylalaninol 175.
Chiral HPLC confirmed that the alcohol 174 was almost chirally pure (97% e.e.). 
Chiral HPLC conditions: Using equipment according to section 8.2.9 with an 
isocratic system eluting with hexane/IPA (98:2) at 10 °C. 










General procedure 8.6.10 was followed using (S)-lll (0.32 g, 1.4 mmol, 6eq.), 
phenylacetamide (0.19 g, 1.4 mmol, 6eq.),/7-toluene sulfonic acid (0.02 g, 0.1 mmol, 
O.Seq.) and 218 (assume 1.23 mmol g" 1 , 0.19 g, 0.2 mmol, leq.) in anhydrous toluene 
(50 mL). The resin was filtered and washed with copious amounts of DMF and 
DCM (>300 mL).
umax (KBr disc)/ cm' 1 , 1703 (CO, urethane), 1652 (CO, amide I), 1600 (CH, aryl), 






General procedure 8.6.10 was followed using (S)-171 (2.5 g, 11 mmol, lOeq.), 
benzamide (1.3 g, 11 mmol, lOeq.), />-toluene sulfonic acid (0.09 g, 0.5 mmol) and 
254 (assume 1.24 mmol g" 1 , 0.86 g, 1.1 mmol, leq.) in anhydrous toluene (40 mL). 
The resin was filtered and washed with copious amounts of DMF and DCM (>300 
mL).
umax (KBr disc)/ cm' 1 3081, 3059, 3024 (CH aryl), 2922 (sat. CH), 1715 (CO, 





1 H-benzotriazole]-carboxyamino- TentaGel 238
General procedure 8.6.10 was followed using (S)-lll (0.60 g, 2.6 mmol), 
phenylacetamide (0.35 g, 2.6 mmol),/?-toluene sulfonic acid (0.02 g, 0.10 mmol) and 
217 (assume 0.45 mmol g" 1 , 0.57 g, 0.30 mmol). The resin was filtered and washed 
with copious amounts of DMF and DCM (>300 mL).
umax (KBr disc)/ cm' 1 , 3025 (=CH stretch), 2920 (sat. CH), 1717 (CO, urethane), 






General procedure 8.6.10 was followed using (S)-lll (0.35 g, 1.5 mmol, lOeq.), 
phenylacetamide (0.20 g, 1.5 mmol, lOeq.), p-toluene sulfonic acid (0.01 g, 0.07 
mmol, 0.5eq.) and 219 (assume 1.19 mmol g" 1 , 0.12 g, 0.15 mmol, leq.) in 
anhydrous toluene (13 mL). The resin was filtered and washed with copious 
amounts of DMF and DCM (>300 mL).
omax (KBr disc)/ cm' 1 3020 (CH, aryl), 2926 (sat. CH), 1718 (masked CO, urethane), 
1664 (CO, amide I), 1600 (CH, aryl), 1509 (CO, amide II).
8,6.16.1 Enzymatic studies on TentaGel and macroporous polystyrene-bound 
benzotriazole substrates 238 and 237.
Hydrolysis experiments were carried out in plastic isolute tubes fitted with a 
plastic cap and tip. To aliquots of the resin-bound benzotriazole substrates 237 and 
238 (~10 mg) was added penicillin acylase (~0.8 mg) in potassium phosphate buffer 
pH 7.5 (10 mM) (1 mL). The suspensions were rotated for 16 h at room temperature 
on a 360° blood rotator. The suspensions were filtered, washed with -10 mL 
acetonitrile/water (1:1) and concentrated. The resulting residues were dissolved in 
acetonitrile/water (1:1) (2 mL) for analysis by reverse-phase HPLC. The control 
experiment contained all reagents except the enzyme.
Acid cleavage: To an aliquot of the resin-bound benzotriazole substrate 237 and 238 
(-500 mg) was added TFA/DCM/H2 O (9:10:1) (1 mL). The suspensions were 
rotated for 16 h at room temperature on a 360° blood rotator. The suspensions were 
filtered, washed with ~10 mL acetonitrile/water (1:1) and concentrated. The 
resulting residues were dissolved in acetonitrile/water (1:1) (2 mL) for analysis by 
reverse-phase HPLC. The control experiment contained all reagents except acid.
HPLC conditions: Using equipment according to Section 8.2.9 with an isocratic 
method eluting with H2O/CH3 CN/TFA (7:3:0.01).
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Table 10: Specificity of HPLC method for substrates.
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1348.6.17 General procedure for preparation of N-acyl benzotriazole resins
To a suspension of the desired benzotriazole-resin (leq.) in anhydrous 
dichloromethane was added triethylamine (lOeq.), followed by the relevant acid 
chloride (lOeq.), dropwise at 0 °C under argon. The resulting mixture was stirred at 
room temperature for 20 h. The resin was filtered and washed according to the 
standard protocol 8.2.3.
8.6.18 1-(1-Benzoyl-1H-benzotriazole)-carboxyamino-polystyrene 281
General procedure 8.6.17 was carried out using 218 (assume 1.23 mmol g" 1 , 
0.52 g, 0.64 mmol), benzoyl chloride (0.74 mL, 0.90g, 6.4 mmol) and triethylamine 
(0.9 mL, 0.65g, 6.4 mmol) in anhydrous dichloromethane (25 mL). 
umax (KBr disc)/ cm' 1 , 3058, 3024 (CH, aryl), 2921 (sat. CH), 1717 (CO, JV-acyl), 
1652 (CO, amide I), 1599 (CH, aryl), 1521 (CO, amide II); 6H (MAS-NMR; CDC13 ; 
600 MHz) 8.70 (C//bt), 8.51 (C//bt), 8.35 (C//bt), 8.11 (CHar0m), 7.59 (CHarom), 7.46
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8.6.19 1-(1-Benzoyl-1H-benzotriazole)~carboxyamino-macroporous polystyrene 
282
General procedure 8.6.17 was carried out using 219 (assume 1.19 mmol g" 1 , 
0.50 g, 0.59 mmol), benzoyl chloride (0.69 mL, 0.83 g, 5.9 mmol) and triethylamine 
(0.84 mL, 0.60 g, 5.9 mmol) in anhydrous dichloromethane (25 mL). 
umax (KBr disc)/ cm' 1 , 3020 (CH, aryl), 2924 (sat. CH), 1717 (CO, N-acyl), 1645 




General procedure 8.6.17 was carried out using 219 (assume 1.19 mmol g" , 0.47 g, 
0.56 mmol), phenylacetyl chloride (0.74 mL, 0.86 g, 5.6 mmol) and triethylamine 
(0.78 mL, 0.57 g, 5.6 mmol) in anhydrous dichloromethane (25 mL). 
umax (KBr disc)/ cm' 1 , 3022 (CH, aryl), 2924 (sat. CH), 1718 (CO, #-acyl), 1644 




General procedure 8.6.17 was carried out using 220 (assume 0.2 mmol g" 1 , 0.5 
g, 0.1 mmol), benzoyl chloride (0.14 g, 0.12 mL, 1.0 mmol) and triethylamine (0.14 
mL, 0.10 g, 1.0 mmol) in anhydrous dichloromethane (25 mL). 
umax (KBr disc)/ cm' 1 2986 (sat. CH), 1661 (CO, W-acyl), 1653 (CO, amide I), 1557 
(CH, aryl), 1507 (CO, amide II); 8H (MAS-NMR; CDC13 ; 600 MHz) 8.80 (CHbi), 
8.23 (C//bt x 2), 8.41 (CHbi), 8.23 (CHarom x 2), 7.72 (CHarom), 7.60 (CHarom).
8.6.22 1-(1-Phenylacetyl-1H-benzotriazole)-carboxyamino-PEGA 190o 285
General procedure 8.6.17 was carried out using 220 (assume 0.2 mmol g' 1 , 0.5 
g, 0.1 mmol), phenylacetyl chloride (0.15 g, 0.13 mL, 1.0 mmol) and triethylamine 
(0.14 mL, 0.10 g, 1.0 mmol) in anhydrous dichloromethane (25 mL). 
umax (KBr disc)/ cm' 1 2986 (sat. CH), 1690 (CO, W-acyl), 1650 (CO, amide I), 1601 
(CH, aryl), 1507 (CO, amide II); 6H (MAS-NMR; CDC13 ; 600 MHz) 8.60-7.20 





General procedure 8.6.17 was carried out using 220 (assume 0.2 mmol g" 1 , 1.14 
g, 0.230 mmol), 4-phenylbutyryl chloride (0.42 g, 2.3 mmol) and triethylamine (0.32 
mL, 0.23 g, 2.3 mmol) in anhydrous dichloromethane (50 mL). 
umax (KBr disc)/ cm' 1 2985 (sat. CH), 1689 (CO, 7V-acyl), 1651 (CO, amide I), 1600 
(CH, aryl), 1505 (CO, amide II); 5H (MAS-NMR; CDC13 ; 600 MHz) 2.35 (CH2), 
8.55-7.10 (combination of C//bt and CHarom).
8.6.24 1-(1-Phenylacetyl-1H-benzotriazole)-carboxyamino-long chain amino- 
propyl CPG 300
General procedure 8.6.17 was carried out using 299 (assume 77.5 j^mol g" 1 , 4.0 
g, 0.31 mmol), phenylacetyl chloride (0.48 g, 0.41 mL, 3.1 mmol) and triethylamine 
(0.43 mL, 0.31 g, 3.1 mmol) in anhydrous dichloromethane (100 mL). 
umax (KBr disc)/ cm' 1 2985 (sat. CH), 1690 (CO, 7V-acyl), 1640 (CO, amide I), 1603 
(CH, aryl), 1500 (CO, amide II);
8.6.25 General procedure for the preparation of hemiaminal linkers
To a suspension of N-acyl benzotriazole resin (leq.) and desired aldehyde (8- 
lOeq.) in acetonitrile was added triethylamine (3eq.) with vigorous shaking. The
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resulting mixture was agitated on a blood rotator at room temperature for 20 h. The 
resin was washed according to the standard protocol.
8.6.26 1-[1-(Benzyloxycarbonyl-methyl)-1H-benzotriazole]-carboxyamino- 
polystyrene 287
General procedure 8.6.25 was followed with 284 (assume 1.23 mmol g' 1 , 0.98 
g, 1.2 mmol), formaldehyde (37% solution in H2O/MeOH) (0.26 mL, 0.29 g, 9.6 
mmol), triethylamine (0.51 mL, 0.36 g, 3.6 mmol) in acetonitrile (5 mL) to afford the 
title compound as pale brown beads (701 jimol g" 1 loading from basic cleavage (1 M 
NaOH/Dioxane 3:2), Lmax = 914 jimol g" 1 , 77%).
umax (KBr disc)/ cm' 1 3058,3023 (CH, aryl), 2919, 2850 (sat. CH), 1731 (CO, ester), 
1645 (CO, amide I), 1600 (CH, aryl), 1521 (CO, amide II). 6H (MAS-NMR; CDC13 ; 
600 MHz) 6.55 (C//2), 7.31 (CHarom), 7.46 (CHarom), 7.95, 7.88 (CHbt x 2), 8.41
8.6.27 Evaluation of chemical cleavage methods for polymer bound 
benzotriazole hemiaminal 287
Cleavage experiments were performed in 2 mL plastic isolute tubes. The 
procedures for each base cleavage are detailed below:
8.6.27.1 Methanolic ammonia:
An aliquot of dry resin 287 (12 mg) was swollen in DMF. A solution of 
ammonia in methanol (7 mmol I" 1 , 0.3 mL) was added at 0 °C. The tube was sealed 
and allowed to warm to room temperature before being agitated for 18 h on a 360° 
blood rotator. The resin was filtered, washed with methanol (5 mL) and the mother 




An aliquot of dry resin 287 (15 mg) was suspended in DMF. A solution of 5% 
hydrazine hydrate in DMF (0.3 mL) was added. The suspension was agitated on a 
360° blood rotator at room temperature for 1 h. The resin was filtered, washed with 
DMF (5 mL) and the mother liquor evaporated to dryness.
8.6.27.3 DIPEA:
An aliquot of dry resin 287 (12 mg) was suspended in DMF. A solution of 
DIPEA/MeOH/DMF (1:5:5) (0.6 mL) was added. The suspension was agitated on a 
360° blood rotator at room temperature for 16 h. The resin was filtered, washed with 
MeOH/DMF (5 mL) and the mother liquor evaporated to dryness.
8.6.27.4 Sodium methoxide:
An aliquot of dry resin 287 (13 mg) was suspended in DMF. A solution of 1 M 
sodium methoxide in H2O/dioxane (1:3) (0.3 mL) was added. The suspension was 
agitated on a 360° blood rotator at room temperature for 1 h. The resin was filtered, 
washed with MeOH and the mother liquor evaporated to dryness.
8.6.27.5 Sodium hydroxide:
A solution of 1 M sodium hydroxide/dioxane (1:3) was cooled to 0 °C in an 
ice/water bath. An aliquot of dry resin 287 (11 mg) was added and the resulting 
suspension was agitated on a 360° blood rotator at room temperature for 1 h. The 
resin was filtered into a flask containing 1 M HC1 (0.2 mL), washed with water and 
the mother liquor evaporated to dryness.
HPLC procedures and conditions: The residues were diluted with 
acetonitrile/water (50:50) (5 mL) and analysed using reverse phase HPLC. Using 
equipment according to Section 8.2.8 with isocratic elutions according to Table 11.
180




Methanolic ammonia Benzamide H2O/CH3CN
TFA (7:3:0.01)
4.7





Diisopropylethylamine/MeOH Methyl benzoate H2O/CH3CN
TFA (1:1:0.01)
7.2.
Sodium methoxide Methyl benzoate H2O/CH3 CN 
TFA (1:1:0.01)
7.2
Sodium hydroxide Benzoic acid H2O/CH3 CN
TFA (7:3:0.01)
7.9




General procedure 8.6.25 was followed with 284 (assume 0.2 mmol g" , 0.50 g, 
0.10 mmol), formaldehyde (37% solution in H2O/MeOH) (0.02 mL, 0.02 g, 0.8 
mmol), triethylamine (0.04 mL, 0.03 g, 0.3 mmol) in acetonitrile (5 mL) to afford the 
title compound as pale brown beads (65 ^mol g" 1 loading from basic cleavage (1 M 
NaOH/Dioxane 3:2), Lmax= 189 ^rniol g" 1 , 34% loading).
umax (KBr disc)/ cm' 1 2922, 2869 (sat. CH), 1731 (CO, ester), 1662 (CO, amide I), 
1604 (CH, aryl), 1557 (CO, amide II). 6H (MAS-NMR; CDC13 ; 600 MHz) 7.05 






General procedure 8.6.25 was followed with 285 (assume 0.2 mmol g" 1 , 0.4 g, 
0.08 mmol), formaldehyde (37% solution in H2O/MeOH) (0.02 mL, 0.02 g, 0.6 
mmol), triethylamine (0.03 mL, 0.02 g, 0.3 mmol) in acetonitrile (5 mL) to afford the 
title compound as pale brown beads.
umax (KBr disc)/ cm' 1 2920, 2870 (sat. CH), 1745 (CO, ester), 1660 (CO, amide I), 
1600 (CH, aryl), 1555 (CO, amide II). 8H (MAS-NMR; CDC13 ; 600 MHz) 6.75 




General procedure 8.6.25 was followed with 286 (assume 0.2 mmol g" 1 , 0.78 g, 
0.15 mmol), formaldehyde (37% solution in H2O/MeOH) (0.03 mL, 0.04 g, 1 mmol), 
triethylamine (0.06 mL, 0.05 g, 0.5 mmol) in acetonitrile (5 mL) to afford the title 
compound as pale brown beads.
umax (KBr disc)/ cm' 1 2922, 2870 (sat. CH), 1740 (CO, ester), 1660 (CO, amide I), 
1600 (CH, aryl), 1554 (CO, amide II). 8H (MAS-NMR; CDC13 ; 600 MHz) 2.51 







General procedure 8.6.25 was followed with 281 (assume 1.23 mmol g" 1 , 1.79 
g, 2.20 mmol), 171 (2.56 g, 11.0 mmol), triethylamine (0.92 mL, 0.67 g, 6.6 mmol) 
in acetonitrile (5 mL) to afford the title compound as brown beads. 
umax (KBr disc)/ cm"1 3059, 3023 (CH, aryl), 2921, 2850 (sat. CH), 1731 (CO, ester 
and urethane), 1644 (CO, amide I), 1539 (CO, amide II). 8H (MAS-NMR; CDC13 ; 
600 MHz) 2.88 (C/fcPh), 4.32 (C//CH2Ph), 4.54 (CH2CH=), 5.06 (CH2=), 5.75 







General procedure 8.6.25 was followed with 282 (assume 1.19 mmol g" 1 , 0.53 
g, 0.63 mmol), (5)-171 (1.47 g, 6.31 mmol), triethylamine (0.27 mL, 0.19 g, 1.9 
mmol) in acetonitrile (10 mL) to obtain the title compound as pale brown beads.
umax (KBr disc)/ cm' 1 3021 (CH, aryl), 2925 (sat. CH), 1718 (CO, ester and 
urethane), 1644 (CO, amide I), 1603 (CH, aryl), 1510 (CO, amide II).




General procedure 8.6.25 was followed with 283 (assume 1.19 mmol g" 1 , 0.47 
g, 0.56 mmol), (S)-lll (1.29 g, 5.56 mmol), triethylamine (0.23 mL, 0.16 g, 1.7 
mmol) in acetonitrile (10 mL) to obtain the title compound as pale brown beads.
VW (KBr disc)/ cm' 1 3022 (CH, aryl), 2924 (sat. CH), 1718 (CO, ester and 




General procedure 8.6.25 was followed with 284 (assume 0.2 mmol g" 1 , 0.093 
g, 19 fimol), (5)-171 (0.035 g, 0.15 mmol), triethylamine (8.0 uL, 6.0 mg, 56 umol) 
in acetonitrile (5 mL) to obtain the title compound as a pale brown gel. 
umax (KBr disc)/ cm' 1 3016 (CH, aryl), 1725 (CO, ester and urethane), 1650 (CO, 
amide I), 1520 (CO, amide II). 5H (MAS-NMR; CDC13 ; 600 MHz) 5.56, 5.37, 5.34, 
5.22, 5.20, 5.07, 4.92, 4.24 (various peaks corresponding to C//2=, CH=, CHN and 







General procedure 8.6.25 was followed with 285 (assume 0.2 mmol g" 1 , 1.1 g, 
0.23 mmol), (5)-171 (0.27 g, 1.1 mmol), triethylamine (90 j^L, 69 mg, 0.69 mmol) in 
acetonitrile (25 mL) to obtain the title compound as a pale brown gel. 
umax (KBr disc)/ cm' 1 2919 (sat. CH), 1700 (CO ester and urethane), 1646 (broad CO, 
amide I), 1540 (CO, amide II). 6H (MAS-NMR; CDC13 ; 600 MHz) 4.24 (C//2CH=), 
4.73 (C//N), 5.15 (CH2=), 5.75 (CH=), 6.92 (CM)), 7.02-7.45 (CHarom x 10), 7.50- 





General procedure 8.6.25 was followed with 286 (assume 0.2 mmol g" 1 , 1.14 g, 
230 jLimol), (5)-171 (270 mg, 1.14 mmol), triethylamine (90 jiL, 69 mg, 0.68 mmol) 
in acetonitrile (25 mL) to obtain the title compound as a pale brown gel. 
umax (KBr disc)/ cm'1 3021 (CH, aryl), 1720 (CO, ester and urethane), 1635 (CO, 
amide I), 1505 (CO, amide II); 8H (MAS-NMR; CDC13 ; 600 MHz) 4.00 (C#2CH=), 
5.30 (C//2=), 5.83 (C//=), 7.40-8.06 (CHbt).
8.6.37 Enzymatic studies on PEGA 1soa-bound benzotriazole substrates
8.6.37.1 Screening of enzymes for hydrolysis of PEGAj goo-bound benzotriazole 
substrates 288-290 and 295-297.
Hydrolysis experiments were carried out in plastic isolute tubes fitted with a 
plastic cap and tip. To an aliquot of the PEGAi 90o-bound benzotriazole substrate, 
288-290 and 295-297 (-500 mg = 50 mg dry) was added the enzyme (-0.8 mg) in 
potassium phosphate buffer pH 7.5 (10 mM)/acetonitrile (9:1) (1 mL). The 
suspensions were rotated for 16 h at room temperature on a 360° blood rotator. The 
suspensions were filtered, washed with -10 mL acetonitrile/water (1:1) and 
concentrated. The resulting residues were dissolved in acetonitrile/water (1:1) (2
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mL) for analysis by reverse-phase HPLC. The control experiment contained all 
reagents except the enzyme. Control and enzyme hydrolyses were repeated with all 
substrates.
Base cleavage: To an aliquot of the PEGAi 900-bound benzotriazole substrate, 288- 
290 and 295-297 (-500 mg = 50 mg dry) was added 7 M ammonia in methanol (1 
mL). The suspensions were rotated for 16 h at room temperature on a 360° blood 
rotator. The suspensions were filtered, washed with -10 mL acetonitrile/water (1:1) 
and concentrated. The resulting residues were dissolved in acetonitrile/water (1:1) (2 
mL) for analysis by reverse-phase HPLC. The control experiment contained all 
reagents except ammonia. Control and base hydrolyses were repeated with all 
substrates.
HPLC conditions: Using equipment according to Section 8.2.9 with an isocratic 
method eluting with H2O/CH3 CN/TFA (7:3:0.01).

















Table 12: Specificity of HPLC method for substrates 288-290 and 295-297..
8.6.37.2 Determination of enantiomeric excess of 171 for enzymatic cleavage of
296.
To an aliquot of 296 (2.70 g = 270 mg dry) was added a solution of the enzyme (0.8 
mg in potassium phosphate buffer pH 7.5 (10 mM)/acetonitrile (9:1)) (1 mL). The 
suspensions were rotated for 16 h at room temperature on a 360° blood rotator. The 
suspensions were filtered, washed with -10 mL acetonitrile/water (1:1) and
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concentrated. The resulting residues were reduced according to Section 8.3.18 and 
the resulting alcohol 174 was dissolved in wo-propanol/hexane (1:1) (2 mL) for 
analysis by chiral normal phase HPLC. The control experiment contained all 
reagents except the enzyme.
Normal phase chiral HPLC conditions: Using equipment according to Section 
8.2.9 with a Chiracel OD-H column with a gradient elution at 10 °C. The gradient 





























propyl)-1H-benzotriazole]-carboxyamino-long chain am/no propyl CPG 
301
General procedure 8.6.25 was followed with 300 (assume 77.5 mmol g" 1 , 3.8 g, 
0.29 mmol), (S)-lll (0.34 g, 1.5 mmol), triethylamine (0.12 mL, 90 mg, 0.88 mmol) 
in acetonitrile (100 mL) to yield the desired compound as pale brown beads (40 jumol
" 1
g", 53% as calculated from elemental analysis).
IW (KBr disc)/ cm' 1 3019 (CH, aryl), 1725 (CO, urethane and ester), 1641 (CO, 
amide I).
8.7 Preparation of safety catch linker
8.7.1 5-Phenylacetylamino-pentanoic acid 323
O O
To a solution of 2-aminovaleric acid (2.0 g, 17 mmol) in 4 M sodium hydroxide 
(3.1 mL) was added in eight portions, phenylacyl chloride (2.6 g, 2.2 mL, 17 mmol) 
in 4 M sodium hydroxide (3.1 mL) at 0 °C, with a few minutes between each
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addition. The reaction mixture was stirred for 15 min, allowed to stand at room 
temperature for 2 h. The reaction mixture was extracted with diethyl ether and the 
aqueous layer was acidified with concentrated HC1 (1 mL). The precipitate that 
formed was removed by filtration, washed with hexane and dried in vacuo to give the 
desired product as a white solid (2.0 g, 50%).
Mpt 65.5-72.0 °C; Rf 0.18 [methanol/chloroform (2:1)]; umax (nujol)/ cm' 1 3295 (OH, 
H-bonded), 1689 (CO, carboxylic acid), 1630 (CO, amide I), 1541 (CO, amide II); 
5H (CDC13 ; 250 MHz) 1.46-1.64 (4H, overlapping tt, J=6.6, 6.6 Hz, NHCH2C//2 and 
C//2CH2CO), 2.34 (2H, t, .7=6.9 Hz, C//2CO) 3.23 (2H, dt, J=6.6, 6.1 Hz, C//2NH), 
3.61 (2H, C#2Ph), 7.25-7.38 (5H, m, Ph); 8C (CDC13 ; 63 MHz) 21.5 (CH2), 28.6 
(CH2), 33.2 (CH2), 39.0 (CH2), 43.5 (CH2), 127.3 (CHarom), 128.9 (CHarom x 2), 129.4 
(CHarom x 2), 133.3 (Q, 171.6 (C=Oamide), 178.8 (OOacid); m/z (ES-MS; -ve), 234 
(100%, M-H-); FAB-MS, Found: MH+ 236.1289, Ci 3H 18NO3 requires MH+ 
236.1286.
8.7.2 5-Phenylacetylamino-pentanoyl chloride 324
O O 
To a solution of 323 (5.0 g, 21 mmol) in anhydrous dichloromethane (50 mL)
was added oxalyl chloride (3.2 g, 2.2 mL, 25 mmol), followed by catalytic 
dimethylformamide (1 drop). The reaction was allowed to stir at room temperature 
for 1 h, evaporated to remove any excess oxalyl chloride, to provide the crude 
product as a moisture sensitive colourless oil (1.6 g, 30%). 






General procedure 8.6.16.1 was carried out using 220 (assume 0.2 mmol g" 1 , 
0.66 g, 0.13 mmol), 324 (0.34 g, 1.3 mmol) and triethylamine (0.18 mL, 0.13 g, 1.3 
mmol) in anhydrous dichloromethane (5 mL).
umax (KBr disc)/ cm' 1 2985 (sat. CH), 1720 (CO, JV-acyl), 1650 (CO, amide I), 1602 




General procedure 8.6.25 was followed with 325 (assume 0.2 mmol g" 1 , 0.39 g, 
0.078 mmol), (5)-171 (0.091 g, 0.39 mmol), triethylamine (0.03 mL, 0.02 g, 0.2 
mmol) in acetonitrile (5 mL) to obtain the title compound as a pale brown gel.
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omax (KBr disc)/ cm'1 3020 (CH, aryl), 2923 (sat. CH), 1740 (CO, ester and 
urethane), 1646 (CO, amide I), 1600 (CH, aryl), 1515 (CO, amide II). 6H (MAS- 
NMR; CDC13 ; 600 MHz) 1.90 (CH2), 4.24 (C//2CH=), 6.10 (CH=), 6.85 (CM)), 
7.02-7.45 (C//arom x 10), 7.50-8.32 (C#bt x 3).
8.8 Solid phase synthesis of peptide aldehydes
8.8. 1 General procedure for solid phase Alloc removal
Borane-dimethylamine complex (6eq.) was added to Alloc-protected resin 
(leq.) in anhydrous dichloromethane under agitation, followed a few minutes later, 
by tetraA:/Xtriprienylphosphine)palladium (0) (10 mol%). After 10 min, at room 
temperature, the suspension was drained and washed with dichloromethane. The 
deprotection procedure was repeated until the Kaiser test 8.2.5.1 gave a blue 
solution. The resin was washed successively with dichloromethane/trifluoroacetic 





General procedure 8.8.1 was followed using 234 (assume 1.23 mmol g" 1 , 0.16 g, 
0.20 mmol), tetra>hXtriphenylphosphine)palladium (0) (0.02 g, 0.02 mmol) and 
borane-dimethyl amine complex (70 mg, 1.2 mmol) in dichloromethane (3 mL). The 
deprotection procedure was repeated to give the title compound as brown beads. 
umax (KBr disc)/ cm'1 3059 (CH, aryl), 1650 (CO, amide I).
8.8.3 General procedure for peptide coupling
Fmoc-amino acid (5eq.) was dissolved in dimethylformamide and 
diisopropylethylamine (8eq.) was added with stirring. The pre-mixed 0.45 M 
HBTU/HOBt reagent (8.8.4) (5eq.) was then added with stirring and the activated 
amino acid solution was transferred to the reaction vessel containing the resin (leq.). 
The suspension was agitated on a blood rotator for ~4 h at room temperature. The 
resin was filtered and washed with dimethylformamide and dichloromethane. 
Coupling was complete when a straw brown colour was observed under Kaiser 
conditions 8.2.5.1. The coupling procedure was repeated, if necessary.
8.8.4 Preparation of 0.45M HBTU/HOBt solution
HBTU (9.4 g) was added to a solution of HOBt (3.4 g) in dimethylformamide 
(50 mL). The mixture was stored at 4 °C for up to 2 months.
8.8.5 General procedure for Fmoc deprotection
A sample of washed resin was treated with 20% piperidine in 
dimethylformamide, over a period of 30 min. The reaction mixture was drained and 
washed with dimethylformamide and dichloromethane. Complete deprotection was 
achieved when a blue colour was observed using the Kaiser test 8.2.5.1. The 




Attempted sythesis of tetrapeptide bound to 1-[1-({2S}-amino-1- 
benzylamino-3-phenyl-propyl)-1H-benzotriazole]-carboxyamino- 
polystyrene 249
General procedure 8.8.1 was followed using 233 (assume 1.23 mmol g" 1 , 0.50 g, 
0.62 mmol), tetraA:w(triphenylphosphine)palladium (0) (0.07 g, 0.06 mmol) and 
borane-dimethyl amine complex (0.22 g, 3.7 mmol) in dichloromethane (10 mL). 
The deprotection procedure was repeated to give the title compound as brown beads. 
General procedure 8.8.3 was followed using G$)-Fmoc-Pro-OH (1.04 g, 3.07 mmol), 
free amine resin (0.50 g, 0.62 mmol), 0.45 M HBTU/HOBt (6.8 mL, 3.1 mmol) and 
diisopropylethylamine (0.86 mL, 4.9 mmol) to obtain the Fmoc-Pro-coupled peptide 
(0.38 mmol g" 1 , Lmax = 0.65 mmol g" 1 , 58% loading by Fmoc analysis 8.2.6.1). The 
Fmoc group was removed using general procedure 8.8.5 and (*S)-Fmoc-Ala-OH (1.01 
g, 3.07 mmol) was coupled by repeating procedure 8.8.3 using similar quantities of 
reagents. The final amino acid was coupled by removal of the Fmoc group (Section 
8.8.5) and addition of (5)-Fmoc-Pro-OH (0.54 g, 1.6 mmol) as described before 
8.8.3. The polymer-bound tetra-peptide was washed exhaustively with 
dimethylformamide and dichloromethane and dried in vacuo. 0.16 mmol g' 1 loading 
by Fmoc analysis 8.2.6.1, Lmax = 0.58 mmol g" 1 , 27% loading. 
umax (KBr disc)/ cm' 1 3080, 3058, 3023 (CH, aryl), 2921, 2851 (sat. CH), 1714 (CO 
urethane). 1651 (CO, amide I), 1600 (CH, aryl),1515 (CO, amide II). 6 H (MAS- 
NMR; CDC13 ; 600 MHz) 7.63 (C//bt), 7.74 (C//bt), 5.78 (NC//N), 4.20-4.60 (broad 
unresolved, CHC//CH2 , OCH 2 , various CH from proline and alanine)
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An aliquot of resin 249 (3.5 mg) was cleaved under acidic conditions 8.2.7.1. The 
residue obtained was dissolved in acetonitrile/water (1:1) (5 mL) and electrospray 
mass spectrometry as described in sections 8.2.9 and 8.2.8. No peak corresponding 
to the peptide aldehyde was evident in the electrospray mass spectrometry.
8.8.7 Tetrapeptide bound to 1-[1-({2S}-amino-1-phenylacetylamino-3-phenyl- 
propyl)-1H-benzotriazole]-carboxyamino-polystyrene 250
General procedure 8.8.3 was followed using (5)-Fmoc-Pro-OH (0.33 g, 0.98 
mmol), 246 (0.16 g, 0.19 mmol), 0.45 M HBTU/HOBt (2.2 mL, 0.98 mmol) and 
diisopropylethylamine (0.27 mL, 1.57 mmol) to obtain the Fmoc-Pro-OH coupled 
peptide. The Fmoc group was removed using general procedure 8.8.5 and (S)-Fmoc- 
Ala-OH (0.32 g, 0.98 mmol) was coupled by repeating procedure 8.8.3. The final 
amino acid was coupled by removal of the Fmoc group 8.8.5 and addition of (S)- 
Fmoc-Pro-OH (0.33 g, 0.98 mmol) as before 8.8.3. The polymer-bound tetra-peptide 
was washed exhaustively with dimethylformamide and dichloromethane and dried in 
vacuo. (0.28 mmol g" 1 by Fmoc analysis 8.2.6.1, Lmax= 0.58 mmol g" 1 , 48% loading). 
6H (MAS-NMR; CDC13 ; 600 MHz) 7.61 (C//bt), 7.73 (C//bt), 5.97 (NCflN), 4.20- 
4.60 (broad unresolved, CHC//CH2 , OC//2, various C//from proline and alanine.
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An aliquot of resin 250 (5 mg) was cleaved under acidic conditions 8.2.7.1. The 
residue obtained was dissolved in acetonitrile/water (1:1) and analysed by LC-MS as 
described in section 8.2.8.
m/z (LC-MS; +ve) 637 (40%, MH+, Rt = 26.0 min), 675 (5%, MNa+). A second 
acidic cleavage showed no presence of further cleavage indicating complete 
cleavage.
8.8.8 Tetrapeptide bound to 1-[1-({2S}-amino-1-benzylamino-3-phenyl-propyl)- 
1 H-benzotriazole]-aminocarboxy-polystyrene 256
General procedure 8.8.1 was followed using 255 (assume 1.24 mmol g" 1 , 0.53 g, 
0.65 mmol), tetraA2s(triphenylphosphine)palladium (0) (0.07 g, 0.06 mmol) and 
borane-dimethyl amine complex (0.23 g, 3.9 mmol) in dichloromethane (5 mL). The 
deprotection procedure was repeated another twice to give the title compound as 
brown beads. General procedure 8.8.3 was followed using C$)-Fmoc-Pro-OH (0.83 
g, 2.4 mmol), free amine resin (0.5 g, 0.6 mmol), 0.45 M HBTU/HOBt (5.4 mL, 2.4 
mmol) and diisopropylethylamine (0.75 mL, 4.3 mmol) to obtain the Fmoc-Pro- 
coupled peptide. The Fmoc group was removed using general procedure 8.8.5 and 
(iS)-Fmoc-Ala-OH (0.81 g, 2.4 mmol) was coupled by repeating procedure 8.8.3 
using similar quantities of reagents. The final amino acid was coupled by removal of 
the Fmoc group 8.8.5 and addition of Fmoc-Pro-OH (0.83 g, 2.4 mmol) as described 
before 8.8.3. The polymer-bound tetra-peptide was washed exhaustively with
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dimethylformamide and dichloromethane and dried in vacua. (91 jamol g" 1 by Fmoc 
analysis 8.2.6.1,1^= 0.60 mmol g' 1 , 15% loading).
An aliquot of resin 256 (3.5 mg) was cleaved under acidic conditions 8.2.7.1. The 
residue obtained was dissolved in acetonitrile/water (1:1) and analysed by ES-MS as 
described in section 8.2.8. 
m/z (ES-MS; +ve) 659 (100%, MNa+), 677 (50%, M+CH3CN+).
8.8.9 Tetrapeptide bound to 1-[1~({2S}-amino-1-benzyloxycarbonyl'3-phenyl- 
propyl)-1 H-benzotriazole]-carboxyamino-polystyrene 328
General procedure 8.8.1 was followed using 293 (assume 1.23 mmol g" 1 , 0.26 g, 
0.32 mmol), tetra&/s(triphenylphosphine)palladium (0) (0.04 g, 0.03 mmol) and 
borane-dimethyl amine complex (0.11 g, 1.9 mmol) in dichloromethane (10 mL). 
The deprotection procedure was repeated to give the title compound as brown beads. 
General procedure 8.8.3 was followed using (5)-Fmoc-Pro-OH (0.54 g, 1.6 mmol), 
free amine resin (0.26 g, 0.32 mmol), 0.45 M HBTU/HOBt (3.5 mL, 1.6 mmol) and 
diisopropylethylamine (0.45 mL, 2.6 mmol) to obtain the Fmoc-Pro-coupled peptide 
(0.38 mmol g" 1 , Lmax = 0.65 mmol g" 1 , 58% loading by Fmoc analysis 8.2.6.1) . The 
Fmoc group was removed using general procedure 8.8.5 and Fmoc-Ala-OH (0.53 g, 
1.6 mmol) was coupled by repeating procedure 8.8.3 using similar quantities of 
reagents. The final amino acid was coupled by removal of the Fmoc group 8.8.5 and 
addition of Fmoc-Pro-OH (0.54 g, 1.6 mmol) as described before 8.8.3. The
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polymer-bound tetra-peptide was washed exhaustively with dimethylformamide and 
dichloromethane and dried in vacuo. (0.38 mmol g" 1 loading by Fmoc analysis 
8.2.6.1,Lmax= 0.58 mmol g' 1 , 65% loading).
omax (KBr disc)/ cm' 1 3058, 3023 (CH, aryl), 2922 (sat. CH), 1730 (CO ester and 
urethane). 1652 (CO, amide I), 1520 (CO, amide II).
An aliquot of resin 328 (3.5 mg) was cleaved under basic conditions 8.2.7.1 using
1 M NaOH/Dioxane (1:3). The residue obtained was dissolved in acetonitrile/water
(1:1) (5 mL) in volumetric flask and analysed by reversed phase HPLC
(CH3CN/H2O/TFA 30:70:0.01; 21 °C) as described in section 8.2.9.
RP-HPLC; Rt = 7.4 min, benzoic acid; Rt = 9.0 min, peptide aldehyde (product
collected and identity confirmed by ES-MS)
m/z (ES-MS; +ve) 637 (60%, MH+), 659 (100%, MNa+), 675 (5%, MK+).
Basic cleavage 8.2.7.2 was repeated however no cleavage products were detected
8.8.10 Dipeptide bound to racemic 1-[1-(amino-1-benzylamino-3-phenyl-propyl)- 
1H-benzotriazole]-carboxyamino-polystyrene 251
General procedure 8.6.10 was followed using (R/S)-113 (1.8 g, 7.8 mmol, 5eq.), 
benzamide (0.94 g, 7.8 mmol, 5eq.), ^-toluene sulfonic acid (70 mg, 0.39 mmol) and 
218 (assume 1.23 mmol g" 1 , 1.27 g, 1.56 mmol, leq.) in anhydrous toluene (50 mL). 
The resin was filtered and washed exhaustively with dichloromethane and 
dimethylformamide before carrying out the next step. General procedure 8.8.1 was
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followed by reacting the diastereomeric resin (assume 1.23 mmol g" 1 , 0.28 g, 0.34 
mmol) with tetra>b5(triphenylphosphine)palladium (0) (40 mg, 0.034 mmol) and 
borane-dimethyl amine complex (0.12 g, 2.0 mmol) in dichloromethane (3.5 mL). 
The deprotection procedure was repeated to give the title compound as brown beads. 
General procedure 8.8.3 was followed using (S)-Fmoc-Pro-OH (0.58 g, 1.7 mmol), 
free amine resin (0.28 g, 0.34 mmol), 0.45 M HBTU/HOBt (3.8 mL, 1.7 mmol) and 
diisopropylethylamine (0.47 mL, 2.7 mmol) to obtain the title compound (209 jamol 
g" 1 , Lmax=0.59 mmol g' 1 , 35% loading)
An aliquot of resin 251 (30 mg) was cleaved under acidic conditions 8.2.7.1. The 
residue obtained was dissolved in acetonitrile/water (1:1) (2 mL) and analysed by 
electrospray mass spectrometry as described in Section 8.2.8. m/z (ES-MS; +ve) 491 
(70%, MNa+), 572 (100%, M+104+), 612 (45%, M+1444"). Purification of the residue 
was attempted to remove the unexpected mass ions at 572 and 612 m/z. Semi- 
preparative TLC was carried out on an aluminium backed TLC place eluting with 1:1 
ethylactate/hexane, which revealed the products; Rf 0.71, 0.33 and baseline product. 
The desired product at Rf = 0.33 was collected and freeze dried before being 
analysed by electrospray mass spectrometry and high resolution ] H NMR. m/z (ES- 
MS; +ve) 491 (70%, MNa+), 572 (100%, M+104+), 612 (45%, M+144+), 693 (15%, 




8.8.11 Tetrapeptide bound to 1-[1-({2S}-amino- 1-benzyloxycarbonyl-3-phenyl- 
propyl)-1H-benzotriazole]-carboxyamino-macroporous polystyrene 329
General procedure 8.8.1 was followed using !-[!-({2S}- 
allyloxycarbonylamino-1 -benzyloxycarbonyl-3-phenyl-propyl)- 17/-benzotriazole]- 
carboxyamino-macroporous polystyrene (assume 1.19 mmol g" 1 , 480 mg, 580 j^mol), 
tetraAw(triphenylphosphine)palladium (0) (0.07 g, 0.06 mmol) and borane-dimethyl 
amine complex (0.20 g, 3.5 mmol) in dichloromethane (10 mL). The deprotection 
procedure was repeated to give the title compound as pale brown beads. General 
procedure 8.8.3 was followed using (^-Fmoc-Pro-OH (0.99 g, 2.9 mmol), free 
amine resin (0.48 g, 0.58 mmol), 0.45 M HBTU/HOBt (6.5 mL, 2.9 mmol) and 
diisopropylethylamine (0.82 mL, 4.7 mmol) to obtain the Fmoc-Pro-coupled peptide. 
The Fmoc group was removed using general procedure 8.8.5 and Fmoc-Ala-OH 
(0.97 g, 2.95 mmol) was coupled by repeating procedure 8.8.3 using similar 
quantities of reagents. The final amino acid was coupled by removal of the Fmoc 
group 8.8.5 and addition of Fmoc-Pro-OH (0.99 g, 2.9 mmol) as described in section 
8.8.3. The polymer-bound tetra-peptide was washed exhaustively with 
dimethylformamide and dichloromethane and dried in vacuo. (0.20 mmol g" 1 loading 
by Fmoc analysis 8.2.6.1, Lmax= 0.58 mmol g" 1 , 35% loading).
umax (KBr disc)/ cm' 1 3020 (CH, aryl), 2925 (sat. CH), 1718 (CO, ester and 




Dipeptide bound to 1-[1-({2S}-amino-1-phenylacetyloxycarbonyl-3~phenyl- 
propyl)-1H-benzotriazole]-carboxyamino-macroporous polystyrene 330
General procedure 8.8.1 was followed using 1-[1-({2S}- 
allyloxycarbonylamino-1 -phenylacetyloxycarbonyl-3-phenyl-propyl)- \H- 
benzotriazolej-carboxyamino-macroporous polystyrene (assume 1.19 mmol g" 1 , 0.43 
g, 0.51 mmol), tetraA:w(triphenylphosphine)palladium (0) (0.06 g, 0.05 mmol) and 
borane-dimethyl amine complex (0.18 g, 3.1 mmol) in dichloromethane (7 mL). The 
deprotection procedure was repeated to give the title compound as pale brown beads. 
General procedure 8.8.3 was followed using (^-Fmoc-Pro-OH (0.80 g, 2.4 mmol), 
free amine resin (0.40 g, 0.47 mmol), 0.45 M HBTU/HOBt (5.2 mL, 2.4 mmol) and 
diisopropyl ethylamine (0.66 mL, 3.8 mmol) to obtain the Fmoc-Pro-coupled 
peptide. The polymer-bound dipeptide was washed exhaustively with 
dimethylformamide and dichloromethane and dried in vacuo. (0.14 mmol g" 1 loading 
by Fmoc analysis 8.2.6.1,1 = 0.63 mmol g" 1 , 22% loading). 
umax (KBr disc)/ cm' 1 3020 (CH, aryl), 1720 (CO urethane and ester). 1642 (CO, 
amide I), 1510 (CO, amide II).
202
Appendix
























leukocyte antigen receptor 
phosphatase
Chymotrypsin
leukocyte antigen receptor 
PTP
Chymotrypsin




































































Most of the material 







FRET based assay, 
cleavage observed30
FRET based assay, 
cleavage observed30
FRET based 





screening of peptide 
libraries. <10% 
cleavage31























































































































































































































































































































CPG (pore size lOOnm)
CPG (pore size lOOnm)
CPG (pore size lOOnm)
CPG (pore size lOOnm)




















































Appendix B: Space filled molecular model illustrating Penicillin G within
the active site of penicillin acylase.
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Appendix D: Molecular model depicting possible favourable 




Appendix E: Molecular model of (R,S)~linker 296 showing possible 
important interactions with the active site.
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Appendix G: Space-filled molecular model of (R,S)-linker 296 in active
site of penicillin acylase.
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Appendix H: Chem3D model of the two diastereomers of linker 296. [(S, 
S)~diastereomer = red; (R,S)-diastereomer = yellow]
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